id	sid	tid	token	lemma	pos
aji-39	1	1	_	_	PUNCT
aji-39	2	1	_	_	PUNCT
aji-39	3	1	_	_	PUNCT
aji-39	4	1	_	_	PUNCT
aji-39	5	1	_	_	PUNCT
aji-39	6	1	_	_	PUNCT
aji-39	7	1	_	_	PUNCT
aji-39	8	1	_	_	PUNCT
aji-39	9	1	_	_	PUNCT
aji-39	10	1	_	_	PUNCT
aji-39	11	1	_	_	PUNCT
aji-39	12	1	_	_	PUNCT
aji-39	13	1	_	_	PUNCT
aji-39	14	1	_	_	PUNCT
aji-39	15	1	_	_	PUNCT
aji-39	16	1	_	_	PUNCT
aji-39	17	1	_	_	PUNCT
aji-39	18	1	_	_	PUNCT
aji-39	19	1	_	_	PUNCT
aji-39	20	1	_	_	PUNCT
aji-39	21	1	_	_	PUNCT
aji-39	22	1	_	_	PUNCT
aji-39	23	1	_	_	PUNCT
aji-39	24	1	_	_	PUNCT
aji-39	25	1	_	_	PUNCT
aji-39	26	1	_	_	PUNCT
aji-39	27	1	_	_	PUNCT
aji-39	28	1	_	_	PUNCT
aji-39	29	1	_	_	PUNCT
aji-39	30	1	_	_	PUNCT
aji-39	31	1	_	_	PUNCT
aji-39	32	1	_	_	PUNCT
aji-39	33	1	_	_	PUNCT
aji-39	34	1	_	_	PUNCT
aji-39	35	1	_	_	PUNCT
aji-39	36	1	_	_	PUNCT
aji-39	37	1	_	_	PUNCT
aji-39	38	1	_	_	PUNCT
aji-39	39	1	_	_	PUNCT
aji-39	40	1	_	_	PUNCT
aji-39	41	1	_	_	PUNCT
aji-39	42	1	_	_	PUNCT
aji-39	43	1	_	_	PUNCT
aji-39	44	1	_	_	PUNCT
aji-39	45	1	_	_	PUNCT
aji-39	46	1	_	_	PUNCT
aji-39	47	1	_	_	PUNCT
aji-39	48	1	_	_	PUNCT
aji-39	49	1	_	_	PUNCT
aji-39	50	1	_	_	PUNCT
aji-39	51	1	_	_	PUNCT
aji-39	52	1	_	_	PUNCT
aji-39	53	1	_	_	PUNCT
aji-39	54	1	_	_	PUNCT
aji-39	55	1	_	_	PUNCT
aji-39	56	1	_	_	PUNCT
aji-39	57	1	_	_	PUNCT
aji-39	58	1	_	_	PUNCT
aji-39	59	1	_	_	PUNCT
aji-39	60	1	_	_	PUNCT
aji-39	61	1	_	_	PUNCT
aji-39	62	1	_	_	PUNCT
aji-39	63	1	_	_	PUNCT
aji-39	64	1	_	_	PUNCT
aji-39	65	1	_	_	PUNCT
aji-39	66	1	_	_	PUNCT
aji-39	67	1	_	_	PUNCT
aji-39	68	1	_	_	PUNCT
aji-39	69	1	_	_	PUNCT
aji-39	70	1	_	_	PUNCT
aji-39	71	1	_	_	PUNCT
aji-39	72	1	_	_	PUNCT
aji-39	73	1	_	_	PUNCT
aji-39	74	1	_	_	PUNCT
aji-39	75	1	_	_	PUNCT
aji-39	76	1	_	_	PUNCT
aji-39	77	1	_	_	PUNCT
aji-39	78	1	_	_	PUNCT
aji-39	79	1	_	_	PUNCT
aji-39	80	1	_	_	PUNCT
aji-39	81	1	_	_	PUNCT
aji-39	82	1	_	_	PUNCT
aji-39	83	1	_	_	PUNCT
aji-39	84	1	_	_	PUNCT
aji-39	85	1	_	_	PUNCT
aji-39	86	1	_	_	PUNCT
aji-39	87	1	_	_	PUNCT
aji-39	88	1	_	_	PUNCT
aji-39	89	1	_	_	PUNCT
aji-39	90	1	_	_	PUNCT
aji-39	91	1	_	_	PUNCT
aji-39	92	1	_	_	PUNCT
aji-39	93	1	_	_	PUNCT
aji-39	94	1	_	_	PUNCT
aji-39	95	1	_	_	PUNCT
aji-39	96	1	_	_	PUNCT
aji-39	97	1	_	_	PUNCT
aji-39	98	1	_	_	PUNCT
aji-39	99	1	_	_	PUNCT
aji-39	100	1	_	_	PUNCT
aji-39	101	1	_	_	PUNCT
aji-39	102	1	*	*	PUNCT
aji-39	102	2	corresponding	correspond	VERB
aji-39	102	3	author	author	NOUN
aji-39	102	4	:	:	PUNCT
aji-39	102	5	e	e	NOUN
aji-39	102	6	-	-	NOUN
aji-39	102	7	mail	mail	NOUN
aji-39	102	8	:	:	PUNCT
aji-39	102	9	akeler@abuad.edu.ng	akeler@abuad.edu.ng	NOUN
aji-39	102	10	;	;	PUNCT
aji-39	102	11	asian	asian	ADJ
aji-39	102	12	journal	journal	NOUN
aji-39	102	13	of	of	ADP
aji-39	102	14	immunology	immunology	NOUN
aji-39	102	15	3(1	3(1	NUM
aji-39	102	16	):	):	PUNCT
aji-39	102	17	199	199	NUM
aji-39	102	18	-	-	SYM
aji-39	102	19	207	207	NUM
aji-39	102	20	,	,	PUNCT
aji-39	102	21	2020	2020	NUM
aji-39	102	22	;	;	PUNCT
aji-39	102	23	article	article	NOUN
aji-39	102	24	no.aji.57099	no.aji.57099	NOUN
aji-39	102	25	seroprevalence	seroprevalence	NOUN
aji-39	102	26	of	of	ADP
aji-39	102	27	rubella	rubella	NOUN
aji-39	102	28	igg	igg	PROPN
aji-39	102	29	and	and	CCONJ
aji-39	102	30	igm	igm	PROPN
aji-39	102	31	antibodies	antibody	NOUN
aji-39	102	32	among	among	ADP
aji-39	102	33	pregnant	pregnant	ADJ
aji-39	102	34	women	woman	NOUN
aji-39	102	35	attending	attend	VERB
aji-39	102	36	antenatal	antenatal	ADJ
aji-39	102	37	clinic	clinic	NOUN
aji-39	102	38	in	in	ADP
aji-39	102	39	federal	federal	ADJ
aji-39	102	40	teaching	teaching	NOUN
aji-39	102	41	hospital	hospital	NOUN
aji-39	102	42	ido	ido	PROPN
aji-39	102	43	-	-	PUNCT
aji-39	102	44	ekiti	ekiti	PROPN
aji-39	102	45	,	,	PUNCT
aji-39	102	46	nigeria	nigeria	PROPN
aji-39	102	47	richard	richard	PROPN
aji-39	102	48	yomi	yomi	PROPN
aji-39	102	49	akele1	akele1	PROPN
aji-39	102	50	*	*	PROPN
aji-39	102	51	,	,	PUNCT
aji-39	102	52	baget	baget	NOUN
aji-39	102	53	nerat	nerat	NOUN
aji-39	102	54	pam1	pam1	PROPN
aji-39	102	55	,	,	PUNCT
aji-39	102	56	bernard	bernard	PROPN
aji-39	102	57	oluwapelumi	oluwapelumi	PROPN
aji-39	102	58	oluboyo1	oluboyo1	PROPN
aji-39	102	59	,	,	PUNCT
aji-39	102	60	seyi	seyi	PROPN
aji-39	102	61	samson	samson	PROPN
aji-39	102	62	enitan2	enitan2	PROPN
aji-39	102	63	,	,	PUNCT
aji-39	102	64	janet	janet	PROPN
aji-39	102	65	funmilayo	funmilayo	PROPN
aji-39	102	66	akinseye1	akinseye1	PROPN
aji-39	102	67	and	and	CCONJ
aji-39	102	68	funmilayo	funmilayo	NOUN
aji-39	102	69	ajoke	ajoke	ADJ
aji-39	102	70	adewumi3	adewumi3	PROPN
aji-39	102	71	1	1	NUM
aji-39	102	72	department	department	NOUN
aji-39	102	73	of	of	ADP
aji-39	102	74	medical	medical	ADJ
aji-39	102	75	laboratory	laboratory	NOUN
aji-39	102	76	science	science	NOUN
aji-39	102	77	,	,	PUNCT
aji-39	102	78	college	college	NOUN
aji-39	102	79	of	of	ADP
aji-39	102	80	medicine	medicine	NOUN
aji-39	102	81	and	and	CCONJ
aji-39	102	82	health	health	NOUN
aji-39	102	83	science	science	NOUN
aji-39	102	84	,	,	PUNCT
aji-39	102	85	afe	afe	PROPN
aji-39	102	86	babalola	babalola	PROPN
aji-39	102	87	university	university	PROPN
aji-39	102	88	,	,	PUNCT
aji-39	102	89	ado	ado	NOUN
aji-39	102	90	-	-	PUNCT
aji-39	102	91	ekiti	ekiti	PROPN
aji-39	102	92	,	,	PUNCT
aji-39	102	93	nigeria	nigeria	PROPN
aji-39	102	94	.	.	PUNCT
aji-39	103	1	2	2	NUM
aji-39	103	2	department	department	NOUN
aji-39	103	3	of	of	ADP
aji-39	103	4	medical	medical	ADJ
aji-39	103	5	laboratory	laboratory	NOUN
aji-39	103	6	science	science	NOUN
aji-39	103	7	,	,	PUNCT
aji-39	103	8	babcock	babcock	PROPN
aji-39	103	9	university	university	PROPN
aji-39	103	10	,	,	PUNCT
aji-39	103	11	ilisan	ilisan	NOUN
aji-39	103	12	-	-	PUNCT
aji-39	103	13	remo	remo	NOUN
aji-39	103	14	,	,	PUNCT
aji-39	103	15	ogun	ogun	PROPN
aji-39	103	16	state	state	PROPN
aji-39	103	17	,	,	PUNCT
aji-39	103	18	nigeria	nigeria	PROPN
aji-39	103	19	.	.	PUNCT
aji-39	104	1	3	3	NUM
aji-39	104	2	department	department	NOUN
aji-39	104	3	of	of	ADP
aji-39	104	4	microbiology	microbiology	NOUN
aji-39	104	5	and	and	CCONJ
aji-39	104	6	parasitology	parasitology	NOUN
aji-39	104	7	,	,	PUNCT
aji-39	104	8	college	college	NOUN
aji-39	104	9	of	of	ADP
aji-39	104	10	medicine	medicine	NOUN
aji-39	104	11	,	,	PUNCT
aji-39	104	12	ekiti	ekiti	PROPN
aji-39	104	13	state	state	PROPN
aji-39	104	14	university	university	PROPN
aji-39	104	15	,	,	PUNCT
aji-39	104	16	ado	ado	NOUN
aji-39	104	17	-	-	PUNCT
aji-39	104	18	ekiti	ekiti	PROPN
aji-39	104	19	,	,	PUNCT
aji-39	104	20	nigeria	nigeria	PROPN
aji-39	104	21	.	.	PUNCT
aji-39	105	1	authors	author	NOUN
aji-39	105	2	’	'	PUNCT
aji-39	105	3	contributions	contribution	NOUN
aji-39	105	4	this	this	DET
aji-39	105	5	work	work	NOUN
aji-39	105	6	was	be	AUX
aji-39	105	7	carried	carry	VERB
aji-39	105	8	out	out	ADP
aji-39	105	9	in	in	ADP
aji-39	105	10	collaboration	collaboration	NOUN
aji-39	105	11	among	among	ADP
aji-39	105	12	all	all	DET
aji-39	105	13	authors	author	NOUN
aji-39	105	14	.	.	PUNCT
aji-39	106	1	authors	author	NOUN
aji-39	106	2	rya	rya	PROPN
aji-39	106	3	and	and	CCONJ
aji-39	106	4	bnp	bnp	PROPN
aji-39	106	5	designed	design	VERB
aji-39	106	6	the	the	DET
aji-39	106	7	study	study	NOUN
aji-39	106	8	,	,	PUNCT
aji-39	106	9	wrote	write	VERB
aji-39	106	10	the	the	DET
aji-39	106	11	protocol	protocol	NOUN
aji-39	106	12	,	,	PUNCT
aji-39	106	13	collected	collect	VERB
aji-39	106	14	data	datum	NOUN
aji-39	106	15	,	,	PUNCT
aji-39	106	16	performed	perform	VERB
aji-39	106	17	analysis	analysis	NOUN
aji-39	106	18	and	and	CCONJ
aji-39	106	19	wrote	write	VERB
aji-39	106	20	the	the	DET
aji-39	106	21	first	first	ADJ
aji-39	106	22	draft	draft	NOUN
aji-39	106	23	of	of	ADP
aji-39	106	24	the	the	DET
aji-39	106	25	manuscript	manuscript	NOUN
aji-39	106	26	.	.	PUNCT
aji-39	107	1	authors	author	NOUN
aji-39	107	2	boo	boo	VERB
aji-39	107	3	and	and	CCONJ
aji-39	107	4	sse	sse	PROPN
aji-39	107	5	performed	perform	VERB
aji-39	107	6	the	the	DET
aji-39	107	7	statistical	statistical	ADJ
aji-39	107	8	analysis	analysis	NOUN
aji-39	107	9	and	and	CCONJ
aji-39	107	10	restructured	restructure	VERB
aji-39	107	11	the	the	DET
aji-39	107	12	manuscript	manuscript	NOUN
aji-39	107	13	.	.	PUNCT
aji-39	108	1	authors	author	NOUN
aji-39	108	2	jfa	jfa	PROPN
aji-39	108	3	and	and	CCONJ
aji-39	108	4	faa	faa	PROPN
aji-39	108	5	managed	manage	VERB
aji-39	108	6	literature	literature	NOUN
aji-39	108	7	searches	search	NOUN
aji-39	108	8	.	.	PUNCT
aji-39	109	1	all	all	DET
aji-39	109	2	authors	author	NOUN
aji-39	109	3	read	read	VERB
aji-39	109	4	and	and	CCONJ
aji-39	109	5	approved	approve	VERB
aji-39	109	6	the	the	DET
aji-39	109	7	final	final	ADJ
aji-39	109	8	manuscript	manuscript	NOUN
aji-39	109	9	.	.	PUNCT
aji-39	110	1	article	article	NOUN
aji-39	110	2	information	information	PROPN
aji-39	110	3	editor(s	editor(s	PROPN
aji-39	110	4	):	):	PUNCT
aji-39	110	5	(	(	PUNCT
aji-39	110	6	1	1	X
aji-39	110	7	)	)	PUNCT
aji-39	110	8	dr	dr	PROPN
aji-39	110	9	.	.	PROPN
aji-39	110	10	darko	darko	PROPN
aji-39	110	11	nozic	nozic	PROPN
aji-39	110	12	,	,	PUNCT
aji-39	110	13	professor	professor	NOUN
aji-39	110	14	,	,	PUNCT
aji-39	110	15	university	university	PROPN
aji-39	110	16	of	of	ADP
aji-39	110	17	belgrade	belgrade	PROPN
aji-39	110	18	,	,	PUNCT
aji-39	110	19	serbia	serbia	PROPN
aji-39	110	20	.	.	PUNCT
aji-39	111	1	(	(	PUNCT
aji-39	111	2	2	2	X
aji-39	111	3	)	)	PUNCT
aji-39	111	4	dr	dr	PROPN
aji-39	111	5	.	.	PROPN
aji-39	111	6	jaffu	jaffu	PROPN
aji-39	111	7	othniel	othniel	PROPN
aji-39	111	8	chilongola	chilongola	PROPN
aji-39	111	9	,	,	PUNCT
aji-39	111	10	tumaini	tumaini	NOUN
aji-39	111	11	university	university	PROPN
aji-39	111	12	,	,	PUNCT
aji-39	111	13	tanzania	tanzania	PROPN
aji-39	111	14	.	.	PUNCT
aji-39	112	1	reviewers	reviewer	NOUN
aji-39	112	2	:	:	PUNCT
aji-39	112	3	(	(	PUNCT
aji-39	112	4	1	1	X
aji-39	112	5	)	)	PUNCT
aji-39	112	6	victor	victor	PROPN
aji-39	112	7	b.	b.	PROPN
aji-39	112	8	oti	oti	PROPN
aji-39	112	9	,	,	PUNCT
aji-39	112	10	nasarawa	nasarawa	PROPN
aji-39	112	11	state	state	PROPN
aji-39	112	12	university	university	PROPN
aji-39	112	13	,	,	PUNCT
aji-39	112	14	nigeria	nigeria	PROPN
aji-39	112	15	.	.	PUNCT
aji-39	113	1	(	(	PUNCT
aji-39	113	2	2	2	X
aji-39	113	3	)	)	PUNCT
aji-39	113	4	simeon	simeon	NOUN
aji-39	113	5	achunam	achunam	NOUN
aji-39	113	6	nwabueze	nwabueze	NOUN
aji-39	113	7	,	,	PUNCT
aji-39	113	8	namdi	namdi	PROPN
aji-39	113	9	azikiwe	azikiwe	PROPN
aji-39	113	10	university	university	PROPN
aji-39	113	11	,	,	PUNCT
aji-39	113	12	nigeria	nigeria	PROPN
aji-39	113	13	.	.	PUNCT
aji-39	114	1	complete	complete	ADJ
aji-39	114	2	peer	peer	NOUN
aji-39	114	3	review	review	NOUN
aji-39	114	4	history	history	NOUN
aji-39	114	5	:	:	PUNCT
aji-39	114	6	http://www.sdiarticle4.com/review-history/57099	http://www.sdiarticle4.com/review-history/57099	VERB
aji-39	114	7	received	receive	VERB
aji-39	114	8	22	22	NUM
aji-39	114	9	march	march	NOUN
aji-39	114	10	2020	2020	NUM
aji-39	114	11	accepted	accept	VERB
aji-39	114	12	29	29	NUM
aji-39	114	13	may	may	NOUN
aji-39	114	14	2020	2020	NUM
aji-39	114	15	published	publish	VERB
aji-39	114	16	04	04	NUM
aji-39	114	17	june	june	PROPN
aji-39	114	18	2020	2020	NUM
aji-39	114	19	abstract	abstract	ADJ
aji-39	114	20	aim	aim	NOUN
aji-39	114	21	:	:	PUNCT
aji-39	114	22	though	though	SCONJ
aji-39	114	23	rubella	rubella	NOUN
aji-39	114	24	is	be	AUX
aji-39	114	25	vaccine	vaccine	NOUN
aji-39	114	26	-	-	PUNCT
aji-39	114	27	preventable	preventable	ADJ
aji-39	114	28	and	and	CCONJ
aji-39	114	29	enlisted	enlist	VERB
aji-39	114	30	on	on	ADP
aji-39	114	31	the	the	DET
aji-39	114	32	expanded	expand	VERB
aji-39	114	33	program	program	NOUN
aji-39	114	34	on	on	ADP
aji-39	114	35	immunization	immunization	NOUN
aji-39	114	36	(	(	PUNCT
aji-39	114	37	epi	epi	NOUN
aji-39	114	38	)	)	PUNCT
aji-39	114	39	list	list	NOUN
aji-39	114	40	,	,	PUNCT
aji-39	114	41	vaccination	vaccination	NOUN
aji-39	114	42	and	and	CCONJ
aji-39	114	43	testing	testing	NOUN
aji-39	114	44	are	be	AUX
aji-39	114	45	not	not	PART
aji-39	114	46	routinely	routinely	ADV
aji-39	114	47	practiced	practice	VERB
aji-39	114	48	in	in	ADP
aji-39	114	49	ido	ido	PROPN
aji-39	114	50	-	-	PUNCT
aji-39	114	51	ekiti	ekiti	ADJ
aji-39	114	52	.	.	PUNCT
aji-39	115	1	there	there	PRON
aji-39	115	2	is	be	VERB
aji-39	115	3	also	also	ADV
aji-39	115	4	paucity	paucity	NOUN
aji-39	115	5	of	of	ADP
aji-39	115	6	epidemiological	epidemiological	ADJ
aji-39	115	7	data	datum	NOUN
aji-39	115	8	on	on	ADP
aji-39	115	9	the	the	DET
aji-39	115	10	prevalence	prevalence	NOUN
aji-39	115	11	of	of	ADP
aji-39	115	12	rubella	rubella	NOUN
aji-39	115	13	infection	infection	NOUN
aji-39	115	14	at	at	ADP
aji-39	115	15	ido	ido	NOUN
aji-39	115	16	-	-	PUNCT
aji-39	115	17	ekiti	ekiti	ADJ
aji-39	115	18	,	,	PUNCT
aji-39	115	19	hence	hence	ADV
aji-39	115	20	the	the	DET
aji-39	115	21	study	study	NOUN
aji-39	115	22	aimed	aim	VERB
aji-39	115	23	at	at	ADP
aji-39	115	24	carrying	carry	VERB
aji-39	115	25	out	out	ADP
aji-39	115	26	a	a	DET
aji-39	115	27	serosurvey	serosurvey	NOUN
aji-39	115	28	to	to	PART
aji-39	115	29	generate	generate	VERB
aji-39	115	30	epidemiological	epidemiological	ADJ
aji-39	115	31	data	datum	NOUN
aji-39	115	32	for	for	ADP
aji-39	115	33	this	this	DET
aji-39	115	34	location	location	NOUN
aji-39	115	35	.	.	PUNCT
aji-39	116	1	study	study	NOUN
aji-39	116	2	design	design	NOUN
aji-39	116	3	:	:	PUNCT
aji-39	116	4	this	this	PRON
aji-39	116	5	was	be	AUX
aji-39	116	6	a	a	DET
aji-39	116	7	cross	cross	ADJ
aji-39	116	8	-	-	ADJ
aji-39	116	9	sectional	sectional	ADJ
aji-39	116	10	study	study	NOUN
aji-39	116	11	.	.	PUNCT
aji-39	117	1	place	place	NOUN
aji-39	117	2	and	and	CCONJ
aji-39	117	3	duration	duration	NOUN
aji-39	117	4	of	of	ADP
aji-39	117	5	study	study	NOUN
aji-39	117	6	:	:	PUNCT
aji-39	117	7	the	the	DET
aji-39	117	8	study	study	NOUN
aji-39	117	9	was	be	AUX
aji-39	117	10	carried	carry	VERB
aji-39	117	11	out	out	ADP
aji-39	117	12	between	between	ADP
aji-39	117	13	october	october	PROPN
aji-39	117	14	2018	2018	NUM
aji-39	117	15	and	and	CCONJ
aji-39	117	16	january	january	PROPN
aji-39	117	17	2019	2019	NUM
aji-39	117	18	at	at	ADP
aji-39	117	19	the	the	DET
aji-39	117	20	antenatal	antenatal	ADJ
aji-39	117	21	clinic	clinic	NOUN
aji-39	117	22	of	of	ADP
aji-39	117	23	federal	federal	ADJ
aji-39	117	24	teaching	teaching	NOUN
aji-39	117	25	hospital	hospital	NOUN
aji-39	117	26	ido	ido	PROPN
aji-39	117	27	-	-	PUNCT
aji-39	117	28	ekiti	ekiti	ADJ
aji-39	117	29	(	(	PUNCT
aji-39	117	30	fethi	fethi	PROPN
aji-39	117	31	)	)	PUNCT
aji-39	117	32	,	,	PUNCT
aji-39	117	33	ekiti	ekiti	ADJ
aji-39	117	34	state	state	PROPN
aji-39	117	35	,	,	PUNCT
aji-39	117	36	nigeria	nigeria	PROPN
aji-39	117	37	.	.	PUNCT
aji-39	118	1	original	original	ADJ
aji-39	118	2	research	research	NOUN
aji-39	118	3	article	article	NOUN
aji-39	118	4	akele	akele	PROPN
aji-39	118	5	et	et	PROPN
aji-39	118	6	al	al	PROPN
aji-39	118	7	.	.	PROPN
aji-39	118	8	;	;	PUNCT
aji-39	118	9	aji	aji	PROPN
aji-39	118	10	,	,	PUNCT
aji-39	118	11	3(1	3(1	NUM
aji-39	118	12	):	):	PUNCT
aji-39	118	13	199	199	NUM
aji-39	118	14	-	-	SYM
aji-39	118	15	207	207	NUM
aji-39	118	16	,	,	PUNCT
aji-39	118	17	2020	2020	NUM
aji-39	118	18	;	;	PUNCT
aji-39	118	19	article	article	NOUN
aji-39	118	20	no.aji.57099	no.aji.57099	VERB
aji-39	118	21	200	200	NUM
aji-39	118	22	methodology	methodology	NOUN
aji-39	118	23	:	:	PUNCT
aji-39	118	24	one	one	NUM
aji-39	118	25	hundred	hundred	NUM
aji-39	118	26	and	and	CCONJ
aji-39	118	27	eighty	eighty	NUM
aji-39	118	28	four	four	NUM
aji-39	118	29	consenting	consent	VERB
aji-39	118	30	pregnant	pregnant	ADJ
aji-39	118	31	women	woman	NOUN
aji-39	118	32	attending	attend	VERB
aji-39	118	33	antenatal	antenatal	ADJ
aji-39	118	34	clinic	clinic	NOUN
aji-39	118	35	at	at	ADP
aji-39	118	36	fethi	fethi	ADJ
aji-39	118	37	were	be	AUX
aji-39	118	38	enrolled	enrol	VERB
aji-39	118	39	.	.	PUNCT
aji-39	119	1	structured	structured	ADJ
aji-39	119	2	questionnaire	questionnaire	NOUN
aji-39	119	3	was	be	AUX
aji-39	119	4	administered	administer	VERB
aji-39	119	5	to	to	PART
aji-39	119	6	collect	collect	VERB
aji-39	119	7	sociodemographic	sociodemographic	ADJ
aji-39	119	8	data	datum	NOUN
aji-39	119	9	and	and	CCONJ
aji-39	119	10	sera	sera	NOUN
aji-39	119	11	samples	sample	NOUN
aji-39	119	12	were	be	AUX
aji-39	119	13	also	also	ADV
aji-39	119	14	collected	collect	VERB
aji-39	119	15	to	to	PART
aji-39	119	16	determine	determine	VERB
aji-39	119	17	seroprevalence	seroprevalence	NOUN
aji-39	119	18	of	of	ADP
aji-39	119	19	rubella	rubella	NOUN
aji-39	119	20	igg	igg	PROPN
aji-39	119	21	and	and	CCONJ
aji-39	119	22	igm	igm	PROPN
aji-39	119	23	antibodies	antibody	NOUN
aji-39	119	24	using	use	VERB
aji-39	119	25	the	the	DET
aji-39	119	26	enzyme	enzyme	NOUN
aji-39	119	27	linked	link	VERB
aji-39	119	28	immunosorbent	immunosorbent	ADJ
aji-39	119	29	assay	assay	PROPN
aji-39	119	30	(	(	PUNCT
aji-39	119	31	elisa	elisa	NOUN
aji-39	119	32	)	)	PUNCT
aji-39	119	33	method	method	NOUN
aji-39	119	34	.	.	PUNCT
aji-39	120	1	prevalence	prevalence	NOUN
aji-39	120	2	rate	rate	NOUN
aji-39	120	3	was	be	AUX
aji-39	120	4	calculated	calculate	VERB
aji-39	120	5	and	and	CCONJ
aji-39	120	6	chi	chi	ADJ
aji-39	120	7	square	square	ADJ
aji-39	120	8	value	value	NOUN
aji-39	120	9	was	be	AUX
aji-39	120	10	determined	determine	VERB
aji-39	120	11	.	.	PUNCT
aji-39	121	1	results	result	NOUN
aji-39	121	2	:	:	PUNCT
aji-39	121	3	of	of	ADP
aji-39	121	4	the	the	DET
aji-39	121	5	184	184	NUM
aji-39	121	6	sera	sera	NOUN
aji-39	121	7	samples	sample	NOUN
aji-39	121	8	analyzed	analyze	VERB
aji-39	121	9	176	176	NUM
aji-39	121	10	(	(	PUNCT
aji-39	121	11	95.7	95.7	NUM
aji-39	121	12	%	%	NOUN
aji-39	121	13	)	)	PUNCT
aji-39	121	14	and	and	CCONJ
aji-39	121	15	22	22	NUM
aji-39	121	16	(	(	PUNCT
aji-39	121	17	12	12	NUM
aji-39	121	18	%	%	NOUN
aji-39	121	19	)	)	PUNCT
aji-39	121	20	were	be	AUX
aji-39	121	21	seropositive	seropositive	ADJ
aji-39	121	22	for	for	ADP
aji-39	121	23	rubella	rubella	NOUN
aji-39	121	24	igg	igg	PROPN
aji-39	121	25	and	and	CCONJ
aji-39	121	26	igm	igm	NOUN
aji-39	121	27	respectively	respectively	ADV
aji-39	121	28	.	.	PUNCT
aji-39	122	1	twenty	twenty	NUM
aji-39	122	2	(	(	PUNCT
aji-39	122	3	11	11	NUM
aji-39	122	4	%	%	NOUN
aji-39	122	5	)	)	PUNCT
aji-39	122	6	of	of	ADP
aji-39	122	7	those	those	PRON
aji-39	122	8	seropositive	seropositive	ADJ
aji-39	122	9	for	for	ADP
aji-39	122	10	igm	igm	NOUN
aji-39	122	11	were	be	AUX
aji-39	122	12	also	also	ADV
aji-39	122	13	positive	positive	ADJ
aji-39	122	14	for	for	ADP
aji-39	122	15	igg	igg	PROPN
aji-39	122	16	and	and	CCONJ
aji-39	122	17	only	only	ADV
aji-39	122	18	2(1	2(1	NUM
aji-39	122	19	%	%	NOUN
aji-39	122	20	)	)	PUNCT
aji-39	122	21	were	be	AUX
aji-39	122	22	positive	positive	ADJ
aji-39	122	23	only	only	ADV
aji-39	122	24	for	for	ADP
aji-39	122	25	igm	igm	PROPN
aji-39	122	26	.	.	PUNCT
aji-39	123	1	prevalence	prevalence	NOUN
aji-39	123	2	rate	rate	NOUN
aji-39	123	3	for	for	ADP
aji-39	123	4	igg	igg	PROPN
aji-39	123	5	was	be	AUX
aji-39	123	6	highest	high	ADJ
aji-39	123	7	among	among	ADP
aji-39	123	8	2630years	2630year	NOUN
aji-39	123	9	(	(	PUNCT
aji-39	123	10	98.3	98.3	NUM
aji-39	123	11	%	%	NOUN
aji-39	123	12	)	)	PUNCT
aji-39	123	13	and	and	CCONJ
aji-39	123	14	31	31	NUM
aji-39	123	15	-	-	SYM
aji-39	123	16	35years	35years	NUM
aji-39	123	17	(	(	PUNCT
aji-39	123	18	18.8	18.8	NUM
aji-39	123	19	%	%	NOUN
aji-39	123	20	)	)	PUNCT
aji-39	123	21	for	for	ADP
aji-39	123	22	igm	igm	PROPN
aji-39	123	23	.	.	PUNCT
aji-39	123	24	age	age	NOUN
aji-39	123	25	had	have	VERB
aji-39	123	26	no	no	PRON
aji-39	123	27	-	-	PUNCT
aji-39	123	28	significant	significant	ADJ
aji-39	123	29	effect	effect	NOUN
aji-39	123	30	(	(	PUNCT
aji-39	123	31	p	p	X
aji-39	123	32	>	>	X
aji-39	123	33	0.05	0.05	NUM
aji-39	123	34	)	)	PUNCT
aji-39	123	35	on	on	ADP
aji-39	123	36	seroprevalence	seroprevalence	NOUN
aji-39	123	37	distribution	distribution	NOUN
aji-39	123	38	.	.	PUNCT
aji-39	124	1	in	in	ADP
aji-39	124	2	like	like	ADP
aji-39	124	3	manner	manner	NOUN
aji-39	124	4	,	,	PUNCT
aji-39	124	5	level	level	NOUN
aji-39	124	6	of	of	ADP
aji-39	124	7	formal	formal	ADJ
aji-39	124	8	education	education	NOUN
aji-39	124	9	,	,	PUNCT
aji-39	124	10	knowledge	knowledge	NOUN
aji-39	124	11	of	of	ADP
aji-39	124	12	the	the	DET
aji-39	124	13	virus	virus	NOUN
aji-39	124	14	,	,	PUNCT
aji-39	124	15	and	and	CCONJ
aji-39	124	16	occupation	occupation	NOUN
aji-39	124	17	had	have	VERB
aji-39	124	18	no	no	DET
aji-39	124	19	significant	significant	ADJ
aji-39	124	20	effect	effect	NOUN
aji-39	124	21	(	(	PUNCT
aji-39	124	22	p	p	X
aji-39	124	23	>	>	X
aji-39	124	24	0.05	0.05	NUM
aji-39	124	25	)	)	PUNCT
aji-39	124	26	on	on	ADP
aji-39	124	27	prevalence	prevalence	NOUN
aji-39	124	28	of	of	ADP
aji-39	124	29	the	the	DET
aji-39	124	30	virus	virus	NOUN
aji-39	124	31	.	.	PUNCT
aji-39	125	1	however	however	ADV
aji-39	125	2	parity	parity	NOUN
aji-39	125	3	significantly	significantly	ADV
aji-39	125	4	(	(	PUNCT
aji-39	125	5	p	p	X
aji-39	125	6	<	<	X
aji-39	125	7	0.05	0.05	NUM
aji-39	125	8	)	)	PUNCT
aji-39	125	9	influenced	influence	VERB
aji-39	125	10	the	the	DET
aji-39	125	11	pattern	pattern	NOUN
aji-39	125	12	of	of	ADP
aji-39	125	13	serostatus	serostatus	NOUN
aji-39	125	14	for	for	ADP
aji-39	125	15	both	both	DET
aji-39	125	16	igg	igg	PROPN
aji-39	125	17	and	and	CCONJ
aji-39	125	18	igm	igm	PROPN
aji-39	125	19	.	.	PROPN
aji-39	126	1	conclusion	conclusion	NOUN
aji-39	126	2	:	:	PUNCT
aji-39	126	3	the	the	DET
aji-39	126	4	high	high	ADJ
aji-39	126	5	prevalence	prevalence	NOUN
aji-39	126	6	and	and	CCONJ
aji-39	126	7	similar	similar	ADJ
aji-39	126	8	distribution	distribution	NOUN
aji-39	126	9	pattern	pattern	NOUN
aji-39	126	10	irrespective	irrespective	ADV
aji-39	126	11	of	of	ADP
aji-39	126	12	sociodemographic	sociodemographic	ADJ
aji-39	126	13	features	feature	NOUN
aji-39	126	14	of	of	ADP
aji-39	126	15	rubella	rubella	NOUN
aji-39	126	16	virus	virus	NOUN
aji-39	126	17	in	in	ADP
aji-39	126	18	this	this	DET
aji-39	126	19	study	study	NOUN
aji-39	126	20	area	area	NOUN
aji-39	126	21	suggests	suggest	VERB
aji-39	126	22	its	its	PRON
aji-39	126	23	endermicity	endermicity	NOUN
aji-39	126	24	and	and	CCONJ
aji-39	126	25	continuous	continuous	ADJ
aji-39	126	26	transmission	transmission	NOUN
aji-39	126	27	in	in	ADP
aji-39	126	28	the	the	DET
aji-39	126	29	area	area	NOUN
aji-39	126	30	.	.	PUNCT
aji-39	127	1	this	this	PRON
aji-39	127	2	emphasizes	emphasize	VERB
aji-39	127	3	the	the	DET
aji-39	127	4	need	need	NOUN
aji-39	127	5	to	to	PART
aji-39	127	6	implement	implement	VERB
aji-39	127	7	routine	routine	ADJ
aji-39	127	8	immunization	immunization	NOUN
aji-39	127	9	of	of	ADP
aji-39	127	10	children	child	NOUN
aji-39	127	11	and	and	CCONJ
aji-39	127	12	susceptible	susceptible	ADJ
aji-39	127	13	women	woman	NOUN
aji-39	127	14	of	of	ADP
aji-39	127	15	child	child	NOUN
aji-39	127	16	bearing	bear	VERB
aji-39	127	17	age	age	NOUN
aji-39	127	18	against	against	ADP
aji-39	127	19	rubella	rubella	NOUN
aji-39	127	20	virus	virus	NOUN
aji-39	127	21	.	.	PUNCT
aji-39	128	1	keywords	keyword	NOUN
aji-39	128	2	:	:	PUNCT
aji-39	128	3	seroprevalence	seroprevalence	NOUN
aji-39	128	4	;	;	PUNCT
aji-39	128	5	rubella	rubella	NOUN
aji-39	128	6	igg	igg	PROPN
aji-39	128	7	and	and	CCONJ
aji-39	128	8	igm	igm	PROPN
aji-39	128	9	;	;	PUNCT
aji-39	128	10	pregnancy	pregnancy	NOUN
aji-39	128	11	;	;	PUNCT
aji-39	128	12	congenital	congenital	ADJ
aji-39	128	13	rubella	rubella	NOUN
aji-39	128	14	syndrome	syndrome	NOUN
aji-39	128	15	;	;	PUNCT
aji-39	128	16	ido	ido	PROPN
aji-39	128	17	-	-	PUNCT
aji-39	128	18	ekiti	ekiti	PROPN
aji-39	128	19	;	;	PUNCT
aji-39	128	20	nigeria	nigeria	PROPN
aji-39	128	21	.	.	PUNCT
aji-39	129	1	1	1	X
aji-39	129	2	.	.	X
aji-39	129	3	introduction	introduction	NOUN
aji-39	129	4	rubella	rubella	NOUN
aji-39	129	5	is	be	AUX
aji-39	129	6	a	a	DET
aji-39	129	7	contagious	contagious	ADJ
aji-39	129	8	viral	viral	ADJ
aji-39	129	9	infection	infection	NOUN
aji-39	129	10	characterized	characterize	VERB
aji-39	129	11	by	by	ADP
aji-39	129	12	distinctive	distinctive	ADJ
aji-39	129	13	macules	macule	NOUN
aji-39	129	14	of	of	ADP
aji-39	129	15	erythematous	erythematous	ADJ
aji-39	129	16	rash	rash	NOUN
aji-39	129	17	popularly	popularly	ADV
aji-39	129	18	called	call	VERB
aji-39	129	19	german	german	ADJ
aji-39	129	20	measles	measle	NOUN
aji-39	129	21	.	.	PUNCT
aji-39	130	1	it	it	PRON
aji-39	130	2	is	be	AUX
aji-39	130	3	an	an	DET
aji-39	130	4	enveloped	envelop	VERB
aji-39	130	5	positive	positive	ADJ
aji-39	130	6	-	-	PUNCT
aji-39	130	7	sense	sense	NOUN
aji-39	130	8	single	single	ADJ
aji-39	130	9	-	-	PUNCT
aji-39	130	10	stranded	strand	VERB
aji-39	130	11	ribonucleic	ribonucleic	ADJ
aji-39	130	12	acid	acid	NOUN
aji-39	130	13	(	(	PUNCT
aji-39	130	14	rna	rna	PROPN
aji-39	130	15	)	)	PUNCT
aji-39	130	16	virus	virus	NOUN
aji-39	130	17	belonging	belong	VERB
aji-39	130	18	to	to	ADP
aji-39	130	19	the	the	DET
aji-39	130	20	family	family	NOUN
aji-39	130	21	togaviridae	togaviridae	NOUN
aji-39	130	22	,	,	PUNCT
aji-39	131	1	genus	genus	ADJ
aji-39	131	2	rubivirus	rubivirus	NOUN
aji-39	132	1	[	[	X
aji-39	132	2	1	1	NUM
aji-39	132	3	-	-	SYM
aji-39	132	4	3	3	NUM
aji-39	132	5	]	]	PUNCT
aji-39	132	6	.	.	PUNCT
aji-39	133	1	rubella	rubella	NOUN
aji-39	133	2	is	be	AUX
aji-39	133	3	transmitted	transmit	VERB
aji-39	133	4	congenitally	congenitally	ADV
aji-39	133	5	and	and	CCONJ
aji-39	133	6	by	by	ADP
aji-39	133	7	respiratory	respiratory	ADJ
aji-39	133	8	aerosols	aerosol	NOUN
aji-39	133	9	,	,	PUNCT
aji-39	133	10	transmission	transmission	NOUN
aji-39	133	11	occurring	occur	VERB
aji-39	133	12	mainly	mainly	ADV
aji-39	133	13	in	in	ADP
aji-39	133	14	children	child	NOUN
aji-39	133	15	and	and	CCONJ
aji-39	133	16	young	young	ADJ
aji-39	133	17	adults	adult	NOUN
aji-39	133	18	.	.	PUNCT
aji-39	134	1	the	the	DET
aji-39	134	2	contagious	contagious	ADJ
aji-39	134	3	period	period	NOUN
aji-39	134	4	of	of	ADP
aji-39	134	5	the	the	DET
aji-39	134	6	virus	virus	NOUN
aji-39	134	7	is	be	AUX
aji-39	134	8	approximately	approximately	ADV
aji-39	134	9	5	5	NUM
aji-39	134	10	to	to	PART
aji-39	134	11	7	7	NUM
aji-39	134	12	-	-	PUNCT
aji-39	134	13	days	day	NOUN
aji-39	134	14	pre	pre	NOUN
aji-39	134	15	and	and	CCONJ
aji-39	134	16	3	3	NUM
aji-39	134	17	to	to	PART
aji-39	134	18	5	5	NUM
aji-39	134	19	-	-	PUNCT
aji-39	134	20	days	day	NOUN
aji-39	134	21	post	post	NOUN
aji-39	134	22	manifestation	manifestation	NOUN
aji-39	134	23	of	of	ADP
aji-39	134	24	clinical	clinical	ADJ
aji-39	134	25	symptoms	symptom	NOUN
aji-39	134	26	[	[	X
aji-39	134	27	4	4	NUM
aji-39	134	28	]	]	PUNCT
aji-39	134	29	.	.	PUNCT
aji-39	135	1	upon	upon	SCONJ
aji-39	135	2	inhalation	inhalation	NOUN
aji-39	135	3	of	of	ADP
aji-39	135	4	virus	virus	NOUN
aji-39	135	5	loaded	load	VERB
aji-39	135	6	droplets	droplet	NOUN
aji-39	135	7	,	,	PUNCT
aji-39	135	8	the	the	DET
aji-39	135	9	virus	virus	NOUN
aji-39	135	10	infects	infect	VERB
aji-39	135	11	cells	cell	NOUN
aji-39	135	12	of	of	ADP
aji-39	135	13	the	the	DET
aji-39	135	14	mucosal	mucosal	ADJ
aji-39	135	15	membranes	membrane	NOUN
aji-39	135	16	of	of	ADP
aji-39	135	17	the	the	DET
aji-39	135	18	upper	upper	ADJ
aji-39	135	19	respiratory	respiratory	ADJ
aji-39	135	20	tract	tract	NOUN
aji-39	135	21	and	and	CCONJ
aji-39	135	22	replicates	replicate	NOUN
aji-39	135	23	consequently	consequently	ADV
aji-39	135	24	spreading	spread	VERB
aji-39	135	25	to	to	ADP
aji-39	135	26	regional	regional	ADJ
aji-39	135	27	lymph	lymph	NOUN
aji-39	135	28	nodes	node	NOUN
aji-39	135	29	.	.	PUNCT
aji-39	136	1	[	[	X
aji-39	136	2	4	4	NUM
aji-39	136	3	]	]	PUNCT
aji-39	136	4	.	.	PUNCT
aji-39	137	1	infection	infection	NOUN
aji-39	137	2	is	be	AUX
aji-39	137	3	mainly	mainly	ADV
aji-39	137	4	subclinical	subclinical	ADJ
aji-39	137	5	,	,	PUNCT
aji-39	137	6	alternatively	alternatively	ADV
aji-39	137	7	causing	cause	VERB
aji-39	137	8	a	a	DET
aji-39	137	9	self	self	NOUN
aji-39	137	10	-	-	PUNCT
aji-39	137	11	limiting	limit	VERB
aji-39	137	12	illness	illness	NOUN
aji-39	137	13	with	with	ADP
aji-39	137	14	low	low	ADJ
aji-39	137	15	-	-	PUNCT
aji-39	137	16	grade	grade	NOUN
aji-39	137	17	fever	fever	NOUN
aji-39	137	18	,	,	PUNCT
aji-39	137	19	lymphadenopathy	lymphadenopathy	ADJ
aji-39	137	20	,	,	PUNCT
aji-39	137	21	and	and	CCONJ
aji-39	137	22	skin	skin	NOUN
aji-39	137	23	rash	rash	NOUN
aji-39	137	24	.	.	PUNCT
aji-39	138	1	of	of	ADP
aji-39	138	2	major	major	ADJ
aji-39	138	3	concern	concern	NOUN
aji-39	138	4	is	be	AUX
aji-39	138	5	the	the	DET
aji-39	138	6	fact	fact	NOUN
aji-39	138	7	that	that	SCONJ
aji-39	138	8	infection	infection	NOUN
aji-39	138	9	in	in	ADP
aji-39	138	10	pregnancy	pregnancy	NOUN
aji-39	138	11	often	often	ADV
aji-39	138	12	result	result	VERB
aji-39	138	13	in	in	ADP
aji-39	138	14	congenital	congenital	ADJ
aji-39	138	15	rubella	rubella	NOUN
aji-39	138	16	infection	infection	NOUN
aji-39	138	17	which	which	PRON
aji-39	138	18	causes	cause	VERB
aji-39	138	19	miscarriages	miscarriage	NOUN
aji-39	138	20	,	,	PUNCT
aji-39	138	21	stillbirth	stillbirth	NOUN
aji-39	138	22	,	,	PUNCT
aji-39	138	23	abortion	abortion	NOUN
aji-39	138	24	,	,	PUNCT
aji-39	138	25	or	or	CCONJ
aji-39	138	26	congenital	congenital	ADJ
aji-39	138	27	rubella	rubella	NOUN
aji-39	138	28	syndrome	syndrome	NOUN
aji-39	138	29	(	(	PUNCT
aji-39	138	30	crs	crs	PROPN
aji-39	138	31	)	)	PUNCT
aji-39	138	32	of	of	ADP
aji-39	138	33	the	the	DET
aji-39	138	34	infants	infant	NOUN
aji-39	138	35	.	.	PUNCT
aji-39	139	1	congenital	congenital	ADJ
aji-39	139	2	rubella	rubella	NOUN
aji-39	139	3	syndrome	syndrome	NOUN
aji-39	139	4	encompasses	encompass	VERB
aji-39	139	5	cardiac	cardiac	ADJ
aji-39	139	6	,	,	PUNCT
aji-39	139	7	cerebral	cerebral	ADJ
aji-39	139	8	,	,	PUNCT
aji-39	139	9	ophthalmic	ophthalmic	ADJ
aji-39	139	10	,	,	PUNCT
aji-39	139	11	and	and	CCONJ
aji-39	139	12	auditory	auditory	ADJ
aji-39	139	13	defects	defect	NOUN
aji-39	139	14	[	[	X
aji-39	139	15	5	5	NUM
aji-39	139	16	-	-	SYM
aji-39	139	17	7	7	NUM
aji-39	139	18	]	]	PUNCT
aji-39	139	19	.	.	PUNCT
aji-39	140	1	it	it	PRON
aji-39	140	2	is	be	AUX
aji-39	140	3	estimated	estimate	VERB
aji-39	140	4	that	that	SCONJ
aji-39	140	5	infection	infection	NOUN
aji-39	140	6	with	with	ADP
aji-39	140	7	the	the	DET
aji-39	140	8	virus	virus	NOUN
aji-39	140	9	in	in	ADP
aji-39	140	10	the	the	DET
aji-39	140	11	first	first	ADJ
aji-39	140	12	trimester	trimester	NOUN
aji-39	140	13	or	or	CCONJ
aji-39	140	14	shortly	shortly	ADV
aji-39	140	15	before	before	SCONJ
aji-39	140	16	pregnancy	pregnancy	NOUN
aji-39	140	17	may	may	AUX
aji-39	140	18	result	result	VERB
aji-39	140	19	in	in	ADP
aji-39	140	20	approximately	approximately	ADV
aji-39	140	21	90	90	NUM
aji-39	140	22	%	%	NOUN
aji-39	140	23	of	of	ADP
aji-39	140	24	fetuses	fetus	NOUN
aji-39	140	25	being	be	AUX
aji-39	140	26	infected	infect	VERB
aji-39	140	27	and	and	CCONJ
aji-39	140	28	100	100	NUM
aji-39	140	29	%	%	NOUN
aji-39	140	30	of	of	ADP
aji-39	140	31	these	these	DET
aji-39	140	32	infected	infect	VERB
aji-39	140	33	fetuses	fetus	NOUN
aji-39	140	34	will	will	AUX
aji-39	140	35	come	come	VERB
aji-39	140	36	down	down	ADP
aji-39	140	37	with	with	ADP
aji-39	140	38	congenital	congenital	ADJ
aji-39	140	39	deformities	deformity	NOUN
aji-39	140	40	,	,	PUNCT
aji-39	140	41	often	often	ADV
aji-39	140	42	resulting	result	VERB
aji-39	140	43	in	in	ADP
aji-39	140	44	miscarriage	miscarriage	NOUN
aji-39	140	45	[	[	X
aji-39	140	46	4,8	4,8	NUM
aji-39	140	47	-	-	SYM
aji-39	140	48	9	9	NUM
aji-39	140	49	]	]	PUNCT
aji-39	140	50	.	.	PUNCT
aji-39	141	1	it	it	PRON
aji-39	141	2	has	have	AUX
aji-39	141	3	been	be	AUX
aji-39	141	4	reported	report	VERB
aji-39	141	5	that	that	SCONJ
aji-39	141	6	as	as	SCONJ
aji-39	141	7	pregnancy	pregnancy	NOUN
aji-39	141	8	progresses	progress	VERB
aji-39	141	9	,	,	PUNCT
aji-39	141	10	the	the	DET
aji-39	141	11	risk	risk	NOUN
aji-39	141	12	of	of	ADP
aji-39	141	13	crs	crs	NOUN
aji-39	141	14	decreases	decrease	NOUN
aji-39	141	15	[	[	X
aji-39	141	16	9	9	NUM
aji-39	141	17	]	]	PUNCT
aji-39	141	18	.	.	PUNCT
aji-39	142	1	in	in	ADP
aji-39	142	2	nigeria	nigeria	PROPN
aji-39	142	3	,	,	PUNCT
aji-39	142	4	a	a	DET
aji-39	142	5	high	high	ADJ
aji-39	142	6	prevalence	prevalence	NOUN
aji-39	142	7	rate	rate	NOUN
aji-39	142	8	of	of	ADP
aji-39	142	9	rubella	rubella	NOUN
aji-39	142	10	has	have	AUX
aji-39	142	11	been	be	AUX
aji-39	142	12	reported	report	VERB
aji-39	142	13	in	in	ADP
aji-39	142	14	some	some	DET
aji-39	142	15	areas	area	NOUN
aji-39	142	16	.	.	PUNCT
aji-39	143	1	for	for	ADP
aji-39	143	2	example	example	NOUN
aji-39	143	3	,	,	PUNCT
aji-39	143	4	77	77	NUM
aji-39	143	5	%	%	NOUN
aji-39	143	6	in	in	ADP
aji-39	143	7	lagos	lago	NOUN
aji-39	143	8	[	[	X
aji-39	143	9	10	10	NUM
aji-39	143	10	]	]	PUNCT
aji-39	143	11	,	,	PUNCT
aji-39	143	12	97.9	97.9	NUM
aji-39	143	13	%	%	NOUN
aji-39	143	14	in	in	ADP
aji-39	143	15	zaria	zaria	PROPN
aji-39	144	1	[	[	X
aji-39	144	2	11	11	NUM
aji-39	144	3	]	]	PUNCT
aji-39	144	4	and	and	CCONJ
aji-39	144	5	93.1	93.1	NUM
aji-39	144	6	%	%	NOUN
aji-39	144	7	in	in	ADP
aji-39	144	8	abakaliki	abakaliki	ADJ
aji-39	144	9	[	[	X
aji-39	144	10	12	12	NUM
aji-39	144	11	]	]	PUNCT
aji-39	144	12	.	.	PUNCT
aji-39	145	1	seroepidermiological	seroepidermiological	ADJ
aji-39	145	2	studies	study	NOUN
aji-39	145	3	in	in	ADP
aji-39	145	4	ethiopia	ethiopia	PROPN
aji-39	145	5	also	also	ADV
aji-39	145	6	has	have	AUX
aji-39	145	7	reported	report	VERB
aji-39	145	8	a	a	DET
aji-39	145	9	similarly	similarly	ADV
aji-39	145	10	high	high	ADJ
aji-39	145	11	prevalence	prevalence	NOUN
aji-39	145	12	,	,	PUNCT
aji-39	145	13	91	91	NUM
aji-39	145	14	%	%	NOUN
aji-39	145	15	in	in	ADP
aji-39	145	16	addis	addis	PROPN
aji-39	145	17	ababa	ababa	PROPN
aji-39	146	1	[	[	X
aji-39	146	2	13	13	NUM
aji-39	146	3	]	]	PUNCT
aji-39	146	4	and	and	CCONJ
aji-39	146	5	86.3	86.3	NUM
aji-39	146	6	%	%	NOUN
aji-39	146	7	[	[	X
aji-39	146	8	14	14	NUM
aji-39	146	9	]	]	PUNCT
aji-39	146	10	in	in	ADP
aji-39	146	11	southern	southern	ADJ
aji-39	146	12	ethiopia	ethiopia	PROPN
aji-39	146	13	.	.	PUNCT
aji-39	147	1	rubella	rubella	NOUN
aji-39	147	2	is	be	AUX
aji-39	147	3	a	a	DET
aji-39	147	4	vaccine	vaccine	NOUN
aji-39	147	5	-	-	PUNCT
aji-39	147	6	preventable	preventable	ADJ
aji-39	147	7	viral	viral	ADJ
aji-39	147	8	infection	infection	NOUN
aji-39	148	1	[	[	X
aji-39	148	2	15	15	NUM
aji-39	148	3	]	]	PUNCT
aji-39	148	4	considered	consider	VERB
aji-39	148	5	as	as	ADP
aji-39	148	6	an	an	DET
aji-39	148	7	eradicable	eradicable	ADJ
aji-39	148	8	infection	infection	NOUN
aji-39	148	9	.	.	PUNCT
aji-39	149	1	based	base	VERB
aji-39	149	2	on	on	ADP
aji-39	149	3	this	this	DET
aji-39	149	4	fact	fact	NOUN
aji-39	149	5	,	,	PUNCT
aji-39	149	6	some	some	DET
aji-39	149	7	vaccination	vaccination	NOUN
aji-39	149	8	programs	program	NOUN
aji-39	149	9	implemented	implement	VERB
aji-39	149	10	between	between	ADP
aji-39	149	11	1996	1996	NUM
aji-39	149	12	and	and	CCONJ
aji-39	149	13	2010	2010	NUM
aji-39	149	14	in	in	ADP
aji-39	149	15	some	some	DET
aji-39	149	16	high	high	ADJ
aji-39	149	17	income	income	NOUN
aji-39	149	18	,	,	PUNCT
aji-39	149	19	middle	middle	ADJ
aji-39	149	20	income	income	NOUN
aji-39	149	21	and	and	CCONJ
aji-39	149	22	low	low	ADJ
aji-39	149	23	-	-	PUNCT
aji-39	149	24	income	income	NOUN
aji-39	149	25	countries	country	NOUN
aji-39	149	26	have	have	AUX
aji-39	149	27	in	in	ADP
aji-39	149	28	the	the	DET
aji-39	149	29	past	past	NOUN
aji-39	149	30	been	be	AUX
aji-39	149	31	able	able	ADJ
aji-39	149	32	to	to	PART
aji-39	149	33	considerably	considerably	ADV
aji-39	149	34	reduce	reduce	VERB
aji-39	149	35	global	global	ADJ
aji-39	149	36	crs	crs	PROPN
aji-39	149	37	cases	case	NOUN
aji-39	149	38	[	[	X
aji-39	149	39	16,17	16,17	NUM
aji-39	149	40	]	]	PUNCT
aji-39	149	41	.	.	PUNCT
aji-39	150	1	this	this	PRON
aji-39	150	2	has	have	AUX
aji-39	150	3	stirred	stir	VERB
aji-39	150	4	the	the	DET
aji-39	150	5	world	world	NOUN
aji-39	150	6	global	global	PROPN
aji-39	150	7	assembly	assembly	NOUN
aji-39	150	8	to	to	PART
aji-39	150	9	endorse	endorse	VERB
aji-39	150	10	the	the	DET
aji-39	150	11	global	global	ADJ
aji-39	150	12	measles	measle	NOUN
aji-39	150	13	and	and	CCONJ
aji-39	150	14	rubella	rubella	NOUN
aji-39	150	15	strategic	strategic	ADJ
aji-39	150	16	plan	plan	NOUN
aji-39	150	17	in	in	ADP
aji-39	150	18	april	april	PROPN
aji-39	150	19	2012	2012	NUM
aji-39	151	1	[	[	X
aji-39	151	2	18	18	NUM
aji-39	151	3	]	]	PUNCT
aji-39	151	4	which	which	PRON
aji-39	151	5	is	be	AUX
aji-39	151	6	targeted	target	VERB
aji-39	151	7	at	at	ADP
aji-39	151	8	eliminating	eliminate	VERB
aji-39	151	9	rubella	rubella	NOUN
aji-39	151	10	in	in	ADP
aji-39	151	11	at	at	ADV
aji-39	151	12	least	least	ADJ
aji-39	151	13	5	5	NUM
aji-39	151	14	who	who	PRON
aji-39	151	15	regions	region	NOUN
aji-39	151	16	by	by	ADP
aji-39	151	17	2020	2020	NUM
aji-39	152	1	[	[	X
aji-39	152	2	19	19	NUM
aji-39	152	3	]	]	PUNCT
aji-39	152	4	.	.	PUNCT
aji-39	153	1	however	however	ADV
aji-39	153	2	,	,	PUNCT
aji-39	153	3	routine	routine	ADJ
aji-39	153	4	administration	administration	NOUN
aji-39	153	5	of	of	ADP
aji-39	153	6	the	the	DET
aji-39	153	7	rubella	rubella	NOUN
aji-39	153	8	vaccine	vaccine	NOUN
aji-39	153	9	is	be	AUX
aji-39	153	10	yet	yet	ADV
aji-39	153	11	to	to	PART
aji-39	153	12	be	be	AUX
aji-39	153	13	implemented	implement	VERB
aji-39	153	14	in	in	ADP
aji-39	153	15	many	many	ADJ
aji-39	153	16	areas	area	NOUN
aji-39	153	17	in	in	ADP
aji-39	153	18	nigeria	nigeria	PROPN
aji-39	153	19	most	most	ADV
aji-39	153	20	especially	especially	ADV
aji-39	153	21	in	in	ADP
aji-39	153	22	ido	ido	PROPN
aji-39	153	23	-	-	PUNCT
aji-39	153	24	ekiti	ekiti	PROPN
aji-39	153	25	were	be	AUX
aji-39	153	26	this	this	DET
aji-39	153	27	study	study	NOUN
aji-39	153	28	was	be	AUX
aji-39	153	29	carried	carry	VERB
aji-39	153	30	out	out	ADP
aji-39	153	31	.	.	PUNCT
aji-39	154	1	routine	routine	ADJ
aji-39	154	2	diagnosis	diagnosis	NOUN
aji-39	154	3	for	for	ADP
aji-39	154	4	the	the	DET
aji-39	154	5	rubella	rubella	NOUN
aji-39	154	6	virus	virus	NOUN
aji-39	154	7	is	be	AUX
aji-39	154	8	also	also	ADV
aji-39	154	9	not	not	PART
aji-39	154	10	practiced	practice	VERB
aji-39	154	11	in	in	ADP
aji-39	154	12	this	this	DET
aji-39	154	13	location	location	NOUN
aji-39	154	14	just	just	ADV
aji-39	154	15	as	as	SCONJ
aji-39	154	16	the	the	DET
aji-39	154	17	case	case	NOUN
aji-39	154	18	is	be	AUX
aji-39	154	19	in	in	ADP
aji-39	154	20	many	many	ADJ
aji-39	154	21	other	other	ADJ
aji-39	154	22	locations	location	NOUN
aji-39	154	23	in	in	ADP
aji-39	154	24	nigeria	nigeria	PROPN
aji-39	154	25	.	.	PUNCT
aji-39	155	1	thus	thus	ADV
aji-39	155	2	,	,	PUNCT
aji-39	155	3	a	a	DET
aji-39	155	4	paucity	paucity	NOUN
aji-39	155	5	of	of	ADP
aji-39	155	6	empirical	empirical	ADJ
aji-39	155	7	data	datum	NOUN
aji-39	155	8	on	on	ADP
aji-39	155	9	serosurvey	serosurvey	NOUN
aji-39	155	10	of	of	ADP
aji-39	155	11	rubella	rubella	NOUN
aji-39	155	12	.	.	PUNCT
aji-39	156	1	though	though	SCONJ
aji-39	156	2	some	some	DET
aji-39	156	3	researchers	researcher	NOUN
aji-39	156	4	have	have	AUX
aji-39	156	5	conducted	conduct	VERB
aji-39	156	6	serosurveillance	serosurveillance	NOUN
aji-39	156	7	in	in	ADP
aji-39	156	8	other	other	ADJ
aji-39	156	9	locations	location	NOUN
aji-39	156	10	,	,	PUNCT
aji-39	156	11	this	this	PRON
aji-39	156	12	is	be	AUX
aji-39	156	13	the	the	DET
aji-39	156	14	first	first	ADJ
aji-39	156	15	to	to	PART
aji-39	156	16	be	be	AUX
aji-39	156	17	carried	carry	VERB
aji-39	156	18	out	out	ADP
aji-39	156	19	in	in	ADP
aji-39	156	20	ido	ido	PROPN
aji-39	156	21	-	-	PUNCT
aji-39	156	22	ekiti	ekiti	PROPN
aji-39	156	23	and	and	CCONJ
aji-39	156	24	environs	environ	NOUN
aji-39	156	25	.	.	PUNCT
aji-39	157	1	this	this	PRON
aji-39	157	2	makes	make	VERB
aji-39	157	3	it	it	PRON
aji-39	157	4	pertinent	pertinent	ADJ
aji-39	157	5	to	to	PART
aji-39	157	6	conduct	conduct	VERB
aji-39	157	7	this	this	DET
aji-39	157	8	serosurvey	serosurvey	NOUN
aji-39	157	9	in	in	ADP
aji-39	157	10	this	this	DET
aji-39	157	11	location	location	NOUN
aji-39	157	12	as	as	SCONJ
aji-39	157	13	findings	finding	NOUN
aji-39	157	14	may	may	AUX
aji-39	157	15	propel	propel	VERB
aji-39	157	16	informed	informed	ADJ
aji-39	157	17	decision	decision	NOUN
aji-39	157	18	making	making	NOUN
aji-39	157	19	and	and	CCONJ
aji-39	157	20	definition	definition	NOUN
aji-39	157	21	of	of	ADP
aji-39	157	22	the	the	DET
aji-39	157	23	best	good	ADJ
aji-39	157	24	interventional	interventional	ADJ
aji-39	157	25	approach	approach	NOUN
aji-39	157	26	by	by	ADP
aji-39	157	27	those	those	PRON
aji-39	157	28	saddled	saddle	VERB
aji-39	157	29	with	with	ADP
aji-39	157	30	such	such	ADJ
aji-39	157	31	responsibilities	responsibility	NOUN
aji-39	157	32	.	.	PUNCT
aji-39	158	1	findings	finding	NOUN
aji-39	158	2	of	of	ADP
aji-39	158	3	such	such	ADJ
aji-39	158	4	investigation	investigation	NOUN
aji-39	158	5	may	may	AUX
aji-39	158	6	be	be	AUX
aji-39	158	7	cardinal	cardinal	ADJ
aji-39	158	8	to	to	ADP
aji-39	158	9	the	the	DET
aji-39	158	10	estimation	estimation	NOUN
aji-39	158	11	of	of	ADP
aji-39	158	12	akele	akele	PROPN
aji-39	158	13	et	et	PROPN
aji-39	158	14	al	al	PROPN
aji-39	158	15	.	.	PROPN
aji-39	158	16	;	;	PUNCT
aji-39	159	1	aji	aji	PROPN
aji-39	159	2	,	,	PUNCT
aji-39	159	3	3(1	3(1	NUM
aji-39	159	4	):	):	PUNCT
aji-39	159	5	199	199	NUM
aji-39	159	6	-	-	SYM
aji-39	159	7	207	207	NUM
aji-39	159	8	,	,	PUNCT
aji-39	159	9	2020	2020	NUM
aji-39	159	10	;	;	PUNCT
aji-39	159	11	article	article	NOUN
aji-39	159	12	no.aji.57099	no.aji.57099	VERB
aji-39	159	13	201	201	NUM
aji-39	159	14	the	the	DET
aji-39	159	15	incidence	incidence	NOUN
aji-39	159	16	of	of	ADP
aji-39	159	17	crs	crs	PROPN
aji-39	159	18	and	and	CCONJ
aji-39	159	19	conversely	conversely	ADV
aji-39	159	20	crs	crs	NOUN
aji-39	159	21	burden	burden	NOUN
aji-39	159	22	at	at	ADP
aji-39	159	23	ido	ido	NOUN
aji-39	159	24	-	-	PUNCT
aji-39	159	25	ekiti	ekiti	PROPN
aji-39	159	26	and	and	CCONJ
aji-39	159	27	its	its	PRON
aji-39	159	28	environs	environ	NOUN
aji-39	159	29	.	.	PUNCT
aji-39	160	1	this	this	DET
aji-39	160	2	study	study	NOUN
aji-39	160	3	was	be	AUX
aji-39	160	4	therefore	therefore	ADV
aji-39	160	5	designed	design	VERB
aji-39	160	6	to	to	PART
aji-39	160	7	find	find	VERB
aji-39	160	8	out	out	ADP
aji-39	160	9	the	the	DET
aji-39	160	10	seroprevalence	seroprevalence	NOUN
aji-39	160	11	of	of	ADP
aji-39	160	12	anti	anti	ADJ
aji-39	160	13	-	-	ADJ
aji-39	160	14	rubella	rubella	ADJ
aji-39	160	15	igg	igg	NOUN
aji-39	160	16	antibodies	antibodie	VERB
aji-39	160	17	(	(	PUNCT
aji-39	160	18	a	a	DET
aji-39	160	19	marker	marker	NOUN
aji-39	160	20	of	of	ADP
aji-39	160	21	prevalence	prevalence	NOUN
aji-39	160	22	rate	rate	NOUN
aji-39	160	23	)	)	PUNCT
aji-39	160	24	,	,	PUNCT
aji-39	160	25	anti	anti	ADJ
aji-39	160	26	-	-	ADJ
aji-39	160	27	rubella	rubella	ADJ
aji-39	160	28	igm	igm	NOUN
aji-39	160	29	(	(	PUNCT
aji-39	160	30	a	a	DET
aji-39	160	31	marker	marker	NOUN
aji-39	160	32	of	of	ADP
aji-39	160	33	incidence	incidence	NOUN
aji-39	160	34	rate	rate	NOUN
aji-39	160	35	)	)	PUNCT
aji-39	160	36	,	,	PUNCT
aji-39	160	37	and	and	CCONJ
aji-39	160	38	some	some	DET
aji-39	160	39	sociodemographic	sociodemographic	ADJ
aji-39	160	40	cardinals	cardinal	NOUN
aji-39	160	41	that	that	PRON
aji-39	160	42	may	may	AUX
aji-39	160	43	influence	influence	VERB
aji-39	160	44	the	the	DET
aji-39	160	45	distribution	distribution	NOUN
aji-39	160	46	of	of	ADP
aji-39	160	47	the	the	DET
aji-39	160	48	disease	disease	NOUN
aji-39	160	49	among	among	ADP
aji-39	160	50	pregnant	pregnant	ADJ
aji-39	160	51	women	woman	NOUN
aji-39	160	52	in	in	ADP
aji-39	160	53	ido	ido	PROPN
aji-39	160	54	-	-	PUNCT
aji-39	160	55	ekiti	ekiti	ADJ
aji-39	160	56	.	.	PUNCT
aji-39	161	1	2	2	X
aji-39	161	2	.	.	X
aji-39	161	3	methodology	methodology	NOUN
aji-39	161	4	2.1	2.1	NUM
aji-39	161	5	study	study	NOUN
aji-39	161	6	area	area	NOUN
aji-39	161	7	and	and	CCONJ
aji-39	161	8	population	population	NOUN
aji-39	161	9	this	this	DET
aji-39	161	10	cross	cross	ADJ
aji-39	161	11	-	-	ADJ
aji-39	161	12	sectional	sectional	ADJ
aji-39	161	13	study	study	NOUN
aji-39	161	14	was	be	AUX
aji-39	161	15	conducted	conduct	VERB
aji-39	161	16	at	at	ADP
aji-39	161	17	the	the	DET
aji-39	161	18	antenatal	antenatal	ADJ
aji-39	161	19	clinic	clinic	NOUN
aji-39	161	20	of	of	ADP
aji-39	161	21	federal	federal	ADJ
aji-39	161	22	teaching	teaching	NOUN
aji-39	161	23	hospital	hospital	NOUN
aji-39	161	24	idoekiti	idoekiti	ADJ
aji-39	161	25	(	(	PUNCT
aji-39	161	26	fethi	fethi	PROPN
aji-39	161	27	)	)	PUNCT
aji-39	161	28	.	.	PUNCT
aji-39	162	1	fethi	fethi	ADJ
aji-39	162	2	is	be	AUX
aji-39	162	3	a	a	DET
aji-39	162	4	referral	referral	ADJ
aji-39	162	5	hospital	hospital	NOUN
aji-39	162	6	that	that	PRON
aji-39	162	7	receives	receive	VERB
aji-39	162	8	patients	patient	NOUN
aji-39	162	9	from	from	ADP
aji-39	162	10	all	all	ADV
aji-39	162	11	over	over	ADP
aji-39	162	12	ekiti	ekiti	ADJ
aji-39	162	13	state	state	NOUN
aji-39	162	14	and	and	CCONJ
aji-39	162	15	neighboring	neighboring	NOUN
aji-39	162	16	states	state	NOUN
aji-39	162	17	like	like	ADP
aji-39	162	18	kwara	kwara	PROPN
aji-39	162	19	and	and	CCONJ
aji-39	162	20	kogi	kogi	PROPN
aji-39	162	21	state	state	NOUN
aji-39	162	22	.	.	PUNCT
aji-39	163	1	it	it	PRON
aji-39	163	2	is	be	AUX
aji-39	163	3	sited	site	VERB
aji-39	163	4	in	in	ADP
aji-39	163	5	a	a	DET
aji-39	163	6	sub	sub	ADJ
aji-39	163	7	-	-	ADJ
aji-39	163	8	urban	urban	ADJ
aji-39	163	9	community	community	NOUN
aji-39	163	10	located	locate	VERB
aji-39	163	11	in	in	ADP
aji-39	163	12	idoosi	idoosi	NOUN
aji-39	163	13	local	local	ADJ
aji-39	163	14	government	government	NOUN
aji-39	163	15	area	area	NOUN
aji-39	163	16	of	of	ADP
aji-39	163	17	ekiti	ekiti	PROPN
aji-39	163	18	state	state	PROPN
aji-39	163	19	nigeria	nigeria	PROPN
aji-39	163	20	,	,	PUNCT
aji-39	163	21	on	on	ADP
aji-39	163	22	latitude	latitude	NOUN
aji-39	163	23	7.843093	7.843093	NUM
aji-39	163	24	and	and	CCONJ
aji-39	163	25	5.182314	5.182314	NUM
aji-39	163	26	(	(	PUNCT
aji-39	163	27	find	find	VERB
aji-39	163	28	coordinates.https://www.distancesto.com/coordi	coordinates.https://www.distancesto.com/coordi	NOUN
aji-39	163	29	nates	nate	NOUN
aji-39	163	30	/	/	SYM
aji-39	163	31	ng	ng	PROPN
aji-39	163	32	/	/	SYM
aji-39	163	33	ido	ido	PROPN
aji-39	163	34	-	-	PUNCT
aji-39	163	35	ekiti	ekiti	ADJ
aji-39	163	36	-	-	PUNCT
aji-39	163	37	latitude	latitude	NOUN
aji-39	163	38	-	-	PUNCT
aji-39	163	39	longitude	longitude	NOUN
aji-39	163	40	/	/	SYM
aji-39	163	41	history/759	history/759	PROPN
aji-39	163	42	44.htmllast	44.htmllast	NUM
aji-39	163	43	accessed	access	VERB
aji-39	163	44	04	04	NUM
aji-39	163	45	april	april	PROPN
aji-39	163	46	2020	2020	NUM
aji-39	163	47	)	)	PUNCT
aji-39	164	1	[	[	X
aji-39	164	2	20	20	NUM
aji-39	164	3	]	]	PUNCT
aji-39	164	4	.	.	PUNCT
aji-39	165	1	the	the	DET
aji-39	165	2	study	study	NOUN
aji-39	165	3	population	population	NOUN
aji-39	165	4	comprised	comprise	VERB
aji-39	165	5	of	of	ADP
aji-39	165	6	184	184	NUM
aji-39	165	7	pregnant	pregnant	ADJ
aji-39	165	8	women	woman	NOUN
aji-39	165	9	at	at	ADP
aji-39	165	10	various	various	ADJ
aji-39	165	11	stages	stage	NOUN
aji-39	165	12	of	of	ADP
aji-39	165	13	pregnancy	pregnancy	NOUN
aji-39	165	14	that	that	PRON
aji-39	165	15	consented	consent	VERB
aji-39	165	16	to	to	PART
aji-39	165	17	participate	participate	VERB
aji-39	165	18	in	in	ADP
aji-39	165	19	the	the	DET
aji-39	165	20	study	study	NOUN
aji-39	165	21	.	.	PUNCT
aji-39	166	1	2.2	2.2	NUM
aji-39	166	2	sample	sample	NOUN
aji-39	166	3	collection	collection	NOUN
aji-39	166	4	and	and	CCONJ
aji-39	166	5	processing	process	VERB
aji-39	166	6	a	a	DET
aji-39	166	7	brief	brief	ADJ
aji-39	166	8	enlightenment	enlightenment	NOUN
aji-39	166	9	on	on	ADP
aji-39	166	10	the	the	DET
aji-39	166	11	basis	basis	NOUN
aji-39	166	12	,	,	PUNCT
aji-39	166	13	benefits	benefit	NOUN
aji-39	166	14	and	and	CCONJ
aji-39	166	15	demerit	demerit	NOUN
aji-39	166	16	of	of	ADP
aji-39	166	17	the	the	DET
aji-39	166	18	study	study	NOUN
aji-39	166	19	was	be	AUX
aji-39	166	20	given	give	VERB
aji-39	166	21	and	and	CCONJ
aji-39	166	22	then	then	ADV
aji-39	166	23	a	a	DET
aji-39	166	24	written	write	VERB
aji-39	166	25	consent	consent	NOUN
aji-39	166	26	obtained	obtain	VERB
aji-39	166	27	from	from	ADP
aji-39	166	28	volunteers	volunteer	NOUN
aji-39	166	29	.	.	PUNCT
aji-39	167	1	a	a	DET
aji-39	167	2	structured	structured	ADJ
aji-39	167	3	questionnaire	questionnaire	NOUN
aji-39	167	4	was	be	AUX
aji-39	167	5	administered	administer	VERB
aji-39	167	6	to	to	ADP
aji-39	167	7	those	those	PRON
aji-39	167	8	who	who	PRON
aji-39	167	9	indicated	indicate	VERB
aji-39	167	10	interest	interest	NOUN
aji-39	167	11	in	in	ADP
aji-39	167	12	participating	participate	VERB
aji-39	167	13	in	in	ADP
aji-39	167	14	the	the	DET
aji-39	167	15	study	study	NOUN
aji-39	167	16	.	.	PUNCT
aji-39	168	1	the	the	DET
aji-39	168	2	questionnaire	questionnaire	NOUN
aji-39	168	3	was	be	AUX
aji-39	168	4	designed	design	VERB
aji-39	168	5	to	to	PART
aji-39	168	6	collect	collect	VERB
aji-39	168	7	sociodemographic	sociodemographic	ADJ
aji-39	168	8	data	datum	NOUN
aji-39	168	9	and	and	CCONJ
aji-39	168	10	data	datum	NOUN
aji-39	168	11	on	on	ADP
aji-39	168	12	possible	possible	ADJ
aji-39	168	13	risk	risk	NOUN
aji-39	168	14	factors	factor	NOUN
aji-39	168	15	that	that	PRON
aji-39	168	16	may	may	AUX
aji-39	168	17	predispose	predispose	VERB
aji-39	168	18	subjects	subject	NOUN
aji-39	168	19	to	to	ADP
aji-39	168	20	infection	infection	NOUN
aji-39	168	21	[	[	X
aji-39	168	22	14	14	NUM
aji-39	168	23	]	]	PUNCT
aji-39	168	24	.	.	PUNCT
aji-39	169	1	after	after	ADP
aji-39	169	2	duly	duly	ADV
aji-39	169	3	filling	fill	VERB
aji-39	169	4	the	the	DET
aji-39	169	5	questionnaire	questionnaire	NOUN
aji-39	169	6	,	,	PUNCT
aji-39	169	7	3	3	NUM
aji-39	169	8	mls	mls	NOUN
aji-39	169	9	of	of	ADP
aji-39	169	10	venous	venous	ADJ
aji-39	169	11	blood	blood	NOUN
aji-39	169	12	was	be	AUX
aji-39	169	13	collected	collect	VERB
aji-39	169	14	into	into	ADP
aji-39	169	15	a	a	DET
aji-39	169	16	labeled	label	VERB
aji-39	169	17	plain	plain	ADJ
aji-39	169	18	tube	tube	NOUN
aji-39	169	19	using	use	VERB
aji-39	169	20	standard	standard	ADJ
aji-39	169	21	aseptic	aseptic	ADJ
aji-39	169	22	procedures	procedure	NOUN
aji-39	169	23	.	.	PUNCT
aji-39	170	1	blood	blood	NOUN
aji-39	170	2	samples	sample	NOUN
aji-39	170	3	were	be	AUX
aji-39	170	4	allowed	allow	VERB
aji-39	170	5	to	to	PART
aji-39	170	6	clot	clot	VERB
aji-39	170	7	,	,	PUNCT
aji-39	170	8	aseptically	aseptically	ADV
aji-39	170	9	,	,	PUNCT
aji-39	170	10	dislodged	dislodge	VERB
aji-39	170	11	,	,	PUNCT
aji-39	170	12	and	and	CCONJ
aji-39	170	13	centrifuged	centrifuge	VERB
aji-39	170	14	at	at	ADP
aji-39	170	15	2,500	2,500	NUM
aji-39	170	16	rpm	rpm	NOUN
aji-39	170	17	for	for	ADP
aji-39	170	18	5	5	NUM
aji-39	170	19	minutes	minute	NOUN
aji-39	170	20	[	[	X
aji-39	170	21	21	21	NUM
aji-39	170	22	]	]	PUNCT
aji-39	170	23	.	.	PUNCT
aji-39	171	1	sera	sera	PROPN
aji-39	171	2	were	be	AUX
aji-39	171	3	then	then	ADV
aji-39	171	4	separated	separate	VERB
aji-39	171	5	into	into	ADP
aji-39	171	6	welllabeled	welllabele	VERB
aji-39	171	7	cryovials	cryovial	NOUN
aji-39	171	8	,	,	PUNCT
aji-39	171	9	transported	transport	VERB
aji-39	171	10	to	to	ADP
aji-39	171	11	the	the	DET
aji-39	171	12	medical	medical	ADJ
aji-39	171	13	microbiology	microbiology	NOUN
aji-39	171	14	laboratory	laboratory	NOUN
aji-39	171	15	of	of	ADP
aji-39	171	16	afe	afe	PROPN
aji-39	171	17	babalola	babalola	PROPN
aji-39	171	18	university	university	PROPN
aji-39	171	19	,	,	PUNCT
aji-39	171	20	ado	ado	NOUN
aji-39	171	21	-	-	PUNCT
aji-39	171	22	ekiti	ekiti	NOUN
aji-39	171	23	on	on	ADP
aji-39	171	24	ice	ice	NOUN
aji-39	171	25	packs	pack	NOUN
aji-39	171	26	.	.	PUNCT
aji-39	172	1	the	the	DET
aji-39	172	2	samples	sample	NOUN
aji-39	172	3	were	be	AUX
aji-39	172	4	stored	store	VERB
aji-39	172	5	at	at	ADP
aji-39	172	6	-20	-20	NUM
aji-39	172	7	°	°	NOUN
aji-39	172	8	c	c	NOUN
aji-39	172	9	until	until	ADP
aji-39	172	10	ready	ready	ADJ
aji-39	172	11	for	for	ADP
aji-39	172	12	laboratory	laboratory	NOUN
aji-39	172	13	analysis	analysis	NOUN
aji-39	172	14	.	.	PUNCT
aji-39	173	1	samples	sample	NOUN
aji-39	173	2	were	be	AUX
aji-39	173	3	collected	collect	VERB
aji-39	173	4	over	over	ADP
aji-39	173	5	a	a	DET
aji-39	173	6	period	period	NOUN
aji-39	173	7	of	of	ADP
aji-39	173	8	four	four	NUM
aji-39	173	9	months	month	NOUN
aji-39	173	10	.	.	PUNCT
aji-39	174	1	2.3	2.3	NUM
aji-39	174	2	sample	sample	NOUN
aji-39	174	3	analysis	analysis	NOUN
aji-39	174	4	sera	sera	NOUN
aji-39	174	5	samples	sample	NOUN
aji-39	174	6	were	be	AUX
aji-39	174	7	analyzed	analyze	VERB
aji-39	174	8	for	for	ADP
aji-39	174	9	rubella	rubella	NOUN
aji-39	174	10	igg	igg	PROPN
aji-39	174	11	and	and	CCONJ
aji-39	174	12	igm	igm	PROPN
aji-39	174	13	antibodies	antibodie	VERB
aji-39	174	14	in	in	ADP
aji-39	174	15	the	the	DET
aji-39	174	16	medical	medical	ADJ
aji-39	174	17	microbiology	microbiology	NOUN
aji-39	174	18	laboratory	laboratory	NOUN
aji-39	174	19	of	of	ADP
aji-39	174	20	afe	afe	PROPN
aji-39	174	21	babalola	babalola	PROPN
aji-39	174	22	university	university	PROPN
aji-39	174	23	ado	ado	PROPN
aji-39	174	24	-	-	PUNCT
aji-39	174	25	ekiti	ekiti	NOUN
aji-39	174	26	using	use	VERB
aji-39	174	27	the	the	DET
aji-39	174	28	enzyme	enzyme	NOUN
aji-39	174	29	-	-	PUNCT
aji-39	174	30	linked	link	VERB
aji-39	174	31	immunosorbent	immunosorbent	NOUN
aji-39	174	32	assay	assay	PROPN
aji-39	174	33	(	(	PUNCT
aji-39	174	34	elisa	elisa	NOUN
aji-39	174	35	)	)	PUNCT
aji-39	174	36	method	method	NOUN
aji-39	174	37	.	.	PUNCT
aji-39	175	1	rubella	rubella	NOUN
aji-39	175	2	igg	igg	PROPN
aji-39	175	3	and	and	CCONJ
aji-39	175	4	igm	igm	PROPN
aji-39	175	5	precoated	precoated	PROPN
aji-39	175	6	elisa	elisa	PROPN
aji-39	175	7	kits	kit	NOUN
aji-39	175	8	were	be	AUX
aji-39	175	9	obtained	obtain	VERB
aji-39	175	10	from	from	ADP
aji-39	175	11	dia	dia	PROPN
aji-39	175	12	pro	pro	PROPN
aji-39	175	13	.	.	PUNCT
aji-39	176	1	diagnostic	diagnostic	PROPN
aji-39	176	2	bioprobes	bioprobes	PROPN
aji-39	176	3	srl	srl	PROPN
aji-39	176	4	®	®	PROPN
aji-39	176	5	,	,	PUNCT
aji-39	176	6	columella	columella	PROPN
aji-39	176	7	millano	millano	PROPN
aji-39	176	8	,	,	PUNCT
aji-39	176	9	italy	italy	PROPN
aji-39	176	10	.	.	PUNCT
aji-39	177	1	the	the	DET
aji-39	177	2	analysis	analysis	NOUN
aji-39	177	3	was	be	AUX
aji-39	177	4	carried	carry	VERB
aji-39	177	5	out	out	ADP
aji-39	177	6	according	accord	VERB
aji-39	177	7	to	to	ADP
aji-39	177	8	the	the	DET
aji-39	177	9	manufacturer	manufacturer	NOUN
aji-39	177	10	’s	’s	PART
aji-39	177	11	instructions	instruction	NOUN
aji-39	177	12	.	.	PUNCT
aji-39	178	1	briefly	briefly	ADV
aji-39	178	2	,	,	PUNCT
aji-39	178	3	reagents	reagent	NOUN
aji-39	178	4	provided	provide	VERB
aji-39	178	5	were	be	AUX
aji-39	178	6	allowed	allow	VERB
aji-39	178	7	to	to	PART
aji-39	178	8	attain	attain	VERB
aji-39	178	9	room	room	NOUN
aji-39	178	10	temperature	temperature	NOUN
aji-39	178	11	for	for	ADP
aji-39	178	12	15	15	NUM
aji-39	178	13	minutes	minute	NOUN
aji-39	178	14	before	before	ADP
aji-39	178	15	use	use	NOUN
aji-39	178	16	.	.	PUNCT
aji-39	179	1	the	the	DET
aji-39	179	2	40x	40x	NOUN
aji-39	179	3	wash	wash	NOUN
aji-39	179	4	buffer	buffer	NOUN
aji-39	179	5	was	be	AUX
aji-39	179	6	diluted	dilute	VERB
aji-39	179	7	with	with	ADP
aji-39	179	8	distilled	distil	VERB
aji-39	179	9	water	water	NOUN
aji-39	179	10	using	use	VERB
aji-39	179	11	a	a	DET
aji-39	179	12	ratio	ratio	NOUN
aji-39	179	13	of	of	ADP
aji-39	179	14	1:40	1:40	NUM
aji-39	179	15	before	before	ADP
aji-39	179	16	use	use	NOUN
aji-39	179	17	.	.	PUNCT
aji-39	180	1	the	the	DET
aji-39	180	2	micro	micro	ADJ
aji-39	180	3	-	-	ADJ
aji-39	180	4	titer	titer	ADJ
aji-39	180	5	plate	plate	NOUN
aji-39	180	6	template	template	NOUN
aji-39	180	7	was	be	AUX
aji-39	180	8	set	set	VERB
aji-39	180	9	up	up	ADP
aji-39	180	10	with	with	ADP
aji-39	180	11	1	1	NUM
aji-39	180	12	well	well	ADV
aji-39	180	13	as	as	ADV
aji-39	180	14	blank	blank	ADJ
aji-39	180	15	,	,	PUNCT
aji-39	180	16	2	2	NUM
aji-39	180	17	wells	well	NOUN
aji-39	180	18	as	as	ADP
aji-39	180	19	negative	negative	ADJ
aji-39	180	20	control	control	NOUN
aji-39	180	21	and	and	CCONJ
aji-39	180	22	2	2	NUM
aji-39	180	23	wells	well	NOUN
aji-39	180	24	as	as	ADP
aji-39	180	25	the	the	DET
aji-39	180	26	positive	positive	ADJ
aji-39	180	27	control	control	NOUN
aji-39	180	28	.	.	PUNCT
aji-39	181	1	10	10	NUM
aji-39	181	2	µl	µl	NOUN
aji-39	181	3	of	of	ADP
aji-39	181	4	sera	sera	NOUN
aji-39	181	5	sample	sample	NOUN
aji-39	181	6	and	and	CCONJ
aji-39	181	7	90µl	90µl	ADJ
aji-39	181	8	sample	sample	NOUN
aji-39	181	9	diluent	diluent	NOUN
aji-39	181	10	were	be	AUX
aji-39	181	11	dispensed	dispense	VERB
aji-39	181	12	into	into	ADP
aji-39	181	13	the	the	DET
aji-39	181	14	respective	respective	ADJ
aji-39	181	15	wells	well	NOUN
aji-39	181	16	except	except	SCONJ
aji-39	181	17	for	for	ADP
aji-39	181	18	the	the	DET
aji-39	181	19	blank	blank	ADJ
aji-39	181	20	well	well	INTJ
aji-39	181	21	,	,	PUNCT
aji-39	181	22	negative	negative	ADJ
aji-39	181	23	control	control	NOUN
aji-39	181	24	well	well	ADV
aji-39	181	25	and	and	CCONJ
aji-39	181	26	positive	positive	ADJ
aji-39	181	27	control	control	NOUN
aji-39	181	28	well	well	ADV
aji-39	181	29	.	.	PUNCT
aji-39	182	1	100	100	NUM
aji-39	182	2	µl	µl	ADP
aji-39	182	3	of	of	ADP
aji-39	182	4	the	the	DET
aji-39	182	5	negative	negative	ADJ
aji-39	182	6	and	and	CCONJ
aji-39	182	7	positive	positive	ADJ
aji-39	182	8	controls	control	NOUN
aji-39	182	9	were	be	AUX
aji-39	182	10	dispensed	dispense	VERB
aji-39	182	11	into	into	ADP
aji-39	182	12	their	their	PRON
aji-39	182	13	wells	well	NOUN
aji-39	182	14	respectively	respectively	ADV
aji-39	182	15	.	.	PUNCT
aji-39	183	1	the	the	DET
aji-39	183	2	content	content	NOUN
aji-39	183	3	was	be	AUX
aji-39	183	4	mixed	mix	VERB
aji-39	183	5	by	by	ADP
aji-39	183	6	vibrating	vibrate	VERB
aji-39	183	7	the	the	DET
aji-39	183	8	plate	plate	NOUN
aji-39	183	9	gently	gently	ADV
aji-39	183	10	.	.	PUNCT
aji-39	184	1	the	the	DET
aji-39	184	2	microplate	microplate	NOUN
aji-39	184	3	was	be	AUX
aji-39	184	4	covered	cover	VERB
aji-39	184	5	with	with	ADP
aji-39	184	6	a	a	DET
aji-39	184	7	sealing	sealing	NOUN
aji-39	184	8	paper	paper	NOUN
aji-39	184	9	and	and	CCONJ
aji-39	184	10	incubated	incubate	VERB
aji-39	184	11	in	in	ADP
aji-39	184	12	a	a	DET
aji-39	184	13	microplate	microplate	NOUN
aji-39	184	14	incubator	incubator	NOUN
aji-39	184	15	(	(	PUNCT
aji-39	184	16	marvotech	marvotech	NOUN
aji-39	184	17	plate	plate	NOUN
aji-39	184	18	incubator	incubator	NOUN
aji-39	184	19	,	,	PUNCT
aji-39	184	20	china	china	PROPN
aji-39	184	21	)	)	PUNCT
aji-39	184	22	at	at	ADP
aji-39	184	23	37	37	NUM
aji-39	184	24	°	°	ADP
aji-39	184	25	c	c	NOUN
aji-39	184	26	for	for	ADP
aji-39	184	27	60	60	NUM
aji-39	184	28	minutes	minute	NOUN
aji-39	184	29	[	[	X
aji-39	184	30	21	21	NUM
aji-39	184	31	]	]	PUNCT
aji-39	184	32	.	.	PUNCT
aji-39	185	1	after	after	ADP
aji-39	185	2	incubation	incubation	NOUN
aji-39	185	3	,	,	PUNCT
aji-39	185	4	the	the	DET
aji-39	185	5	microplate	microplate	NOUN
aji-39	185	6	was	be	AUX
aji-39	185	7	washed	wash	VERB
aji-39	185	8	five	five	NUM
aji-39	185	9	times	time	NOUN
aji-39	185	10	using	use	VERB
aji-39	185	11	wash	wash	NOUN
aji-39	185	12	buffer	buffer	NOUN
aji-39	185	13	.	.	PUNCT
aji-39	186	1	100	100	NUM
aji-39	186	2	µl	µl	NOUN
aji-39	186	3	of	of	ADP
aji-39	186	4	horseradish	horseradish	ADJ
aji-39	186	5	peroxidase	peroxidase	NOUN
aji-39	186	6	enzyme	enzyme	NOUN
aji-39	186	7	(	(	PUNCT
aji-39	186	8	hrp	hrp	PROPN
aji-39	186	9	)	)	PUNCT
aji-39	186	10	conjugate	conjugate	NOUN
aji-39	186	11	was	be	AUX
aji-39	186	12	added	add	VERB
aji-39	186	13	to	to	ADP
aji-39	186	14	each	each	DET
aji-39	186	15	well	well	NOUN
aji-39	186	16	except	except	SCONJ
aji-39	186	17	the	the	DET
aji-39	186	18	blank	blank	NOUN
aji-39	186	19	;	;	PUNCT
aji-39	186	20	the	the	DET
aji-39	186	21	microplate	microplate	NOUN
aji-39	186	22	was	be	AUX
aji-39	186	23	covered	cover	VERB
aji-39	186	24	with	with	ADP
aji-39	186	25	a	a	DET
aji-39	186	26	sealing	sealing	NOUN
aji-39	186	27	paper	paper	NOUN
aji-39	186	28	and	and	CCONJ
aji-39	186	29	also	also	ADV
aji-39	186	30	incubated	incubate	VERB
aji-39	186	31	in	in	ADP
aji-39	186	32	a	a	DET
aji-39	186	33	microplate	microplate	NOUN
aji-39	186	34	incubator	incubator	NOUN
aji-39	186	35	at	at	ADP
aji-39	186	36	37	37	NUM
aji-39	186	37	°	°	ADP
aji-39	186	38	c	c	NOUN
aji-39	186	39	for	for	ADP
aji-39	186	40	15	15	NUM
aji-39	186	41	minutes	minute	NOUN
aji-39	186	42	.	.	PUNCT
aji-39	187	1	after	after	ADP
aji-39	187	2	incubation	incubation	NOUN
aji-39	187	3	,	,	PUNCT
aji-39	187	4	the	the	DET
aji-39	187	5	microplate	microplate	NOUN
aji-39	187	6	was	be	AUX
aji-39	187	7	washed	wash	VERB
aji-39	187	8	five	five	NUM
aji-39	187	9	times	time	NOUN
aji-39	187	10	with	with	ADP
aji-39	187	11	the	the	DET
aji-39	187	12	diluted	dilute	VERB
aji-39	187	13	wash	wash	NOUN
aji-39	187	14	buffer	buffer	NOUN
aji-39	187	15	in	in	ADP
aji-39	187	16	an	an	DET
aji-39	187	17	automatic	automatic	ADJ
aji-39	187	18	plate	plate	NOUN
aji-39	187	19	washer	washer	NOUN
aji-39	187	20	(	(	PUNCT
aji-39	187	21	marvotech	marvotech	NOUN
aji-39	187	22	plate	plate	NOUN
aji-39	187	23	washer	washer	NOUN
aji-39	187	24	,	,	PUNCT
aji-39	187	25	china	china	PROPN
aji-39	187	26	)	)	PUNCT
aji-39	188	1	[	[	X
aji-39	188	2	21	21	NUM
aji-39	188	3	]	]	PUNCT
aji-39	188	4	.	.	PUNCT
aji-39	189	1	50	50	NUM
aji-39	189	2	µl	µl	NOUN
aji-39	189	3	of	of	ADP
aji-39	189	4	substrate	substrate	NOUN
aji-39	189	5	solution	solution	NOUN
aji-39	189	6	a	a	PRON
aji-39	189	7	and	and	CCONJ
aji-39	189	8	b	b	NOUN
aji-39	189	9	were	be	AUX
aji-39	189	10	added	add	VERB
aji-39	189	11	to	to	ADP
aji-39	189	12	each	each	DET
aji-39	189	13	well	well	ADV
aji-39	189	14	respectively	respectively	ADV
aji-39	189	15	and	and	CCONJ
aji-39	189	16	were	be	AUX
aji-39	189	17	mixed	mix	VERB
aji-39	189	18	;	;	PUNCT
aji-39	189	19	the	the	DET
aji-39	189	20	plate	plate	NOUN
aji-39	189	21	was	be	AUX
aji-39	189	22	covered	cover	VERB
aji-39	189	23	and	and	CCONJ
aji-39	189	24	incubated	incubate	VERB
aji-39	189	25	at	at	ADP
aji-39	189	26	37	37	NUM
aji-39	189	27	°	°	ADP
aji-39	189	28	c	c	NOUN
aji-39	189	29	for	for	ADP
aji-39	189	30	15	15	NUM
aji-39	189	31	minutes	minute	NOUN
aji-39	189	32	.	.	PUNCT
aji-39	190	1	50	50	NUM
aji-39	190	2	µl	µl	NOUN
aji-39	190	3	of	of	ADP
aji-39	190	4	stop	stop	NOUN
aji-39	190	5	solution	solution	NOUN
aji-39	190	6	was	be	AUX
aji-39	190	7	added	add	VERB
aji-39	190	8	to	to	ADP
aji-39	190	9	each	each	DET
aji-39	190	10	well	well	ADV
aji-39	190	11	and	and	CCONJ
aji-39	190	12	mixed	mixed	ADJ
aji-39	190	13	.	.	PUNCT
aji-39	191	1	the	the	DET
aji-39	191	2	absorbance	absorbance	NOUN
aji-39	191	3	was	be	AUX
aji-39	191	4	read	read	VERB
aji-39	191	5	in	in	ADP
aji-39	191	6	an	an	DET
aji-39	191	7	elisa	elisa	NOUN
aji-39	191	8	reader	reader	NOUN
aji-39	191	9	machine	machine	NOUN
aji-39	191	10	(	(	PUNCT
aji-39	191	11	marvotech	marvotech	PROPN
aji-39	191	12	elisa	elisa	PROPN
aji-39	191	13	reader	reader	PROPN
aji-39	191	14	,	,	PUNCT
aji-39	191	15	china	china	PROPN
aji-39	191	16	)	)	PUNCT
aji-39	191	17	at	at	ADP
aji-39	191	18	a	a	DET
aji-39	191	19	wavelength	wavelength	NOUN
aji-39	191	20	of	of	ADP
aji-39	191	21	450	450	NUM
aji-39	191	22	nm	nm	NOUN
aji-39	191	23	[	[	X
aji-39	191	24	21	21	NUM
aji-39	191	25	]	]	PUNCT
aji-39	191	26	.	.	PUNCT
aji-39	192	1	2.31	2.31	NUM
aji-39	192	2	interpretation	interpretation	NOUN
aji-39	192	3	of	of	ADP
aji-39	192	4	rubella	rubella	NOUN
aji-39	192	5	igg	igg	PROPN
aji-39	192	6	/	/	SYM
aji-39	192	7	igm	igm	PROPN
aji-39	192	8	result	result	VERB
aji-39	192	9	if	if	SCONJ
aji-39	192	10	the	the	DET
aji-39	192	11	mean	mean	ADJ
aji-39	192	12	negative	negative	ADJ
aji-39	192	13	control	control	NOUN
aji-39	192	14	o.d	o.d	PROPN
aji-39	192	15	≤	≤	NUM
aji-39	192	16	0.1and	0.1and	NOUN
aji-39	192	17	the	the	DET
aji-39	192	18	mean	mean	ADJ
aji-39	192	19	positive	positive	ADJ
aji-39	192	20	control	control	NOUN
aji-39	192	21	o.d	o.d	PROPN
aji-39	192	22	≥	≥	NUM
aji-39	192	23	0.8	0.8	NUM
aji-39	192	24	,	,	PUNCT
aji-39	192	25	the	the	DET
aji-39	192	26	test	test	NOUN
aji-39	192	27	is	be	AUX
aji-39	192	28	valid	valid	ADJ
aji-39	192	29	.	.	PUNCT
aji-39	193	1	cut	cut	VERB
aji-39	193	2	-	-	PUNCT
aji-39	193	3	off	off	ADP
aji-39	193	4	o.d	o.d	PROPN
aji-39	193	5	=	=	NOUN
aji-39	193	6	the	the	DET
aji-39	193	7	mean	mean	INTJ
aji-39	193	8	o.d	o.d	NOUN
aji-39	193	9	value	value	NOUN
aji-39	193	10	of	of	ADP
aji-39	193	11	the	the	DET
aji-39	193	12	negative	negative	ADJ
aji-39	193	13	control	control	NOUN
aji-39	193	14	×	×	NOUN
aji-39	193	15	2.1	2.1	NUM
aji-39	193	16	positive	positive	ADJ
aji-39	193	17	results	result	NOUN
aji-39	193	18	:	:	PUNCT
aji-39	193	19	sample	sample	PROPN
aji-39	193	20	o.d	o.d	PROPN
aji-39	193	21	≥	≥	PROPN
aji-39	193	22	cut	cut	VERB
aji-39	193	23	-	-	PUNCT
aji-39	193	24	off	off	ADP
aji-39	193	25	o.d	o.d	PROPN
aji-39	193	26	negative	negative	ADJ
aji-39	193	27	results	result	NOUN
aji-39	193	28	:	:	PUNCT
aji-39	193	29	sample	sample	NOUN
aji-39	193	30	o.d	o.d	X
aji-39	193	31	<	<	X
aji-39	193	32	cut	cut	VERB
aji-39	193	33	-	-	PUNCT
aji-39	193	34	off	off	ADP
aji-39	193	35	o.d	o.d	PROPN
aji-39	193	36	2.4	2.4	NUM
aji-39	193	37	statistical	statistical	ADJ
aji-39	193	38	analysis	analysis	NOUN
aji-39	193	39	the	the	DET
aji-39	193	40	data	datum	NOUN
aji-39	193	41	obtained	obtain	VERB
aji-39	193	42	from	from	ADP
aji-39	193	43	questionnaires	questionnaire	NOUN
aji-39	193	44	administered	administer	VERB
aji-39	193	45	and	and	CCONJ
aji-39	193	46	those	those	PRON
aji-39	193	47	obtained	obtain	VERB
aji-39	193	48	from	from	ADP
aji-39	193	49	the	the	DET
aji-39	193	50	laboratory	laboratory	NOUN
aji-39	193	51	analysis	analysis	NOUN
aji-39	193	52	were	be	AUX
aji-39	193	53	managed	manage	VERB
aji-39	193	54	and	and	CCONJ
aji-39	193	55	analyzed	analyze	VERB
aji-39	193	56	using	use	VERB
aji-39	193	57	the	the	DET
aji-39	193	58	epi	epi	NOUN
aji-39	193	59	-	-	NOUN
aji-39	193	60	info	info	NOUN
aji-39	193	61	version	version	NOUN
aji-39	193	62	7.2	7.2	NUM
aji-39	193	63	statistical	statistical	ADJ
aji-39	193	64	akele	akele	NOUN
aji-39	193	65	et	et	PROPN
aji-39	193	66	al	al	PROPN
aji-39	193	67	.	.	PROPN
aji-39	193	68	;	;	PUNCT
aji-39	193	69	aji	aji	PROPN
aji-39	193	70	,	,	PUNCT
aji-39	193	71	3(1	3(1	NUM
aji-39	193	72	):	):	PUNCT
aji-39	193	73	199	199	NUM
aji-39	193	74	-	-	SYM
aji-39	193	75	207	207	NUM
aji-39	193	76	,	,	PUNCT
aji-39	193	77	2020	2020	NUM
aji-39	193	78	;	;	PUNCT
aji-39	193	79	article	article	NOUN
aji-39	193	80	no.aji.57099	no.aji.57099	VERB
aji-39	193	81	202	202	NUM
aji-39	193	82	package	package	NOUN
aji-39	193	83	.	.	PUNCT
aji-39	194	1	results	result	NOUN
aji-39	194	2	were	be	AUX
aji-39	194	3	reduced	reduce	VERB
aji-39	194	4	to	to	ADP
aji-39	194	5	percentiles	percentile	NOUN
aji-39	194	6	and	and	CCONJ
aji-39	194	7	a	a	DET
aji-39	194	8	pearson	pearson	NOUN
aji-39	194	9	chi	chi	PROPN
aji-39	194	10	-	-	PUNCT
aji-39	194	11	square	square	PROPN
aji-39	194	12	test	test	NOUN
aji-39	194	13	was	be	AUX
aji-39	194	14	performed	perform	VERB
aji-39	194	15	at	at	ADP
aji-39	194	16	a	a	DET
aji-39	194	17	95	95	NUM
aji-39	194	18	%	%	NOUN
aji-39	194	19	confidence	confidence	NOUN
aji-39	194	20	interval	interval	NOUN
aji-39	194	21	.	.	PUNCT
aji-39	195	1	p	p	X
aji-39	195	2	-	-	PUNCT
aji-39	195	3	values	value	NOUN
aji-39	195	4	less	less	ADJ
aji-39	195	5	than	than	ADP
aji-39	195	6	0.05	0.05	NUM
aji-39	195	7	(	(	PUNCT
aji-39	195	8	p	p	X
aji-39	195	9	<	<	X
aji-39	195	10	0.05	0.05	NUM
aji-39	195	11	)	)	PUNCT
aji-39	195	12	was	be	AUX
aji-39	195	13	used	use	VERB
aji-39	195	14	to	to	PART
aji-39	195	15	determine	determine	VERB
aji-39	195	16	relationships	relationship	NOUN
aji-39	195	17	between	between	ADP
aji-39	195	18	parameters	parameter	NOUN
aji-39	195	19	evaluated	evaluate	VERB
aji-39	195	20	and	and	CCONJ
aji-39	195	21	seroprevalence	seroprevalence	NOUN
aji-39	195	22	.	.	PUNCT
aji-39	196	1	3	3	X
aji-39	196	2	.	.	NOUN
aji-39	196	3	results	result	NOUN
aji-39	196	4	and	and	CCONJ
aji-39	196	5	discussion	discussion	NOUN
aji-39	196	6	a	a	DET
aji-39	196	7	total	total	NOUN
aji-39	196	8	of	of	ADP
aji-39	196	9	one	one	NUM
aji-39	196	10	hundred	hundred	NUM
aji-39	196	11	and	and	CCONJ
aji-39	196	12	eighty	eighty	NUM
aji-39	196	13	-	-	PUNCT
aji-39	196	14	four	four	NUM
aji-39	196	15	pregnant	pregnant	ADJ
aji-39	196	16	women	woman	NOUN
aji-39	196	17	attending	attend	VERB
aji-39	196	18	antenatal	antenatal	ADJ
aji-39	196	19	clinic	clinic	NOUN
aji-39	196	20	at	at	ADP
aji-39	196	21	the	the	DET
aji-39	196	22	federal	federal	ADJ
aji-39	196	23	teaching	teaching	NOUN
aji-39	196	24	hospital	hospital	NOUN
aji-39	197	1	ado	ado	INTJ
aji-39	198	1	ekiti	ekiti	PROPN
aji-39	198	2	were	be	AUX
aji-39	198	3	enrolled	enrol	VERB
aji-39	198	4	in	in	ADP
aji-39	198	5	this	this	DET
aji-39	198	6	study	study	NOUN
aji-39	198	7	.	.	PUNCT
aji-39	199	1	their	their	PRON
aji-39	199	2	ages	age	NOUN
aji-39	199	3	ranged	range	VERB
aji-39	199	4	between	between	ADP
aji-39	199	5	16	16	NUM
aji-39	199	6	to	to	PART
aji-39	199	7	41	41	NUM
aji-39	199	8	years	year	NOUN
aji-39	199	9	with	with	ADP
aji-39	199	10	a	a	DET
aji-39	199	11	mean	mean	ADJ
aji-39	199	12	age	age	NOUN
aji-39	199	13	of	of	ADP
aji-39	199	14	28±13	28±13	NUM
aji-39	199	15	years	year	NOUN
aji-39	199	16	(	(	PUNCT
aji-39	199	17	table	table	NOUN
aji-39	199	18	1	1	NUM
aji-39	199	19	)	)	PUNCT
aji-39	199	20	.	.	PUNCT
aji-39	200	1	one	one	NUM
aji-39	200	2	hundred	hundred	NUM
aji-39	200	3	and	and	CCONJ
aji-39	200	4	seventy	seventy	NUM
aji-39	200	5	-	-	PUNCT
aji-39	200	6	six	six	NUM
aji-39	200	7	(	(	PUNCT
aji-39	200	8	95.6	95.6	NUM
aji-39	200	9	%	%	NOUN
aji-39	200	10	)	)	PUNCT
aji-39	200	11	of	of	ADP
aji-39	200	12	the	the	DET
aji-39	200	13	subjects	subject	NOUN
aji-39	200	14	were	be	AUX
aji-39	200	15	seropositive	seropositive	ADJ
aji-39	200	16	for	for	ADP
aji-39	200	17	rubella	rubella	NOUN
aji-39	200	18	igg	igg	NOUN
aji-39	200	19	and	and	CCONJ
aji-39	200	20	22	22	NUM
aji-39	200	21	(	(	PUNCT
aji-39	200	22	12.0	12.0	NUM
aji-39	200	23	%	%	NOUN
aji-39	200	24	)	)	PUNCT
aji-39	200	25	for	for	ADP
aji-39	200	26	rubella	rubella	NOUN
aji-39	200	27	igm	igm	PROPN
aji-39	200	28	.	.	PROPN
aji-39	201	1	twenty	twenty	NUM
aji-39	201	2	(	(	PUNCT
aji-39	201	3	10.9	10.9	NUM
aji-39	201	4	%	%	NOUN
aji-39	201	5	)	)	PUNCT
aji-39	201	6	were	be	AUX
aji-39	201	7	seropositive	seropositive	ADJ
aji-39	201	8	for	for	ADP
aji-39	201	9	both	both	DET
aji-39	201	10	rubella	rubella	NOUN
aji-39	201	11	igg	igg	PROPN
aji-39	201	12	and	and	CCONJ
aji-39	201	13	igm	igm	PROPN
aji-39	201	14	,	,	PUNCT
aji-39	201	15	2	2	NUM
aji-39	201	16	(	(	PUNCT
aji-39	201	17	1.1	1.1	NUM
aji-39	201	18	%	%	NOUN
aji-39	201	19	)	)	PUNCT
aji-39	201	20	only	only	ADV
aji-39	201	21	for	for	ADP
aji-39	201	22	rubella	rubella	NOUN
aji-39	201	23	igm	igm	NOUN
aji-39	201	24	;	;	PUNCT
aji-39	201	25	and	and	CCONJ
aji-39	201	26	154	154	NUM
aji-39	201	27	(	(	PUNCT
aji-39	201	28	83.7	83.7	NUM
aji-39	201	29	%	%	NOUN
aji-39	201	30	)	)	PUNCT
aji-39	201	31	for	for	SCONJ
aji-39	201	32	rubella	rubella	NOUN
aji-39	201	33	igg	igg	PROPN
aji-39	201	34	.	.	PROPN
aji-39	201	35	seropositivity	seropositivity	PROPN
aji-39	201	36	was	be	AUX
aji-39	201	37	higher	high	ADJ
aji-39	201	38	among	among	ADP
aji-39	201	39	age	age	NOUN
aji-39	201	40	group	group	NOUN
aji-39	201	41	above	above	ADP
aji-39	201	42	35	35	NUM
aji-39	201	43	years	year	NOUN
aji-39	201	44	:	:	PUNCT
aji-39	201	45	12	12	NUM
aji-39	201	46	(	(	PUNCT
aji-39	201	47	100	100	NUM
aji-39	201	48	%	%	NOUN
aji-39	201	49	)	)	PUNCT
aji-39	201	50	for	for	ADP
aji-39	201	51	igg	igg	PROPN
aji-39	201	52	and	and	CCONJ
aji-39	201	53	age	age	NOUN
aji-39	201	54	group	group	NOUN
aji-39	201	55	31	31	NUM
aji-39	201	56	-	-	SYM
aji-39	201	57	35	35	NUM
aji-39	201	58	years	year	NOUN
aji-39	201	59	,	,	PUNCT
aji-39	201	60	6	6	NUM
aji-39	201	61	(	(	PUNCT
aji-39	201	62	18.8	18.8	NUM
aji-39	201	63	)	)	PUNCT
aji-39	201	64	for	for	ADP
aji-39	201	65	igm	igm	PROPN
aji-39	201	66	(	(	PUNCT
aji-39	201	67	table	table	NOUN
aji-39	201	68	1	1	NUM
aji-39	201	69	)	)	PUNCT
aji-39	201	70	.	.	PUNCT
aji-39	202	1	the	the	DET
aji-39	202	2	distribution	distribution	NOUN
aji-39	202	3	was	be	AUX
aji-39	202	4	however	however	ADV
aji-39	202	5	non	non	ADJ
aji-39	202	6	-	-	ADJ
aji-39	202	7	statistically	statistically	ADV
aji-39	202	8	significant	significant	ADJ
aji-39	202	9	(	(	PUNCT
aji-39	202	10	p	p	X
aji-39	202	11	=	=	NOUN
aji-39	202	12	0.50	0.50	NUM
aji-39	202	13	and	and	CCONJ
aji-39	202	14	0.85	0.85	NUM
aji-39	202	15	respectively	respectively	ADV
aji-39	202	16	)	)	PUNCT
aji-39	202	17	.	.	PUNCT
aji-39	203	1	higher	high	ADJ
aji-39	203	2	but	but	CCONJ
aji-39	203	3	non	non	ADJ
aji-39	203	4	-	-	ADJ
aji-39	203	5	significant	significant	ADJ
aji-39	203	6	proportion	proportion	NOUN
aji-39	203	7	of	of	ADP
aji-39	203	8	subjects	subject	NOUN
aji-39	203	9	in	in	ADP
aji-39	203	10	the	the	DET
aji-39	203	11	third	third	ADJ
aji-39	203	12	trimester	trimester	NOUN
aji-39	203	13	62	62	NUM
aji-39	203	14	(	(	PUNCT
aji-39	203	15	98.4	98.4	NUM
aji-39	203	16	%	%	NOUN
aji-39	203	17	)	)	PUNCT
aji-39	203	18	and	and	CCONJ
aji-39	203	19	second	second	ADJ
aji-39	203	20	trimester	trimester	NOUN
aji-39	203	21	84	84	NUM
aji-39	203	22	(	(	PUNCT
aji-39	203	23	96.6	96.6	NUM
aji-39	203	24	%	%	NOUN
aji-39	203	25	)	)	PUNCT
aji-39	203	26	as	as	ADP
aji-39	203	27	against	against	ADP
aji-39	203	28	30	30	NUM
aji-39	203	29	(	(	PUNCT
aji-39	203	30	88.2	88.2	NUM
aji-39	203	31	%	%	NOUN
aji-39	203	32	)	)	PUNCT
aji-39	203	33	in	in	ADP
aji-39	203	34	the	the	DET
aji-39	203	35	first	first	ADJ
aji-39	203	36	trimester	trimester	NOUN
aji-39	203	37	were	be	AUX
aji-39	203	38	seropositive	seropositive	ADJ
aji-39	203	39	for	for	ADP
aji-39	203	40	igg	igg	PROPN
aji-39	203	41	.	.	PUNCT
aji-39	204	1	in	in	ADP
aji-39	204	2	contrast	contrast	NOUN
aji-39	204	3	to	to	ADP
aji-39	204	4	this	this	DET
aji-39	204	5	pattern	pattern	NOUN
aji-39	204	6	,	,	PUNCT
aji-39	204	7	a	a	DET
aji-39	204	8	higher	high	ADJ
aji-39	204	9	proportion	proportion	NOUN
aji-39	204	10	of	of	ADP
aji-39	204	11	the	the	DET
aji-39	204	12	subjects	subject	NOUN
aji-39	204	13	in	in	ADP
aji-39	204	14	first	first	ADJ
aji-39	204	15	trimester	trimester	NOUN
aji-39	204	16	8	8	NUM
aji-39	204	17	(	(	PUNCT
aji-39	204	18	23.5	23.5	NUM
aji-39	204	19	%	%	NOUN
aji-39	204	20	)	)	PUNCT
aji-39	204	21	and	and	CCONJ
aji-39	204	22	second	second	ADJ
aji-39	204	23	trimester	trimester	NOUN
aji-39	204	24	12	12	NUM
aji-39	204	25	(	(	PUNCT
aji-39	204	26	13.8	13.8	NUM
aji-39	204	27	%	%	NOUN
aji-39	204	28	)	)	PUNCT
aji-39	204	29	as	as	ADP
aji-39	204	30	against	against	ADP
aji-39	204	31	2	2	NUM
aji-39	204	32	(	(	PUNCT
aji-39	204	33	3.2	3.2	NUM
aji-39	204	34	%	%	NOUN
aji-39	204	35	)	)	PUNCT
aji-39	204	36	in	in	ADP
aji-39	204	37	the	the	DET
aji-39	204	38	third	third	ADJ
aji-39	204	39	trimester	trimester	NOUN
aji-39	204	40	were	be	AUX
aji-39	204	41	seropositive	seropositive	ADJ
aji-39	204	42	for	for	ADP
aji-39	204	43	rubella	rubella	NOUN
aji-39	204	44	igm	igm	PROPN
aji-39	204	45	.	.	PUNCT
aji-39	205	1	the	the	DET
aji-39	205	2	highest	high	ADJ
aji-39	205	3	rate	rate	NOUN
aji-39	205	4	of	of	ADP
aji-39	205	5	co	co	NOUN
aji-39	205	6	-	-	NOUN
aji-39	205	7	positivity	positivity	NOUN
aji-39	205	8	for	for	ADP
aji-39	205	9	rubella	rubella	NOUN
aji-39	205	10	igg	igg	PROPN
aji-39	205	11	and	and	CCONJ
aji-39	205	12	igm	igm	PROPN
aji-39	205	13	was	be	AUX
aji-39	205	14	observed	observe	VERB
aji-39	205	15	in	in	ADP
aji-39	205	16	the	the	DET
aji-39	205	17	second	second	ADJ
aji-39	205	18	trimester	trimester	NOUN
aji-39	205	19	15	15	NUM
aji-39	205	20	(	(	PUNCT
aji-39	205	21	17.2	17.2	NUM
aji-39	205	22	%	%	NOUN
aji-39	205	23	)	)	PUNCT
aji-39	205	24	(	(	PUNCT
aji-39	205	25	table	table	NOUN
aji-39	205	26	2	2	NUM
aji-39	205	27	)	)	PUNCT
aji-39	205	28	.	.	PUNCT
aji-39	206	1	the	the	DET
aji-39	206	2	married	married	ADJ
aji-39	206	3	ones	one	NOUN
aji-39	206	4	among	among	ADP
aji-39	206	5	the	the	DET
aji-39	206	6	subjects	subject	NOUN
aji-39	206	7	had	have	VERB
aji-39	206	8	a	a	DET
aji-39	206	9	higher	high	ADJ
aji-39	206	10	seroprevalence	seroprevalence	NOUN
aji-39	206	11	152	152	NUM
aji-39	206	12	(	(	PUNCT
aji-39	206	13	97.4	97.4	NUM
aji-39	206	14	%	%	NOUN
aji-39	206	15	)	)	PUNCT
aji-39	206	16	for	for	ADP
aji-39	206	17	rubella	rubella	NOUN
aji-39	206	18	igg	igg	PROPN
aji-39	206	19	while	while	SCONJ
aji-39	206	20	the	the	DET
aji-39	206	21	singles	single	NOUN
aji-39	206	22	had	have	VERB
aji-39	206	23	a	a	DET
aji-39	206	24	higher	high	ADJ
aji-39	206	25	seroprevalence	seroprevalence	NOUN
aji-39	206	26	6	6	NUM
aji-39	206	27	(	(	PUNCT
aji-39	206	28	26.1	26.1	NUM
aji-39	206	29	%	%	NOUN
aji-39	206	30	)	)	PUNCT
aji-39	206	31	for	for	ADP
aji-39	206	32	rubella	rubella	NOUN
aji-39	206	33	igm	igm	NOUN
aji-39	206	34	(	(	PUNCT
aji-39	206	35	table	table	NOUN
aji-39	206	36	3	3	NUM
aji-39	206	37	)	)	PUNCT
aji-39	206	38	.	.	PUNCT
aji-39	207	1	the	the	DET
aji-39	207	2	subjects	subject	NOUN
aji-39	207	3	with	with	ADP
aji-39	207	4	no	no	DET
aji-39	207	5	form	form	NOUN
aji-39	207	6	of	of	ADP
aji-39	207	7	formal	formal	ADJ
aji-39	207	8	education	education	NOUN
aji-39	207	9	,	,	PUNCT
aji-39	207	10	zero	zero	NUM
aji-39	207	11	number	number	NOUN
aji-39	207	12	of	of	ADP
aji-39	207	13	parity	parity	NOUN
aji-39	207	14	and	and	CCONJ
aji-39	207	15	some	some	DET
aji-39	207	16	level	level	NOUN
aji-39	207	17	of	of	ADP
aji-39	207	18	knowledge	knowledge	NOUN
aji-39	207	19	of	of	ADP
aji-39	207	20	the	the	DET
aji-39	207	21	virus	virus	NOUN
aji-39	207	22	had	have	VERB
aji-39	207	23	the	the	DET
aji-39	207	24	least	least	ADJ
aji-39	207	25	seroprevalence	seroprevalence	NOUN
aji-39	207	26	for	for	ADP
aji-39	207	27	rubella	rubella	NOUN
aji-39	207	28	igg	igg	NOUN
aji-39	207	29	3	3	NUM
aji-39	207	30	(	(	PUNCT
aji-39	207	31	60.0	60.0	NUM
aji-39	207	32	%	%	NOUN
aji-39	207	33	)	)	PUNCT
aji-39	207	34	,	,	PUNCT
aji-39	207	35	53	53	NUM
aji-39	207	36	(	(	PUNCT
aji-39	207	37	91.3	91.3	NUM
aji-39	207	38	%	%	NOUN
aji-39	207	39	)	)	PUNCT
aji-39	207	40	,	,	PUNCT
aji-39	207	41	32	32	NUM
aji-39	207	42	(	(	PUNCT
aji-39	207	43	94.1	94.1	NUM
aji-39	207	44	%	%	NOUN
aji-39	207	45	)	)	PUNCT
aji-39	207	46	respectively	respectively	ADV
aji-39	207	47	.	.	PUNCT
aji-39	208	1	on	on	ADP
aji-39	208	2	the	the	DET
aji-39	208	3	other	other	ADJ
aji-39	208	4	hand	hand	NOUN
aji-39	208	5	,	,	PUNCT
aji-39	208	6	those	those	PRON
aji-39	208	7	with	with	ADP
aji-39	208	8	zero	zero	NUM
aji-39	208	9	number	number	NOUN
aji-39	208	10	of	of	ADP
aji-39	208	11	parity	parity	NOUN
aji-39	208	12	had	have	VERB
aji-39	208	13	significant	significant	ADJ
aji-39	208	14	(	(	PUNCT
aji-39	208	15	p	p	X
aji-39	208	16	=	=	NOUN
aji-39	208	17	0.04	0.04	NUM
aji-39	208	18	)	)	PUNCT
aji-39	208	19	seronegativity	seronegativity	NOUN
aji-39	208	20	for	for	ADP
aji-39	208	21	rubella	rubella	NOUN
aji-39	208	22	igm	igm	NOUN
aji-39	208	23	56	56	NUM
aji-39	208	24	(	(	PUNCT
aji-39	208	25	93.6	93.6	NUM
aji-39	208	26	%	%	NOUN
aji-39	208	27	)	)	PUNCT
aji-39	208	28	.	.	PUNCT
aji-39	209	1	despite	despite	SCONJ
aji-39	209	2	the	the	DET
aji-39	209	3	global	global	ADJ
aji-39	209	4	public	public	ADJ
aji-39	209	5	health	health	NOUN
aji-39	209	6	implication	implication	NOUN
aji-39	209	7	of	of	ADP
aji-39	209	8	rubella	rubella	NOUN
aji-39	209	9	infection	infection	NOUN
aji-39	209	10	which	which	PRON
aji-39	209	11	has	have	AUX
aji-39	209	12	stimulated	stimulate	VERB
aji-39	209	13	the	the	DET
aji-39	209	14	endorsement	endorsement	NOUN
aji-39	209	15	of	of	ADP
aji-39	209	16	the	the	DET
aji-39	209	17	global	global	ADJ
aji-39	209	18	measles	measle	NOUN
aji-39	209	19	and	and	CCONJ
aji-39	209	20	rubella	rubella	NOUN
aji-39	209	21	strategic	strategic	ADJ
aji-39	209	22	plan	plan	NOUN
aji-39	209	23	in	in	ADP
aji-39	209	24	2012	2012	NUM
aji-39	209	25	,	,	PUNCT
aji-39	209	26	which	which	PRON
aji-39	209	27	was	be	AUX
aji-39	209	28	planned	plan	VERB
aji-39	209	29	to	to	PART
aji-39	209	30	cover	cover	VERB
aji-39	209	31	2012	2012	NUM
aji-39	209	32	-	-	SYM
aji-39	209	33	2020	2020	NUM
aji-39	209	34	,	,	PUNCT
aji-39	209	35	it	it	PRON
aji-39	209	36	is	be	AUX
aji-39	209	37	a	a	DET
aji-39	209	38	thing	thing	NOUN
aji-39	209	39	of	of	ADP
aji-39	209	40	concern	concern	NOUN
aji-39	209	41	that	that	SCONJ
aji-39	209	42	there	there	PRON
aji-39	209	43	is	be	VERB
aji-39	209	44	still	still	ADV
aji-39	209	45	a	a	DET
aji-39	209	46	paucity	paucity	NOUN
aji-39	209	47	of	of	ADP
aji-39	209	48	epidemiological	epidemiological	ADJ
aji-39	209	49	data	datum	NOUN
aji-39	209	50	on	on	ADP
aji-39	209	51	seroprevalence	seroprevalence	NOUN
aji-39	209	52	of	of	ADP
aji-39	209	53	rubella	rubella	NOUN
aji-39	209	54	infection	infection	NOUN
aji-39	209	55	in	in	ADP
aji-39	209	56	nigeria	nigeria	PROPN
aji-39	209	57	.	.	PUNCT
aji-39	210	1	the	the	DET
aji-39	210	2	few	few	ADJ
aji-39	210	3	that	that	PRON
aji-39	210	4	exist	exist	VERB
aji-39	210	5	are	be	AUX
aji-39	210	6	skewed	skew	VERB
aji-39	210	7	to	to	PART
aji-39	210	8	areas	area	NOUN
aji-39	210	9	like	like	ADP
aji-39	210	10	zaria	zaria	PROPN
aji-39	210	11	,	,	PUNCT
aji-39	210	12	jos	jos	PROPN
aji-39	210	13	,	,	PUNCT
aji-39	210	14	maiduguri	maiduguri	PROPN
aji-39	210	15	,	,	PUNCT
aji-39	210	16	abia	abia	NOUN
aji-39	210	17	,	,	PUNCT
aji-39	210	18	and	and	CCONJ
aji-39	210	19	osogbo	osogbo	VERB
aji-39	210	20	.	.	PUNCT
aji-39	211	1	this	this	DET
aji-39	211	2	impact	impact	NOUN
aji-39	211	3	negatively	negatively	ADV
aji-39	211	4	on	on	ADP
aji-39	211	5	making	make	VERB
aji-39	211	6	rightful	rightful	ADJ
aji-39	211	7	decisions	decision	NOUN
aji-39	211	8	on	on	ADP
aji-39	211	9	intervention	intervention	NOUN
aji-39	211	10	approaches	approach	NOUN
aji-39	211	11	to	to	PART
aji-39	211	12	curb	curb	VERB
aji-39	211	13	the	the	DET
aji-39	211	14	incidences	incidence	NOUN
aji-39	211	15	of	of	ADP
aji-39	211	16	crs	crs	PROPN
aji-39	211	17	.	.	PUNCT
aji-39	212	1	rubella	rubella	NOUN
aji-39	212	2	igg	igg	PROPN
aji-39	212	3	serostatus	serostatus	NOUN
aji-39	212	4	is	be	AUX
aji-39	212	5	an	an	DET
aji-39	212	6	indicator	indicator	NOUN
aji-39	212	7	of	of	ADP
aji-39	212	8	previous	previous	ADJ
aji-39	212	9	exposure	exposure	NOUN
aji-39	212	10	to	to	ADP
aji-39	212	11	the	the	DET
aji-39	212	12	virus	virus	NOUN
aji-39	212	13	or	or	CCONJ
aji-39	212	14	immunization	immunization	NOUN
aji-39	212	15	,	,	PUNCT
aji-39	212	16	thus	thus	ADV
aji-39	212	17	it	it	PRON
aji-39	212	18	is	be	AUX
aji-39	212	19	used	use	VERB
aji-39	212	20	as	as	ADP
aji-39	212	21	a	a	DET
aji-39	212	22	reliable	reliable	ADJ
aji-39	212	23	biomarker	biomarker	NOUN
aji-39	212	24	for	for	ADP
aji-39	212	25	the	the	DET
aji-39	212	26	prevalence	prevalence	NOUN
aji-39	212	27	of	of	ADP
aji-39	212	28	the	the	DET
aji-39	212	29	disease	disease	NOUN
aji-39	212	30	where	where	SCONJ
aji-39	212	31	vaccination	vaccination	NOUN
aji-39	212	32	history	history	NOUN
aji-39	212	33	is	be	AUX
aji-39	212	34	known	know	VERB
aji-39	212	35	.	.	PUNCT
aji-39	213	1	on	on	ADP
aji-39	213	2	the	the	DET
aji-39	213	3	other	other	ADJ
aji-39	213	4	hand	hand	NOUN
aji-39	213	5	,	,	PUNCT
aji-39	213	6	igm	igm	PROPN
aji-39	213	7	is	be	AUX
aji-39	213	8	an	an	DET
aji-39	213	9	indication	indication	NOUN
aji-39	213	10	of	of	ADP
aji-39	213	11	a	a	DET
aji-39	213	12	fresh	fresh	ADJ
aji-39	213	13	infection	infection	NOUN
aji-39	213	14	and	and	CCONJ
aji-39	213	15	as	as	ADP
aji-39	213	16	such	such	ADJ
aji-39	213	17	used	use	VERB
aji-39	213	18	to	to	PART
aji-39	213	19	estimate	estimate	VERB
aji-39	213	20	the	the	DET
aji-39	213	21	incidence	incidence	NOUN
aji-39	213	22	of	of	ADP
aji-39	213	23	the	the	DET
aji-39	213	24	disease	disease	NOUN
aji-39	213	25	.	.	PUNCT
aji-39	214	1	when	when	SCONJ
aji-39	214	2	igg	igg	PROPN
aji-39	214	3	co	co	VERB
aji-39	214	4	-	-	VERB
aji-39	214	5	exist	exist	VERB
aji-39	214	6	with	with	ADP
aji-39	214	7	igm	igm	PROPN
aji-39	214	8	,	,	PUNCT
aji-39	214	9	it	it	PRON
aji-39	214	10	could	could	AUX
aji-39	214	11	be	be	AUX
aji-39	214	12	an	an	DET
aji-39	214	13	indicator	indicator	NOUN
aji-39	214	14	of	of	ADP
aji-39	214	15	an	an	DET
aji-39	214	16	infected	infected	ADJ
aji-39	214	17	person	person	NOUN
aji-39	214	18	who	who	PRON
aji-39	214	19	is	be	AUX
aji-39	214	20	just	just	ADV
aji-39	214	21	recovering	recover	VERB
aji-39	214	22	and	and	CCONJ
aji-39	214	23	rarely	rarely	ADV
aji-39	214	24	reinfection	reinfection	NOUN
aji-39	214	25	.	.	PUNCT
aji-39	215	1	the	the	DET
aji-39	215	2	seronegative	seronegative	ADJ
aji-39	215	3	population	population	NOUN
aji-39	215	4	for	for	ADP
aji-39	215	5	igg	igg	PROPN
aji-39	215	6	is	be	AUX
aji-39	215	7	the	the	DET
aji-39	215	8	susceptible	susceptible	ADJ
aji-39	215	9	population	population	NOUN
aji-39	215	10	which	which	PRON
aji-39	215	11	is	be	AUX
aji-39	215	12	considered	consider	VERB
aji-39	215	13	high	high	ADJ
aji-39	215	14	risk	risk	NOUN
aji-39	215	15	.	.	PUNCT
aji-39	216	1	in	in	ADP
aji-39	216	2	this	this	DET
aji-39	216	3	present	present	ADJ
aji-39	216	4	study	study	NOUN
aji-39	216	5	,	,	PUNCT
aji-39	216	6	95.6	95.6	NUM
aji-39	216	7	%	%	NOUN
aji-39	216	8	of	of	ADP
aji-39	216	9	the	the	DET
aji-39	216	10	pregnant	pregnant	ADJ
aji-39	216	11	women	woman	NOUN
aji-39	216	12	enrolled	enrol	VERB
aji-39	216	13	were	be	AUX
aji-39	216	14	seropositive	seropositive	ADJ
aji-39	216	15	for	for	SCONJ
aji-39	216	16	anti	anti	ADJ
aji-39	216	17	-	-	ADJ
aji-39	216	18	rubella	rubella	ADJ
aji-39	216	19	igg	igg	NOUN
aji-39	216	20	antibodies	antibodie	VERB
aji-39	216	21	.	.	PUNCT
aji-39	217	1	this	this	DET
aji-39	217	2	high	high	ADJ
aji-39	217	3	seroprevalence	seroprevalence	NOUN
aji-39	217	4	is	be	AUX
aji-39	217	5	similar	similar	ADJ
aji-39	217	6	to	to	ADP
aji-39	217	7	97.9	97.9	NUM
aji-39	217	8	%	%	NOUN
aji-39	217	9	report	report	NOUN
aji-39	217	10	by	by	ADP
aji-39	217	11	muhammad	muhammad	PROPN
aji-39	217	12	et	et	PROPN
aji-39	217	13	al	al	PROPN
aji-39	217	14	.	.	PUNCT
aji-39	218	1	[	[	X
aji-39	218	2	22	22	NUM
aji-39	218	3	]	]	PUNCT
aji-39	218	4	,	,	PUNCT
aji-39	218	5	93.1	93.1	NUM
aji-39	218	6	%	%	NOUN
aji-39	218	7	by	by	ADP
aji-39	218	8	olajide	olajide	NOUN
aji-39	218	9	et	et	PROPN
aji-39	218	10	al	al	PROPN
aji-39	218	11	.	.	PUNCT
aji-39	219	1	[	[	X
aji-39	219	2	5	5	NUM
aji-39	219	3	]	]	PUNCT
aji-39	219	4	and	and	CCONJ
aji-39	219	5	90.2	90.2	NUM
aji-39	219	6	%	%	NOUN
aji-39	219	7	by	by	ADP
aji-39	219	8	gubio	gubio	PROPN
aji-39	219	9	et	et	PROPN
aji-39	219	10	al	al	PROPN
aji-39	219	11	.	.	PUNCT
aji-39	220	1	[	[	X
aji-39	220	2	23	23	NUM
aji-39	220	3	]	]	X
aji-39	220	4	all	all	PRON
aji-39	220	5	in	in	ADP
aji-39	220	6	zaria	zaria	PROPN
aji-39	220	7	,	,	PUNCT
aji-39	220	8	nigeria	nigeria	PROPN
aji-39	220	9	.	.	PUNCT
aji-39	221	1	a	a	DET
aji-39	221	2	lower	low	ADJ
aji-39	221	3	seroprevalence	seroprevalence	NOUN
aji-39	221	4	was	be	AUX
aji-39	221	5	reported	report	VERB
aji-39	221	6	from	from	ADP
aji-39	221	7	a	a	DET
aji-39	221	8	closer	close	ADJ
aji-39	221	9	location	location	NOUN
aji-39	221	10	to	to	ADP
aji-39	221	11	that	that	PRON
aji-39	221	12	of	of	ADP
aji-39	221	13	this	this	DET
aji-39	221	14	present	present	ADJ
aji-39	221	15	study	study	NOUN
aji-39	221	16	by	by	ADP
aji-39	221	17	kolawole	kolawole	PROPN
aji-39	221	18	et	et	PROPN
aji-39	221	19	al	al	PROPN
aji-39	221	20	.	.	PUNCT
aji-39	222	1	[	[	X
aji-39	222	2	24	24	NUM
aji-39	222	3	]	]	PUNCT
aji-39	222	4	who	who	PRON
aji-39	222	5	reported	report	VERB
aji-39	222	6	87.5	87.5	NUM
aji-39	222	7	%	%	NOUN
aji-39	222	8	igg	igg	NOUN
aji-39	222	9	seroprevalence	seroprevalence	NOUN
aji-39	222	10	in	in	ADP
aji-39	222	11	osogbo	osogbo	PROPN
aji-39	222	12	,	,	PUNCT
aji-39	222	13	south	south	NOUN
aji-39	222	14	-	-	PUNCT
aji-39	222	15	west	west	NOUN
aji-39	222	16	of	of	ADP
aji-39	222	17	nigeria	nigeria	PROPN
aji-39	222	18	.	.	PUNCT
aji-39	223	1	this	this	DET
aji-39	223	2	lower	low	ADJ
aji-39	223	3	prevalence	prevalence	NOUN
aji-39	223	4	is	be	AUX
aji-39	223	5	likely	likely	ADJ
aji-39	223	6	due	due	ADP
aji-39	223	7	to	to	ADP
aji-39	223	8	the	the	DET
aji-39	223	9	time	time	NOUN
aji-39	223	10	lag	lag	NOUN
aji-39	223	11	between	between	ADP
aji-39	223	12	the	the	DET
aji-39	223	13	two	two	NUM
aji-39	223	14	studies	study	NOUN
aji-39	223	15	.	.	PUNCT
aji-39	224	1	lower	low	ADJ
aji-39	224	2	igg	igg	PROPN
aji-39	224	3	seroprevalences	seroprevalence	NOUN
aji-39	224	4	have	have	AUX
aji-39	224	5	also	also	ADV
aji-39	224	6	been	be	AUX
aji-39	224	7	reported	report	VERB
aji-39	224	8	by	by	ADP
aji-39	224	9	hamdan	hamdan	PROPN
aji-39	224	10	et	et	PROPN
aji-39	224	11	al	al	PROPN
aji-39	224	12	.	.	PUNCT
aji-39	225	1	[	[	X
aji-39	225	2	25	25	NUM
aji-39	225	3	]	]	PUNCT
aji-39	225	4	in	in	ADP
aji-39	225	5	sudan	sudan	PROPN
aji-39	225	6	(	(	PUNCT
aji-39	225	7	65.3	65.3	NUM
aji-39	225	8	%	%	NOUN
aji-39	225	9	)	)	PUNCT
aji-39	225	10	and	and	CCONJ
aji-39	225	11	oyinloye	oyinloye	VERB
aji-39	225	12	et	et	PROPN
aji-39	225	13	al	al	PROPN
aji-39	225	14	.	.	PUNCT
aji-39	226	1	[	[	X
aji-39	226	2	26	26	NUM
aji-39	226	3	]	]	PUNCT
aji-39	226	4	in	in	ADP
aji-39	226	5	maiduguri	maiduguri	PROPN
aji-39	226	6	,	,	PUNCT
aji-39	226	7	nigeria	nigeria	PROPN
aji-39	226	8	.	.	PUNCT
aji-39	227	1	this	this	PRON
aji-39	227	2	indicates	indicate	VERB
aji-39	227	3	variability	variability	NOUN
aji-39	227	4	in	in	ADP
aji-39	227	5	the	the	DET
aji-39	227	6	epidemiology	epidemiology	NOUN
aji-39	227	7	of	of	ADP
aji-39	227	8	the	the	DET
aji-39	227	9	virus	virus	NOUN
aji-39	227	10	from	from	ADP
aji-39	227	11	one	one	NUM
aji-39	227	12	location	location	NOUN
aji-39	227	13	to	to	ADP
aji-39	227	14	another	another	PRON
aji-39	227	15	.	.	PUNCT
aji-39	228	1	we	we	PRON
aji-39	228	2	also	also	ADV
aji-39	228	3	recorded	record	VERB
aji-39	228	4	12	12	NUM
aji-39	228	5	%	%	NOUN
aji-39	228	6	seropositivity	seropositivity	NOUN
aji-39	228	7	for	for	ADP
aji-39	228	8	antirubella	antirubella	NOUN
aji-39	228	9	igm	igm	PROPN
aji-39	228	10	.	.	PUNCT
aji-39	229	1	this	this	PRON
aji-39	229	2	was	be	AUX
aji-39	229	3	a	a	DET
aji-39	229	4	little	little	ADV
aji-39	229	5	higher	high	ADJ
aji-39	229	6	than	than	ADP
aji-39	229	7	the	the	DET
aji-39	229	8	findings	finding	NOUN
aji-39	229	9	of	of	ADP
aji-39	229	10	mengouo	mengouo	PROPN
aji-39	229	11	et	et	PROPN
aji-39	229	12	al	al	PROPN
aji-39	229	13	.	.	PUNCT
aji-39	230	1	[	[	X
aji-39	230	2	27	27	NUM
aji-39	230	3	]	]	PUNCT
aji-39	230	4	in	in	ADP
aji-39	230	5	cameroon	cameroon	NOUN
aji-39	230	6	who	who	PRON
aji-39	230	7	surveyed	survey	VERB
aji-39	230	8	2008	2008	NUM
aji-39	230	9	-2014	-2014	PROPN
aji-39	230	10	.	.	PUNCT
aji-39	231	1	they	they	PRON
aji-39	231	2	,	,	PUNCT
aji-39	231	3	however	however	ADV
aji-39	231	4	,	,	PUNCT
aji-39	231	5	record	record	VERB
aji-39	231	6	12.4	12.4	NUM
aji-39	231	7	%	%	NOUN
aji-39	231	8	igm	igm	NOUN
aji-39	231	9	seroprevalence	seroprevalence	NOUN
aji-39	231	10	in	in	ADP
aji-39	231	11	2012	2012	NUM
aji-39	231	12	.	.	PUNCT
aji-39	232	1	the	the	DET
aji-39	232	2	findings	finding	NOUN
aji-39	232	3	of	of	ADP
aji-39	232	4	getehun	getehun	PROPN
aji-39	232	5	et	et	PROPN
aji-39	232	6	al	al	PROPN
aji-39	232	7	.	.	PUNCT
aji-39	233	1	[	[	X
aji-39	233	2	13	13	NUM
aji-39	233	3	]	]	PUNCT
aji-39	233	4	and	and	CCONJ
aji-39	233	5	junaid	junaid	VERB
aji-39	233	6	et	et	PROPN
aji-39	233	7	al	al	PROPN
aji-39	233	8	.	.	PUNCT
aji-39	234	1	[	[	X
aji-39	234	2	28	28	NUM
aji-39	234	3	]	]	PUNCT
aji-39	234	4	were	be	AUX
aji-39	234	5	higher	high	ADJ
aji-39	234	6	(	(	PUNCT
aji-39	234	7	39.4	39.4	NUM
aji-39	234	8	and	and	CCONJ
aji-39	234	9	45.2	45.2	NUM
aji-39	234	10	%	%	NOUN
aji-39	234	11	respectively	respectively	ADV
aji-39	234	12	)	)	PUNCT
aji-39	234	13	possibly	possibly	ADV
aji-39	234	14	because	because	SCONJ
aji-39	234	15	their	their	PRON
aji-39	234	16	studies	study	NOUN
aji-39	234	17	were	be	AUX
aji-39	234	18	not	not	PART
aji-39	234	19	restricted	restrict	VERB
aji-39	234	20	to	to	ADP
aji-39	234	21	pregnant	pregnant	ADJ
aji-39	234	22	women	woman	NOUN
aji-39	234	23	and	and	CCONJ
aji-39	234	24	time	time	NOUN
aji-39	234	25	lag	lag	PROPN
aji-39	234	26	.	.	PUNCT
aji-39	235	1	from	from	ADP
aji-39	235	2	this	this	DET
aji-39	235	3	present	present	ADJ
aji-39	235	4	study	study	NOUN
aji-39	235	5	,	,	PUNCT
aji-39	235	6	11	11	NUM
aji-39	235	7	%	%	NOUN
aji-39	235	8	of	of	ADP
aji-39	235	9	subjects	subject	NOUN
aji-39	235	10	positive	positive	ADJ
aji-39	235	11	for	for	ADP
aji-39	235	12	igm	igm	PROPN
aji-39	235	13	were	be	AUX
aji-39	235	14	also	also	ADV
aji-39	235	15	positive	positive	ADJ
aji-39	235	16	for	for	ADP
aji-39	235	17	igg	igg	PROPN
aji-39	235	18	while	while	SCONJ
aji-39	235	19	1	1	NUM
aji-39	235	20	%	%	NOUN
aji-39	235	21	was	be	AUX
aji-39	235	22	just	just	ADV
aji-39	235	23	igm	igm	PROPN
aji-39	235	24	.	.	PUNCT
aji-39	236	1	this	this	PRON
aji-39	236	2	could	could	AUX
aji-39	236	3	imply	imply	VERB
aji-39	236	4	that	that	SCONJ
aji-39	236	5	the	the	DET
aji-39	236	6	12	12	NUM
aji-39	236	7	%	%	NOUN
aji-39	236	8	got	get	AUX
aji-39	236	9	infected	infect	VERB
aji-39	236	10	in	in	ADP
aji-39	236	11	the	the	DET
aji-39	236	12	recent	recent	ADJ
aji-39	236	13	past	past	NOUN
aji-39	236	14	but	but	CCONJ
aji-39	236	15	the	the	DET
aji-39	236	16	11	11	NUM
aji-39	236	17	%	%	NOUN
aji-39	236	18	with	with	ADP
aji-39	236	19	igg	igg	PROPN
aji-39	236	20	and	and	CCONJ
aji-39	236	21	igm	igm	NOUN
aji-39	236	22	are	be	AUX
aji-39	236	23	already	already	ADV
aji-39	236	24	recovering	recover	VERB
aji-39	236	25	while	while	SCONJ
aji-39	236	26	the	the	DET
aji-39	236	27	remaining	remain	VERB
aji-39	236	28	1	1	NUM
aji-39	236	29	%	%	NOUN
aji-39	236	30	was	be	AUX
aji-39	236	31	yet	yet	ADV
aji-39	236	32	to	to	PART
aji-39	236	33	produce	produce	VERB
aji-39	236	34	igg	igg	NOUN
aji-39	236	35	(	(	PUNCT
aji-39	236	36	meaning	mean	VERB
aji-39	236	37	they	they	PRON
aji-39	236	38	are	be	AUX
aji-39	236	39	still	still	ADV
aji-39	236	40	at	at	ADP
aji-39	236	41	the	the	DET
aji-39	236	42	active	active	ADJ
aji-39	236	43	stage	stage	NOUN
aji-39	236	44	of	of	ADP
aji-39	236	45	infection	infection	NOUN
aji-39	236	46	)	)	PUNCT
aji-39	236	47	.	.	PUNCT
aji-39	237	1	incidentally	incidentally	ADV
aji-39	237	2	,	,	PUNCT
aji-39	237	3	the	the	DET
aji-39	237	4	1	1	NUM
aji-39	237	5	%	%	NOUN
aji-39	237	6	population	population	NOUN
aji-39	237	7	with	with	ADP
aji-39	237	8	only	only	ADJ
aji-39	237	9	igm	igm	PROPN
aji-39	237	10	were	be	AUX
aji-39	237	11	all	all	PRON
aji-39	237	12	in	in	ADP
aji-39	237	13	the	the	DET
aji-39	237	14	first	first	ADJ
aji-39	237	15	trimester	trimester	NOUN
aji-39	237	16	;	;	PUNCT
aji-39	237	17	a	a	DET
aji-39	237	18	high	high	ADJ
aji-39	237	19	-	-	PUNCT
aji-39	237	20	risk	risk	NOUN
aji-39	237	21	period	period	NOUN
aji-39	237	22	.	.	PUNCT
aji-39	238	1	the	the	DET
aji-39	238	2	other	other	ADJ
aji-39	238	3	12	12	NUM
aji-39	238	4	%	%	NOUN
aji-39	238	5	thought	think	VERB
aji-39	238	6	to	to	PART
aji-39	238	7	have	have	AUX
aji-39	238	8	recovered	recover	VERB
aji-39	238	9	were	be	AUX
aji-39	238	10	all	all	PRON
aji-39	238	11	distributed	distribute	VERB
aji-39	238	12	through	through	ADP
aji-39	238	13	the	the	DET
aji-39	238	14	first	first	ADJ
aji-39	238	15	,	,	PUNCT
aji-39	238	16	second	second	ADJ
aji-39	238	17	,	,	PUNCT
aji-39	238	18	and	and	CCONJ
aji-39	238	19	third	third	ADJ
aji-39	238	20	trimester	trimester	NOUN
aji-39	238	21	of	of	ADP
aji-39	238	22	pregnancy	pregnancy	NOUN
aji-39	238	23	.	.	PUNCT
aji-39	239	1	these	these	PRON
aji-39	239	2	imply	imply	VERB
aji-39	239	3	that	that	SCONJ
aji-39	239	4	most	most	ADJ
aji-39	239	5	of	of	ADP
aji-39	239	6	them	they	PRON
aji-39	239	7	especially	especially	ADV
aji-39	239	8	those	those	PRON
aji-39	239	9	in	in	ADP
aji-39	239	10	the	the	DET
aji-39	239	11	first	first	ADJ
aji-39	239	12	and	and	CCONJ
aji-39	239	13	early	early	ADJ
aji-39	239	14	part	part	NOUN
aji-39	239	15	of	of	ADP
aji-39	239	16	the	the	DET
aji-39	239	17	akele	akele	PROPN
aji-39	239	18	et	et	PROPN
aji-39	239	19	al	al	PROPN
aji-39	239	20	.	.	PROPN
aji-39	239	21	;	;	PUNCT
aji-39	239	22	aji	aji	PROPN
aji-39	239	23	,	,	PUNCT
aji-39	239	24	3(1	3(1	NUM
aji-39	239	25	):	):	PUNCT
aji-39	239	26	199	199	NUM
aji-39	239	27	-	-	SYM
aji-39	239	28	207	207	NUM
aji-39	239	29	,	,	PUNCT
aji-39	239	30	2020	2020	NUM
aji-39	239	31	;	;	PUNCT
aji-39	239	32	article	article	NOUN
aji-39	239	33	no.aji.57099	no.aji.57099	VERB
aji-39	239	34	203	203	NUM
aji-39	239	35	table	table	NOUN
aji-39	239	36	1	1	NUM
aji-39	239	37	.	.	PUNCT
aji-39	239	38	seroprevalence	seroprevalence	NOUN
aji-39	239	39	of	of	ADP
aji-39	239	40	rubella	rubella	NOUN
aji-39	239	41	igg	igg	PROPN
aji-39	239	42	and	and	CCONJ
aji-39	239	43	igm	igm	PROPN
aji-39	239	44	based	base	VERB
aji-39	239	45	on	on	ADP
aji-39	239	46	the	the	DET
aji-39	239	47	age	age	NOUN
aji-39	239	48	group	group	NOUN
aji-39	239	49	age	age	NOUN
aji-39	239	50	group	group	NOUN
aji-39	239	51	(	(	PUNCT
aji-39	239	52	years	year	NOUN
aji-39	239	53	)	)	PUNCT
aji-39	239	54	number	number	NOUN
aji-39	239	55	rubella	rubella	NOUN
aji-39	239	56	igg	igg	NOUN
aji-39	239	57	rubella	rubella	PROPN
aji-39	239	58	igm	igm	NOUN
aji-39	239	59	rubella	rubella	NOUN
aji-39	239	60	igg	igg	PROPN
aji-39	239	61	and	and	CCONJ
aji-39	239	62	igm	igm	PROPN
aji-39	239	63	positive	positive	ADJ
aji-39	239	64	(	(	PUNCT
aji-39	239	65	%	%	NOUN
aji-39	239	66	)	)	PUNCT
aji-39	239	67	p	p	X
aji-39	239	68	-	-	PUNCT
aji-39	239	69	value	value	NOUN
aji-39	239	70	positive	positive	ADJ
aji-39	239	71	(	(	PUNCT
aji-39	239	72	%	%	NOUN
aji-39	239	73	)	)	PUNCT
aji-39	239	74	p	p	X
aji-39	239	75	-	-	PUNCT
aji-39	239	76	value	value	NOUN
aji-39	239	77	positive	positive	ADJ
aji-39	239	78	(	(	PUNCT
aji-39	239	79	%	%	NOUN
aji-39	239	80	)	)	PUNCT
aji-39	239	81	p	p	X
aji-39	239	82	-	-	PUNCT
aji-39	239	83	value	value	NOUN
aji-39	239	84	16	16	NUM
aji-39	239	85	-	-	SYM
aji-39	239	86	20	20	NUM
aji-39	239	87	8	8	NUM
aji-39	239	88	5	5	NUM
aji-39	239	89	(	(	PUNCT
aji-39	239	90	62.5	62.5	NUM
aji-39	239	91	)	)	PUNCT
aji-39	239	92	1	1	NUM
aji-39	239	93	(	(	PUNCT
aji-39	239	94	12.5	12.5	NUM
aji-39	239	95	)	)	SYM
aji-39	239	96	1	1	NUM
aji-39	239	97	(	(	PUNCT
aji-39	239	98	12.5	12.5	NUM
aji-39	239	99	)	)	PUNCT
aji-39	239	100	21	21	NUM
aji-39	239	101	-	-	SYM
aji-39	239	102	25	25	NUM
aji-39	239	103	72	72	NUM
aji-39	239	104	69	69	NUM
aji-39	239	105	(	(	PUNCT
aji-39	239	106	95.8	95.8	NUM
aji-39	239	107	)	)	SYM
aji-39	239	108	8	8	NUM
aji-39	239	109	(	(	PUNCT
aji-39	239	110	11.1	11.1	NUM
aji-39	239	111	)	)	PUNCT
aji-39	239	112	7	7	NUM
aji-39	239	113	(	(	PUNCT
aji-39	239	114	9.7	9.7	NUM
aji-39	239	115	)	)	SYM
aji-39	239	116	26	26	NUM
aji-39	239	117	-	-	SYM
aji-39	239	118	30	30	NUM
aji-39	239	119	60	60	NUM
aji-39	239	120	59	59	NUM
aji-39	239	121	(	(	PUNCT
aji-39	239	122	98.3	98.3	NUM
aji-39	239	123	)	)	PUNCT
aji-39	239	124	0.50	0.50	NUM
aji-39	239	125	2.34	2.34	NUM
aji-39	239	126	6	6	NUM
aji-39	239	127	(	(	PUNCT
aji-39	239	128	10.0	10.0	NUM
aji-39	239	129	)	)	PUNCT
aji-39	239	130	0.89	0.89	NUM
aji-39	239	131	0.58	0.58	NUM
aji-39	239	132	5	5	NUM
aji-39	239	133	(	(	PUNCT
aji-39	239	134	8.3	8.3	NUM
aji-39	239	135	)	)	PUNCT
aji-39	239	136	0.15	0.15	NUM
aji-39	239	137	3.76	3.76	NUM
aji-39	239	138	31	31	NUM
aji-39	239	139	-	-	SYM
aji-39	239	140	35	35	NUM
aji-39	239	141	32	32	NUM
aji-39	239	142	31	31	NUM
aji-39	239	143	(	(	PUNCT
aji-39	239	144	96.9	96.9	NUM
aji-39	239	145	)	)	PUNCT
aji-39	239	146	6	6	NUM
aji-39	239	147	(	(	PUNCT
aji-39	239	148	18.8	18.8	NUM
aji-39	239	149	)	)	PUNCT
aji-39	239	150	6	6	NUM
aji-39	239	151	(	(	PUNCT
aji-39	239	152	18.8	18.8	NUM
aji-39	239	153	)	)	PUNCT
aji-39	239	154	above	above	ADP
aji-39	239	155	35	35	NUM
aji-39	239	156	12	12	NUM
aji-39	239	157	12	12	NUM
aji-39	239	158	(	(	PUNCT
aji-39	239	159	100	100	NUM
aji-39	239	160	)	)	PUNCT
aji-39	239	161	1	1	NUM
aji-39	239	162	(	(	PUNCT
aji-39	239	163	8.3	8.3	NUM
aji-39	239	164	)	)	SYM
aji-39	239	165	1	1	NUM
aji-39	239	166	(	(	PUNCT
aji-39	239	167	8.3	8.3	NUM
aji-39	239	168	)	)	PUNCT
aji-39	239	169	total	total	NOUN
aji-39	239	170	184	184	NUM
aji-39	239	171	176	176	NUM
aji-39	239	172	(	(	PUNCT
aji-39	239	173	95.6	95.6	NUM
aji-39	239	174	)	)	PUNCT
aji-39	239	175	22	22	NUM
aji-39	239	176	(	(	PUNCT
aji-39	239	177	12.0	12.0	NUM
aji-39	239	178	)	)	PUNCT
aji-39	239	179	20	20	NUM
aji-39	239	180	(	(	PUNCT
aji-39	239	181	11.0	11.0	NUM
aji-39	239	182	)	)	PUNCT
aji-39	239	183	table	table	NOUN
aji-39	239	184	2	2	NUM
aji-39	239	185	.	.	X
aji-39	239	186	seroprevalence	seroprevalence	NOUN
aji-39	239	187	of	of	ADP
aji-39	239	188	rubella	rubella	NOUN
aji-39	239	189	igg	igg	PROPN
aji-39	239	190	and	and	CCONJ
aji-39	239	191	igm	igm	PROPN
aji-39	239	192	in	in	ADP
aji-39	239	193	relation	relation	NOUN
aji-39	239	194	to	to	ADP
aji-39	239	195	stages	stage	NOUN
aji-39	239	196	of	of	ADP
aji-39	239	197	pregnancy	pregnancy	NOUN
aji-39	239	198	trimester	trimester	NOUN
aji-39	239	199	number	number	NOUN
aji-39	239	200	rubella	rubella	NOUN
aji-39	239	201	igg	igg	NOUN
aji-39	239	202	rubella	rubella	PROPN
aji-39	239	203	igm	igm	NOUN
aji-39	239	204	rubella	rubella	NOUN
aji-39	239	205	igg	igg	PROPN
aji-39	239	206	and	and	CCONJ
aji-39	239	207	igm	igm	PROPN
aji-39	239	208	positive	positive	ADJ
aji-39	239	209	(	(	PUNCT
aji-39	239	210	%	%	NOUN
aji-39	239	211	)	)	PUNCT
aji-39	239	212	p	p	X
aji-39	239	213	-	-	PUNCT
aji-39	239	214	value	value	NOUN
aji-39	239	215	positive	positive	ADJ
aji-39	239	216	(	(	PUNCT
aji-39	239	217	%	%	NOUN
aji-39	239	218	)	)	PUNCT
aji-39	239	219	p	p	X
aji-39	239	220	-	-	PUNCT
aji-39	239	221	value	value	NOUN
aji-39	239	222	positive	positive	ADJ
aji-39	239	223	(	(	PUNCT
aji-39	239	224	%	%	NOUN
aji-39	239	225	)	)	PUNCT
aji-39	239	226	p	p	X
aji-39	239	227	-	-	PUNCT
aji-39	239	228	value	value	NOUN
aji-39	239	229	first	first	ADJ
aji-39	239	230	34	34	NUM
aji-39	239	231	30	30	NUM
aji-39	239	232	(	(	PUNCT
aji-39	239	233	88.2	88.2	NUM
aji-39	239	234	)	)	PUNCT
aji-39	239	235	8	8	NUM
aji-39	239	236	(	(	PUNCT
aji-39	239	237	23.5	23.5	NUM
aji-39	239	238	)	)	PUNCT
aji-39	239	239	6(17.6	6(17.6	NOUN
aji-39	239	240	)	)	PUNCT
aji-39	239	241	second	second	ADJ
aji-39	239	242	87	87	NUM
aji-39	239	243	84	84	NUM
aji-39	239	244	(	(	PUNCT
aji-39	239	245	96.6	96.6	NUM
aji-39	239	246	)	)	PUNCT
aji-39	239	247	0.17	0.17	NUM
aji-39	239	248	2.52	2.52	NUM
aji-39	239	249	12	12	NUM
aji-39	239	250	(	(	PUNCT
aji-39	239	251	13.8	13.8	NUM
aji-39	239	252	)	)	PUNCT
aji-39	239	253	0.07	0.07	NUM
aji-39	239	254	5.12	5.12	NUM
aji-39	239	255	12	12	NUM
aji-39	239	256	(	(	PUNCT
aji-39	239	257	13.8	13.8	NUM
aji-39	239	258	)	)	PUNCT
aji-39	239	259	0.06	0.06	NUM
aji-39	239	260	1.55	1.55	NUM
aji-39	239	261	third	third	ADJ
aji-39	239	262	63	63	NUM
aji-39	239	263	62	62	NUM
aji-39	239	264	(	(	PUNCT
aji-39	239	265	98.4	98.4	NUM
aji-39	239	266	)	)	SYM
aji-39	239	267	2	2	NUM
aji-39	239	268	(	(	PUNCT
aji-39	239	269	3.2	3.2	NUM
aji-39	239	270	)	)	SYM
aji-39	239	271	2	2	NUM
aji-39	239	272	(	(	PUNCT
aji-39	239	273	3.2	3.2	NUM
aji-39	239	274	)	)	PUNCT
aji-39	239	275	total	total	NOUN
aji-39	239	276	184	184	NUM
aji-39	239	277	176	176	NUM
aji-39	239	278	(	(	PUNCT
aji-39	239	279	95.6	95.6	NUM
aji-39	239	280	)	)	PUNCT
aji-39	239	281	22	22	NUM
aji-39	239	282	(	(	PUNCT
aji-39	239	283	12.0	12.0	NUM
aji-39	239	284	)	)	PUNCT
aji-39	239	285	20	20	NUM
aji-39	239	286	(	(	PUNCT
aji-39	239	287	10.9	10.9	NUM
aji-39	239	288	)	)	PUNCT
aji-39	239	289	akele	akele	NOUN
aji-39	239	290	et	et	PROPN
aji-39	239	291	al	al	PROPN
aji-39	239	292	.	.	PROPN
aji-39	239	293	;	;	PUNCT
aji-39	239	294	aji	aji	PROPN
aji-39	239	295	,	,	PUNCT
aji-39	239	296	3(1	3(1	NUM
aji-39	239	297	):	):	PUNCT
aji-39	239	298	199	199	NUM
aji-39	239	299	-	-	SYM
aji-39	239	300	207	207	NUM
aji-39	239	301	,	,	PUNCT
aji-39	239	302	2020	2020	NUM
aji-39	239	303	;	;	PUNCT
aji-39	239	304	article	article	NOUN
aji-39	239	305	no.aji.57099	no.aji.57099	VERB
aji-39	239	306	204	204	NUM
aji-39	239	307	table	table	NOUN
aji-39	239	308	3	3	NUM
aji-39	239	309	.	.	X
aji-39	240	1	seroprevalence	seroprevalence	NOUN
aji-39	240	2	of	of	ADP
aji-39	240	3	rubella	rubella	NOUN
aji-39	240	4	igg	igg	PROPN
aji-39	240	5	and	and	CCONJ
aji-39	240	6	igm	igm	PROPN
aji-39	240	7	antibodies	antibody	NOUN
aji-39	240	8	in	in	ADP
aji-39	240	9	relation	relation	NOUN
aji-39	240	10	to	to	ADP
aji-39	240	11	some	some	DET
aji-39	240	12	sociodemographic	sociodemographic	ADJ
aji-39	240	13	data	datum	NOUN
aji-39	240	14	sociodemographic	sociodemographic	ADJ
aji-39	240	15	data	data	NOUN
aji-39	240	16	number	number	NOUN
aji-39	240	17	rubella	rubella	NOUN
aji-39	240	18	igg	igg	NOUN
aji-39	240	19	rubella	rubella	PROPN
aji-39	240	20	igm	igm	NOUN
aji-39	240	21	positive	positive	ADJ
aji-39	240	22	(	(	PUNCT
aji-39	240	23	%	%	NOUN
aji-39	240	24	)	)	PUNCT
aji-39	240	25	p	p	X
aji-39	240	26	-	-	PUNCT
aji-39	240	27	value	value	NOUN
aji-39	240	28	positive	positive	ADJ
aji-39	240	29	(	(	PUNCT
aji-39	240	30	%	%	NOUN
aji-39	240	31	)	)	PUNCT
aji-39	240	32	p	p	X
aji-39	240	33	-	-	PUNCT
aji-39	240	34	value	value	NOUN
aji-39	240	35	marital	marital	ADJ
aji-39	240	36	status	status	NOUN
aji-39	240	37	married	marry	VERB
aji-39	240	38	156	156	NUM
aji-39	240	39	152	152	NUM
aji-39	240	40	(	(	PUNCT
aji-39	240	41	97.4	97.4	NUM
aji-39	240	42	)	)	SYM
aji-39	240	43	15	15	NUM
aji-39	240	44	(	(	PUNCT
aji-39	240	45	9.6	9.6	NUM
aji-39	240	46	)	)	PUNCT
aji-39	240	47	single	single	ADJ
aji-39	240	48	23	23	NUM
aji-39	240	49	21	21	NUM
aji-39	240	50	(	(	PUNCT
aji-39	240	51	91.3	91.3	NUM
aji-39	240	52	)	)	PUNCT
aji-39	240	53	0.76	0.76	NUM
aji-39	240	54	1.56	1.56	NUM
aji-39	240	55	6	6	NUM
aji-39	240	56	(	(	PUNCT
aji-39	240	57	26.1	26.1	NUM
aji-39	240	58	)	)	PUNCT
aji-39	240	59	0.56	0.56	NUM
aji-39	240	60	0.85	0.85	NUM
aji-39	240	61	separated	separate	VERB
aji-39	240	62	5	5	NUM
aji-39	240	63	3	3	NUM
aji-39	240	64	(	(	PUNCT
aji-39	240	65	60.0	60.0	NUM
aji-39	240	66	)	)	SYM
aji-39	240	67	1	1	NUM
aji-39	240	68	(	(	PUNCT
aji-39	240	69	20	20	NUM
aji-39	240	70	)	)	PUNCT
aji-39	240	71	educational	educational	ADJ
aji-39	240	72	status	status	NOUN
aji-39	240	73	primary	primary	ADJ
aji-39	240	74	52	52	NUM
aji-39	240	75	49	49	NUM
aji-39	240	76	(	(	PUNCT
aji-39	240	77	94.2	94.2	NUM
aji-39	240	78	)	)	PUNCT
aji-39	240	79	6	6	NUM
aji-39	240	80	(	(	PUNCT
aji-39	240	81	11.5	11.5	NUM
aji-39	240	82	)	)	PUNCT
aji-39	240	83	secondary	secondary	ADJ
aji-39	240	84	86	86	NUM
aji-39	240	85	85	85	NUM
aji-39	240	86	(	(	PUNCT
aji-39	240	87	98.8	98.8	NUM
aji-39	240	88	)	)	PUNCT
aji-39	240	89	0.10	0.10	NUM
aji-39	240	90	2.59	2.59	NUM
aji-39	240	91	10	10	NUM
aji-39	240	92	(	(	PUNCT
aji-39	240	93	11.6	11.6	NUM
aji-39	240	94	)	)	PUNCT
aji-39	240	95	0.30	0.30	NUM
aji-39	240	96	0.99	0.99	NUM
aji-39	240	97	tertiary	tertiary	ADJ
aji-39	240	98	41	41	NUM
aji-39	240	99	39	39	NUM
aji-39	240	100	(	(	PUNCT
aji-39	240	101	95.1	95.1	NUM
aji-39	240	102	)	)	SYM
aji-39	240	103	5	5	NUM
aji-39	240	104	(	(	PUNCT
aji-39	240	105	12.2	12.2	NUM
aji-39	240	106	)	)	PUNCT
aji-39	240	107	none	none	NOUN
aji-39	240	108	5	5	NUM
aji-39	240	109	3	3	NUM
aji-39	240	110	(	(	PUNCT
aji-39	240	111	60.0	60.0	NUM
aji-39	240	112	)	)	SYM
aji-39	240	113	1	1	NUM
aji-39	240	114	(	(	PUNCT
aji-39	240	115	20	20	NUM
aji-39	240	116	)	)	PUNCT
aji-39	240	117	religion	religion	NOUN
aji-39	240	118	christianity	christianity	NOUN
aji-39	240	119	143	143	NUM
aji-39	240	120	140	140	NUM
aji-39	240	121	(	(	PUNCT
aji-39	240	122	97.9	97.9	NUM
aji-39	240	123	)	)	PUNCT
aji-39	240	124	17	17	NUM
aji-39	240	125	(	(	PUNCT
aji-39	240	126	11.9	11.9	NUM
aji-39	240	127	)	)	PUNCT
aji-39	240	128	islam	islam	PROPN
aji-39	240	129	37	37	NUM
aji-39	240	130	34	34	NUM
aji-39	240	131	(	(	PUNCT
aji-39	240	132	91.9	91.9	NUM
aji-39	240	133	)	)	PUNCT
aji-39	240	134	0.71	0.71	NUM
aji-39	240	135	0.91	0.91	NUM
aji-39	240	136	5	5	NUM
aji-39	240	137	(	(	PUNCT
aji-39	240	138	13.5	13.5	NUM
aji-39	240	139	)	)	PUNCT
aji-39	240	140	0.32	0.32	NUM
aji-39	240	141	2.12	2.12	NUM
aji-39	240	142	others	other	NOUN
aji-39	240	143	4	4	NUM
aji-39	240	144	2	2	NUM
aji-39	240	145	(	(	PUNCT
aji-39	240	146	50.0	50.0	NUM
aji-39	240	147	)	)	PUNCT
aji-39	240	148	nil	nil	NOUN
aji-39	240	149	occupation	occupation	NOUN
aji-39	240	150	student	student	NOUN
aji-39	240	151	15	15	NUM
aji-39	240	152	11	11	NUM
aji-39	240	153	(	(	PUNCT
aji-39	240	154	73.3	73.3	NUM
aji-39	240	155	)	)	PUNCT
aji-39	240	156	nil	nil	NOUN
aji-39	240	157	housewife	housewife	NOUN
aji-39	240	158	49	49	NUM
aji-39	240	159	47	47	NUM
aji-39	240	160	(	(	PUNCT
aji-39	240	161	95.9	95.9	NUM
aji-39	240	162	)	)	SYM
aji-39	240	163	8	8	NUM
aji-39	240	164	(	(	PUNCT
aji-39	240	165	16.3	16.3	NUM
aji-39	240	166	)	)	PUNCT
aji-39	240	167	public	public	ADJ
aji-39	240	168	servant	servant	NOUN
aji-39	240	169	41	41	NUM
aji-39	240	170	40	40	NUM
aji-39	240	171	(	(	PUNCT
aji-39	240	172	97.6	97.6	NUM
aji-39	240	173	)	)	PUNCT
aji-39	240	174	0.07	0.07	NUM
aji-39	240	175	3.10	3.10	NUM
aji-39	240	176	5	5	NUM
aji-39	240	177	(	(	PUNCT
aji-39	240	178	12.2	12.2	NUM
aji-39	240	179	)	)	PUNCT
aji-39	240	180	0.07	0.07	NUM
aji-39	240	181	3.46	3.46	NUM
aji-39	240	182	trader	trader	NOUN
aji-39	240	183	42	42	NUM
aji-39	240	184	40	40	NUM
aji-39	240	185	(	(	PUNCT
aji-39	240	186	95.2	95.2	NUM
aji-39	240	187	)	)	PUNCT
aji-39	240	188	6	6	NUM
aji-39	240	189	(	(	PUNCT
aji-39	240	190	14.3	14.3	NUM
aji-39	240	191	)	)	PUNCT
aji-39	240	192	farmer	farmer	NOUN
aji-39	240	193	37	37	NUM
aji-39	240	194	34	34	NUM
aji-39	240	195	(	(	PUNCT
aji-39	240	196	91.9	91.9	NUM
aji-39	240	197	)	)	PUNCT
aji-39	240	198	3	3	NUM
aji-39	240	199	(	(	PUNCT
aji-39	240	200	8.1	8.1	NUM
aji-39	240	201	)	)	PUNCT
aji-39	240	202	parity	parity	NOUN
aji-39	240	203	0	0	NUM
aji-39	240	204	58	58	NUM
aji-39	240	205	53	53	NUM
aji-39	240	206	(	(	PUNCT
aji-39	240	207	91.3	91.3	NUM
aji-39	240	208	)	)	SYM
aji-39	240	209	2	2	NUM
aji-39	240	210	(	(	PUNCT
aji-39	240	211	3.4	3.4	NUM
aji-39	240	212	)	)	PUNCT
aji-39	240	213	1	1	NUM
aji-39	240	214	-	-	SYM
aji-39	240	215	2	2	NUM
aji-39	240	216	79	79	NUM
aji-39	240	217	76	76	NUM
aji-39	240	218	(	(	PUNCT
aji-39	240	219	96.2	96.2	NUM
aji-39	240	220	)	)	PUNCT
aji-39	240	221	0.05	0.05	NUM
aji-39	240	222	3.14	3.14	NUM
aji-39	240	223	14	14	NUM
aji-39	240	224	(	(	PUNCT
aji-39	240	225	18.7	18.7	NUM
aji-39	240	226	)	)	PUNCT
aji-39	240	227	0.04	0.04	NUM
aji-39	240	228	3.75	3.75	NUM
aji-39	240	229	3	3	NUM
aji-39	240	230	-	-	SYM
aji-39	240	231	4	4	NUM
aji-39	240	232	29	29	NUM
aji-39	240	233	29	29	NUM
aji-39	240	234	(	(	PUNCT
aji-39	240	235	100	100	NUM
aji-39	240	236	)	)	PUNCT
aji-39	240	237	6	6	NUM
aji-39	240	238	(	(	PUNCT
aji-39	240	239	20.7	20.7	NUM
aji-39	240	240	)	)	PUNCT
aji-39	240	241	above	above	ADP
aji-39	240	242	4	4	NUM
aji-39	240	243	18	18	NUM
aji-39	240	244	18	18	NUM
aji-39	240	245	(	(	PUNCT
aji-39	240	246	100	100	NUM
aji-39	240	247	)	)	PUNCT
aji-39	240	248	nil	nil	NOUN
aji-39	240	249	knowledge	knowledge	NOUN
aji-39	240	250	of	of	ADP
aji-39	240	251	the	the	DET
aji-39	240	252	virus	virus	NOUN
aji-39	241	1	yes	yes	INTJ
aji-39	241	2	34	34	NUM
aji-39	241	3	32	32	NUM
aji-39	241	4	(	(	PUNCT
aji-39	241	5	94.1	94.1	NUM
aji-39	241	6	)	)	PUNCT
aji-39	241	7	0.48	0.48	NUM
aji-39	241	8	2.01	2.01	NUM
aji-39	241	9	6	6	NUM
aji-39	241	10	(	(	PUNCT
aji-39	241	11	17.6	17.6	NUM
aji-39	241	12	)	)	PUNCT
aji-39	241	13	0.42	0.42	NUM
aji-39	241	14	0.22	0.22	NUM
aji-39	241	15	no	no	DET
aji-39	241	16	150	150	NUM
aji-39	241	17	144	144	NUM
aji-39	241	18	(	(	PUNCT
aji-39	241	19	96.0	96.0	NUM
aji-39	241	20	)	)	PUNCT
aji-39	241	21	16	16	NUM
aji-39	241	22	(	(	PUNCT
aji-39	241	23	10.7	10.7	NUM
aji-39	241	24	)	)	PUNCT
aji-39	241	25	akele	akele	NOUN
aji-39	241	26	et	et	PROPN
aji-39	241	27	al	al	PROPN
aji-39	241	28	.	.	PROPN
aji-39	241	29	;	;	PUNCT
aji-39	241	30	aji	aji	PROPN
aji-39	241	31	,	,	PUNCT
aji-39	241	32	3(1	3(1	NUM
aji-39	241	33	):	):	PUNCT
aji-39	241	34	199	199	NUM
aji-39	241	35	-	-	SYM
aji-39	241	36	207	207	NUM
aji-39	241	37	,	,	PUNCT
aji-39	241	38	2020	2020	NUM
aji-39	241	39	;	;	PUNCT
aji-39	241	40	article	article	NOUN
aji-39	241	41	no.aji.57099	no.aji.57099	VERB
aji-39	241	42	205	205	NUM
aji-39	241	43	second	second	ADJ
aji-39	241	44	trimester	trimester	NOUN
aji-39	241	45	must	must	AUX
aji-39	241	46	have	have	AUX
aji-39	241	47	been	be	AUX
aji-39	241	48	going	go	VERB
aji-39	241	49	through	through	ADP
aji-39	241	50	the	the	DET
aji-39	241	51	active	active	ADJ
aji-39	241	52	phase	phase	NOUN
aji-39	241	53	of	of	ADP
aji-39	241	54	infection	infection	NOUN
aji-39	241	55	during	during	ADP
aji-39	241	56	the	the	DET
aji-39	241	57	first	first	ADJ
aji-39	241	58	trimester	trimester	NOUN
aji-39	241	59	which	which	PRON
aji-39	241	60	might	might	AUX
aji-39	241	61	put	put	VERB
aji-39	241	62	the	the	DET
aji-39	241	63	fetus	fetus	NOUN
aji-39	241	64	at	at	ADP
aji-39	241	65	the	the	DET
aji-39	241	66	risk	risk	NOUN
aji-39	241	67	of	of	ADP
aji-39	241	68	crs	crs	PROPN
aji-39	241	69	.	.	PUNCT
aji-39	242	1	the	the	DET
aji-39	242	2	susceptibility	susceptibility	NOUN
aji-39	242	3	of	of	ADP
aji-39	242	4	these	these	DET
aji-39	242	5	populations	population	NOUN
aji-39	242	6	is	be	AUX
aji-39	242	7	4	4	NUM
aji-39	242	8	%	%	NOUN
aji-39	242	9	going	go	VERB
aji-39	242	10	by	by	ADP
aji-39	242	11	the	the	DET
aji-39	242	12	igg	igg	PROPN
aji-39	242	13	seroprevalence	seroprevalence	NOUN
aji-39	242	14	,	,	PUNCT
aji-39	242	15	but	but	CCONJ
aji-39	242	16	considering	consider	VERB
aji-39	242	17	that	that	SCONJ
aji-39	242	18	the	the	DET
aji-39	242	19	remaining	remain	VERB
aji-39	242	20	11	11	NUM
aji-39	242	21	%	%	NOUN
aji-39	242	22	which	which	PRON
aji-39	242	23	had	have	VERB
aji-39	242	24	both	both	CCONJ
aji-39	242	25	igg	igg	PROPN
aji-39	242	26	and	and	CCONJ
aji-39	242	27	igm	igm	NOUN
aji-39	242	28	are	be	AUX
aji-39	242	29	likely	likely	ADJ
aji-39	242	30	to	to	PART
aji-39	242	31	have	have	AUX
aji-39	242	32	had	have	VERB
aji-39	242	33	a	a	DET
aji-39	242	34	recent	recent	ADJ
aji-39	242	35	infection	infection	NOUN
aji-39	242	36	and	and	CCONJ
aji-39	242	37	were	be	AUX
aji-39	242	38	just	just	ADV
aji-39	242	39	recovering	recover	VERB
aji-39	242	40	;	;	PUNCT
aji-39	242	41	the	the	DET
aji-39	242	42	susceptibility	susceptibility	NOUN
aji-39	242	43	could	could	AUX
aji-39	242	44	be	be	AUX
aji-39	242	45	placed	place	VERB
aji-39	242	46	at	at	ADP
aji-39	242	47	15.2	15.2	NUM
aji-39	242	48	%	%	NOUN
aji-39	242	49	.	.	PUNCT
aji-39	243	1	this	this	PRON
aji-39	243	2	is	be	AUX
aji-39	243	3	comparable	comparable	ADJ
aji-39	243	4	with	with	ADP
aji-39	243	5	13.7	13.7	NUM
aji-39	243	6	%	%	NOUN
aji-39	243	7	susceptibility	susceptibility	NOUN
aji-39	243	8	reported	report	VERB
aji-39	243	9	by	by	ADP
aji-39	243	10	tamirat	tamirat	NOUN
aji-39	243	11	et	et	PROPN
aji-39	243	12	al	al	PROPN
aji-39	243	13	.	.	PUNCT
aji-39	244	1	[	[	X
aji-39	244	2	14	14	NUM
aji-39	244	3	]	]	PUNCT
aji-39	244	4	in	in	ADP
aji-39	244	5	southern	southern	ADJ
aji-39	244	6	ethiopia	ethiopia	PROPN
aji-39	244	7	.	.	PUNCT
aji-39	245	1	rubella	rubella	NOUN
aji-39	245	2	infectivity	infectivity	NOUN
aji-39	245	3	is	be	AUX
aji-39	245	4	not	not	PART
aji-39	245	5	associated	associate	VERB
aji-39	245	6	with	with	ADP
aji-39	245	7	age	age	NOUN
aji-39	245	8	(	(	PUNCT
aji-39	245	9	p	p	X
aji-39	245	10	>	>	X
aji-39	245	11	0.05	0.05	NUM
aji-39	245	12	)	)	PUNCT
aji-39	245	13	though	though	SCONJ
aji-39	245	14	ages	age	NOUN
aji-39	245	15	16	16	NUM
aji-39	245	16	–	–	PUNCT
aji-39	245	17	20	20	NUM
aji-39	245	18	had	have	VERB
aji-39	245	19	the	the	DET
aji-39	245	20	least	least	ADJ
aji-39	245	21	prevalence	prevalence	NOUN
aji-39	245	22	for	for	ADP
aji-39	245	23	igg	igg	PROPN
aji-39	245	24	likewise	likewise	ADV
aji-39	245	25	igm	igm	PROPN
aji-39	245	26	.	.	PUNCT
aji-39	246	1	this	this	PRON
aji-39	246	2	agrees	agree	VERB
aji-39	246	3	with	with	ADP
aji-39	246	4	the	the	DET
aji-39	246	5	report	report	NOUN
aji-39	246	6	of	of	ADP
aji-39	246	7	muhammad	muhammad	PROPN
aji-39	246	8	et	et	PROPN
aji-39	246	9	al	al	PROPN
aji-39	246	10	.	.	PUNCT
aji-39	247	1	[	[	X
aji-39	247	2	22	22	NUM
aji-39	247	3	]	]	PUNCT
aji-39	247	4	but	but	CCONJ
aji-39	247	5	contrary	contrary	ADJ
aji-39	247	6	to	to	ADP
aji-39	247	7	some	some	DET
aji-39	247	8	others	other	NOUN
aji-39	247	9	within	within	ADP
aji-39	247	10	the	the	DET
aji-39	247	11	country	country	NOUN
aji-39	247	12	.	.	PUNCT
aji-39	248	1	this	this	PRON
aji-39	248	2	was	be	AUX
aji-39	248	3	probably	probably	ADV
aji-39	248	4	due	due	ADJ
aji-39	248	5	to	to	ADP
aji-39	248	6	the	the	DET
aji-39	248	7	high	high	ADJ
aji-39	248	8	endemic	endemic	ADJ
aji-39	248	9	nature	nature	NOUN
aji-39	248	10	of	of	ADP
aji-39	248	11	the	the	DET
aji-39	248	12	virus	virus	NOUN
aji-39	248	13	in	in	ADP
aji-39	248	14	zaria	zaria	PROPN
aji-39	248	15	,	,	PUNCT
aji-39	248	16	nigeria	nigeria	PROPN
aji-39	248	17	.	.	PUNCT
aji-39	249	1	the	the	DET
aji-39	249	2	virus	virus	NOUN
aji-39	249	3	is	be	AUX
aji-39	249	4	said	say	VERB
aji-39	249	5	to	to	PART
aji-39	249	6	be	be	AUX
aji-39	249	7	in	in	ADP
aji-39	249	8	constant	constant	ADJ
aji-39	249	9	circulation	circulation	NOUN
aji-39	249	10	among	among	ADP
aji-39	249	11	the	the	DET
aji-39	249	12	population	population	NOUN
aji-39	249	13	thus	thus	ADV
aji-39	249	14	downplaying	downplay	VERB
aji-39	249	15	the	the	DET
aji-39	249	16	effect	effect	NOUN
aji-39	249	17	of	of	ADP
aji-39	249	18	some	some	PRON
aji-39	249	19	of	of	ADP
aji-39	249	20	the	the	DET
aji-39	249	21	risk	risk	NOUN
aji-39	249	22	factors	factor	NOUN
aji-39	249	23	like	like	ADP
aji-39	249	24	age	age	NOUN
aji-39	249	25	[	[	X
aji-39	249	26	22	22	NUM
aji-39	249	27	]	]	PUNCT
aji-39	249	28	.	.	PUNCT
aji-39	250	1	a	a	DET
aji-39	250	2	similar	similar	ADJ
aji-39	250	3	situation	situation	NOUN
aji-39	250	4	is	be	AUX
aji-39	250	5	observed	observe	VERB
aji-39	250	6	in	in	ADP
aji-39	250	7	this	this	DET
aji-39	250	8	present	present	ADJ
aji-39	250	9	study	study	NOUN
aji-39	250	10	.	.	PUNCT
aji-39	251	1	higher	high	ADJ
aji-39	251	2	rubella	rubella	NOUN
aji-39	251	3	igm	igm	NOUN
aji-39	251	4	seroprevalence	seroprevalence	NOUN
aji-39	251	5	rates	rate	NOUN
aji-39	251	6	have	have	AUX
aji-39	251	7	also	also	ADV
aji-39	251	8	been	be	AUX
aji-39	251	9	documented	document	VERB
aji-39	251	10	among	among	ADP
aji-39	251	11	children	child	NOUN
aji-39	251	12	and	and	CCONJ
aji-39	251	13	adolescents	adolescent	NOUN
aji-39	251	14	than	than	ADP
aji-39	251	15	in	in	ADP
aji-39	251	16	adults	adult	NOUN
aji-39	251	17	with	with	ADP
aji-39	251	18	the	the	DET
aji-39	251	19	trend	trend	NOUN
aji-39	251	20	seen	see	VERB
aji-39	251	21	to	to	PART
aji-39	251	22	decrease	decrease	VERB
aji-39	251	23	with	with	ADP
aji-39	251	24	an	an	DET
aji-39	251	25	increase	increase	NOUN
aji-39	251	26	in	in	ADP
aji-39	251	27	age	age	NOUN
aji-39	251	28	[	[	X
aji-39	251	29	23,28	23,28	NUM
aji-39	251	30	-	-	SYM
aji-39	251	31	32	32	NUM
aji-39	251	32	]	]	PUNCT
aji-39	251	33	.	.	PUNCT
aji-39	252	1	antibodies	antibody	NOUN
aji-39	252	2	were	be	AUX
aji-39	252	3	found	find	VERB
aji-39	252	4	at	at	ADP
aji-39	252	5	every	every	DET
aji-39	252	6	trimester	trimester	NOUN
aji-39	252	7	which	which	PRON
aji-39	252	8	did	do	AUX
aji-39	252	9	not	not	PART
aji-39	252	10	differ	differ	VERB
aji-39	252	11	significantly	significantly	ADV
aji-39	252	12	from	from	ADP
aji-39	252	13	one	one	NUM
aji-39	252	14	another	another	DET
aji-39	252	15	(	(	PUNCT
aji-39	252	16	p	p	X
aji-39	252	17	>	>	X
aji-39	252	18	0.05	0.05	NUM
aji-39	252	19	)	)	PUNCT
aji-39	252	20	,	,	PUNCT
aji-39	252	21	a	a	DET
aji-39	252	22	finding	finding	NOUN
aji-39	252	23	that	that	PRON
aji-39	252	24	agreed	agree	VERB
aji-39	252	25	with	with	ADP
aji-39	252	26	that	that	PRON
aji-39	252	27	of	of	ADP
aji-39	252	28	olajide	olajide	NOUN
aji-39	252	29	et	et	PROPN
aji-39	252	30	al	al	PROPN
aji-39	252	31	.	.	PUNCT
aji-39	253	1	[	[	X
aji-39	253	2	5	5	NUM
aji-39	253	3	]	]	PUNCT
aji-39	253	4	.	.	PUNCT
aji-39	254	1	igg	igg	PROPN
aji-39	254	2	was	be	AUX
aji-39	254	3	highest	high	ADJ
aji-39	254	4	in	in	ADP
aji-39	254	5	the	the	DET
aji-39	254	6	third	third	ADJ
aji-39	254	7	trimester	trimester	NOUN
aji-39	254	8	and	and	CCONJ
aji-39	254	9	igm	igm	NOUN
aji-39	254	10	higher	high	ADJ
aji-39	254	11	in	in	ADP
aji-39	254	12	the	the	DET
aji-39	254	13	first	first	ADJ
aji-39	254	14	trimester	trimester	NOUN
aji-39	254	15	.	.	PUNCT
aji-39	255	1	this	this	PRON
aji-39	255	2	is	be	AUX
aji-39	255	3	contrary	contrary	ADJ
aji-39	255	4	to	to	ADP
aji-39	255	5	fokunang	fokunang	PROPN
aji-39	255	6	et	et	PROPN
aji-39	255	7	al	al	PROPN
aji-39	255	8	.	.	PUNCT
aji-39	256	1	[	[	X
aji-39	256	2	33	33	NUM
aji-39	256	3	]	]	PUNCT
aji-39	256	4	who	who	PRON
aji-39	256	5	reported	report	VERB
aji-39	256	6	the	the	DET
aji-39	256	7	highest	high	ADJ
aji-39	256	8	prevalence	prevalence	NOUN
aji-39	256	9	in	in	ADP
aji-39	256	10	the	the	DET
aji-39	256	11	second	second	ADJ
aji-39	256	12	trimester	trimester	NOUN
aji-39	256	13	.	.	PUNCT
aji-39	257	1	this	this	DET
aji-39	257	2	difference	difference	NOUN
aji-39	257	3	may	may	AUX
aji-39	257	4	be	be	AUX
aji-39	257	5	accrued	accrue	VERB
aji-39	257	6	to	to	ADP
aji-39	257	7	cultural	cultural	ADJ
aji-39	257	8	variation	variation	NOUN
aji-39	257	9	.	.	PUNCT
aji-39	258	1	some	some	DET
aji-39	258	2	ethnic	ethnic	ADJ
aji-39	258	3	groups	group	NOUN
aji-39	258	4	are	be	AUX
aji-39	258	5	more	more	ADV
aji-39	258	6	predisposed	predisposed	ADJ
aji-39	258	7	to	to	ADP
aji-39	258	8	presenting	present	VERB
aji-39	258	9	early	early	ADV
aji-39	258	10	at	at	ADP
aji-39	258	11	antenatal	antenatal	ADJ
aji-39	258	12	clinics	clinic	NOUN
aji-39	258	13	during	during	ADP
aji-39	258	14	pregnancy	pregnancy	NOUN
aji-39	258	15	than	than	ADP
aji-39	258	16	the	the	DET
aji-39	258	17	others	other	NOUN
aji-39	258	18	.	.	PUNCT
aji-39	259	1	formal	formal	ADJ
aji-39	259	2	educational	educational	ADJ
aji-39	259	3	status	status	NOUN
aji-39	259	4	,	,	PUNCT
aji-39	259	5	religion	religion	NOUN
aji-39	259	6	,	,	PUNCT
aji-39	259	7	and	and	CCONJ
aji-39	259	8	occupation	occupation	NOUN
aji-39	259	9	had	have	VERB
aji-39	259	10	no	no	DET
aji-39	259	11	significant	significant	ADJ
aji-39	259	12	effect	effect	NOUN
aji-39	259	13	(	(	PUNCT
aji-39	259	14	p	p	X
aji-39	259	15	>	>	X
aji-39	259	16	0.05	0.05	NUM
aji-39	259	17	)	)	PUNCT
aji-39	259	18	on	on	ADP
aji-39	259	19	the	the	DET
aji-39	259	20	distribution	distribution	NOUN
aji-39	259	21	of	of	ADP
aji-39	259	22	seroprevalence	seroprevalence	NOUN
aji-39	259	23	of	of	ADP
aji-39	259	24	igg	igg	PROPN
aji-39	259	25	and	and	CCONJ
aji-39	259	26	igm	igm	PROPN
aji-39	259	27	in	in	ADP
aji-39	259	28	this	this	DET
aji-39	259	29	present	present	ADJ
aji-39	259	30	study	study	NOUN
aji-39	259	31	.	.	PUNCT
aji-39	260	1	this	this	DET
aji-39	260	2	finding	finding	NOUN
aji-39	260	3	is	be	AUX
aji-39	260	4	similar	similar	ADJ
aji-39	260	5	to	to	ADP
aji-39	260	6	the	the	DET
aji-39	260	7	findings	finding	NOUN
aji-39	260	8	of	of	ADP
aji-39	260	9	mohammed	mohammed	PROPN
aji-39	260	10	et	et	PROPN
aji-39	260	11	al	al	PROPN
aji-39	260	12	.	.	PUNCT
aji-39	261	1	[	[	X
aji-39	261	2	22	22	NUM
aji-39	261	3	]	]	PUNCT
aji-39	261	4	.	.	PUNCT
aji-39	262	1	it	it	PRON
aji-39	262	2	was	be	AUX
aji-39	262	3	observed	observe	VERB
aji-39	262	4	that	that	SCONJ
aji-39	262	5	though	though	SCONJ
aji-39	262	6	a	a	DET
aji-39	262	7	high	high	ADJ
aji-39	262	8	percentage	percentage	NOUN
aji-39	262	9	of	of	ADP
aji-39	262	10	the	the	DET
aji-39	262	11	subjects	subject	NOUN
aji-39	262	12	had	have	VERB
aji-39	262	13	a	a	DET
aji-39	262	14	tertiary	tertiary	ADJ
aji-39	262	15	or	or	CCONJ
aji-39	262	16	at	at	ADP
aji-39	262	17	least	least	ADJ
aji-39	262	18	a	a	DET
aji-39	262	19	secondary	secondary	ADJ
aji-39	262	20	school	school	NOUN
aji-39	262	21	level	level	NOUN
aji-39	262	22	formal	formal	ADJ
aji-39	262	23	education	education	NOUN
aji-39	262	24	,	,	PUNCT
aji-39	262	25	it	it	PRON
aji-39	262	26	did	do	AUX
aji-39	262	27	not	not	PART
aji-39	262	28	cumulate	cumulate	VERB
aji-39	262	29	to	to	ADP
aji-39	262	30	adequate	adequate	ADJ
aji-39	262	31	knowledge	knowledge	NOUN
aji-39	262	32	about	about	ADP
aji-39	262	33	the	the	DET
aji-39	262	34	virus	virus	NOUN
aji-39	262	35	.	.	PUNCT
aji-39	263	1	even	even	ADV
aji-39	263	2	the	the	DET
aji-39	263	3	few	few	ADJ
aji-39	263	4	who	who	PRON
aji-39	263	5	indicated	indicate	VERB
aji-39	263	6	knowledge	knowledge	NOUN
aji-39	263	7	of	of	ADP
aji-39	263	8	the	the	DET
aji-39	263	9	virus	virus	NOUN
aji-39	263	10	did	do	AUX
aji-39	263	11	not	not	PART
aji-39	263	12	request	request	VERB
aji-39	263	13	to	to	PART
aji-39	263	14	be	be	AUX
aji-39	263	15	vaccinated	vaccinate	VERB
aji-39	263	16	as	as	ADP
aji-39	263	17	all	all	DET
aji-39	263	18	subjects	subject	NOUN
aji-39	263	19	in	in	ADP
aji-39	263	20	this	this	DET
aji-39	263	21	study	study	NOUN
aji-39	263	22	claimed	claim	VERB
aji-39	263	23	not	not	PART
aji-39	263	24	to	to	PART
aji-39	263	25	have	have	AUX
aji-39	263	26	been	be	AUX
aji-39	263	27	vaccinated	vaccinate	VERB
aji-39	263	28	against	against	ADP
aji-39	263	29	the	the	DET
aji-39	263	30	virus	virus	NOUN
aji-39	263	31	.	.	PUNCT
aji-39	264	1	parity	parity	NOUN
aji-39	264	2	was	be	AUX
aji-39	264	3	however	however	ADV
aji-39	264	4	associated	associate	VERB
aji-39	264	5	with	with	ADP
aji-39	264	6	the	the	DET
aji-39	264	7	risk	risk	NOUN
aji-39	264	8	of	of	ADP
aji-39	264	9	rubella	rubella	NOUN
aji-39	264	10	infection	infection	NOUN
aji-39	264	11	(	(	PUNCT
aji-39	264	12	p	p	X
aji-39	264	13	<	<	X
aji-39	264	14	0.05	0.05	NUM
aji-39	264	15	)	)	PUNCT
aji-39	264	16	.	.	PUNCT
aji-39	265	1	its	its	PRON
aji-39	265	2	effect	effect	NOUN
aji-39	265	3	was	be	AUX
aji-39	265	4	seen	see	VERB
aji-39	265	5	both	both	PRON
aji-39	265	6	on	on	ADP
aji-39	265	7	igg	igg	PROPN
aji-39	265	8	and	and	CCONJ
aji-39	265	9	igm	igm	PROPN
aji-39	265	10	serostatus	serostatus	NOUN
aji-39	265	11	.	.	PUNCT
aji-39	266	1	the	the	DET
aji-39	266	2	nulliparous	nulliparous	ADJ
aji-39	266	3	(	(	PUNCT
aji-39	266	4	zero	zero	NUM
aji-39	266	5	parity	parity	NOUN
aji-39	266	6	)	)	PUNCT
aji-39	266	7	had	have	VERB
aji-39	266	8	a	a	DET
aji-39	266	9	93.1	93.1	NUM
aji-39	266	10	%	%	NOUN
aji-39	266	11	igg	igg	NOUN
aji-39	266	12	prevalence	prevalence	NOUN
aji-39	266	13	and	and	CCONJ
aji-39	266	14	3.4	3.4	NUM
aji-39	266	15	%	%	NOUN
aji-39	266	16	for	for	ADP
aji-39	266	17	igm	igm	NOUN
aji-39	266	18	as	as	ADP
aji-39	266	19	compared	compare	VERB
aji-39	266	20	to	to	ADP
aji-39	266	21	the	the	DET
aji-39	266	22	multiparous	multiparous	NOUN
aji-39	266	23	that	that	PRON
aji-39	266	24	had	have	VERB
aji-39	266	25	at	at	ADV
aji-39	266	26	least	least	ADV
aji-39	266	27	18.7	18.7	NUM
aji-39	266	28	%	%	NOUN
aji-39	266	29	and	and	CCONJ
aji-39	266	30	more	more	ADJ
aji-39	266	31	igm	igm	NOUN
aji-39	266	32	prevalence	prevalence	NOUN
aji-39	266	33	which	which	PRON
aji-39	266	34	aligns	align	VERB
aji-39	266	35	with	with	ADP
aji-39	266	36	the	the	DET
aji-39	266	37	repost	repost	NOUN
aji-39	266	38	of	of	ADP
aji-39	266	39	onakewhor	onakewhor	NOUN
aji-39	266	40	and	and	CCONJ
aji-39	266	41	chiwuzie	chiwuzie	VERB
aji-39	266	42	[	[	X
aji-39	266	43	31	31	NUM
aji-39	266	44	]	]	PUNCT
aji-39	266	45	but	but	CCONJ
aji-39	266	46	contrary	contrary	ADJ
aji-39	266	47	to	to	ADP
aji-39	266	48	that	that	PRON
aji-39	266	49	of	of	ADP
aji-39	266	50	olajide	olajide	NOUN
aji-39	266	51	et	et	PROPN
aji-39	266	52	al	al	PROPN
aji-39	266	53	.	.	PUNCT
aji-39	267	1	[	[	X
aji-39	267	2	5	5	NUM
aji-39	267	3	]	]	PUNCT
aji-39	267	4	who	who	PRON
aji-39	267	5	reported	report	VERB
aji-39	267	6	no	no	DET
aji-39	267	7	association	association	NOUN
aji-39	267	8	between	between	ADP
aji-39	267	9	reproductive	reproductive	ADJ
aji-39	267	10	character	character	NOUN
aji-39	267	11	and	and	CCONJ
aji-39	267	12	risk	risk	NOUN
aji-39	267	13	of	of	ADP
aji-39	267	14	rubella	rubella	NOUN
aji-39	267	15	infection	infection	NOUN
aji-39	267	16	.	.	PUNCT
aji-39	268	1	parity	parity	NOUN
aji-39	268	2	may	may	AUX
aji-39	268	3	be	be	AUX
aji-39	268	4	associated	associate	VERB
aji-39	268	5	with	with	ADP
aji-39	268	6	the	the	DET
aji-39	268	7	risk	risk	NOUN
aji-39	268	8	of	of	ADP
aji-39	268	9	infection	infection	NOUN
aji-39	268	10	since	since	SCONJ
aji-39	268	11	mothers	mother	NOUN
aji-39	268	12	who	who	PRON
aji-39	268	13	have	have	VERB
aji-39	268	14	a	a	DET
aji-39	268	15	number	number	NOUN
aji-39	268	16	of	of	ADP
aji-39	268	17	children	child	NOUN
aji-39	268	18	may	may	AUX
aji-39	268	19	stand	stand	VERB
aji-39	268	20	a	a	DET
aji-39	268	21	risk	risk	NOUN
aji-39	268	22	of	of	ADP
aji-39	268	23	being	be	AUX
aji-39	268	24	infected	infect	VERB
aji-39	268	25	from	from	ADP
aji-39	268	26	the	the	DET
aji-39	268	27	children	child	NOUN
aji-39	269	1	[	[	X
aji-39	269	2	12	12	NUM
aji-39	269	3	]	]	PUNCT
aji-39	269	4	.	.	PUNCT
aji-39	270	1	the	the	DET
aji-39	270	2	study	study	NOUN
aji-39	270	3	is	be	AUX
aji-39	270	4	limited	limit	VERB
aji-39	270	5	by	by	ADP
aji-39	270	6	the	the	DET
aji-39	270	7	unwillingness	unwillingness	NOUN
aji-39	270	8	of	of	ADP
aji-39	270	9	some	some	PRON
aji-39	270	10	of	of	ADP
aji-39	270	11	the	the	DET
aji-39	270	12	participants	participant	NOUN
aji-39	270	13	to	to	PART
aji-39	270	14	provide	provide	VERB
aji-39	270	15	genuine	genuine	ADJ
aji-39	270	16	information	information	NOUN
aji-39	270	17	and	and	CCONJ
aji-39	270	18	inability	inability	NOUN
aji-39	270	19	to	to	PART
aji-39	270	20	recall	recall	VERB
aji-39	270	21	past	past	ADJ
aji-39	270	22	experiences	experience	NOUN
aji-39	270	23	,	,	PUNCT
aji-39	270	24	hence	hence	ADV
aji-39	270	25	,	,	PUNCT
aji-39	270	26	possibly	possibly	ADV
aji-39	270	27	introducing	introduce	VERB
aji-39	270	28	some	some	DET
aji-39	270	29	biases	bias	NOUN
aji-39	270	30	to	to	ADP
aji-39	270	31	the	the	DET
aji-39	270	32	study	study	NOUN
aji-39	270	33	.	.	PUNCT
aji-39	271	1	the	the	DET
aji-39	271	2	accuracy	accuracy	NOUN
aji-39	271	3	generalizations	generalization	NOUN
aji-39	271	4	about	about	ADP
aji-39	271	5	pregnant	pregnant	ADJ
aji-39	271	6	women	woman	NOUN
aji-39	271	7	based	base	VERB
aji-39	271	8	on	on	ADP
aji-39	271	9	this	this	DET
aji-39	271	10	study	study	NOUN
aji-39	271	11	may	may	AUX
aji-39	271	12	also	also	ADV
aji-39	271	13	be	be	AUX
aji-39	271	14	limited	limit	VERB
aji-39	271	15	because	because	SCONJ
aji-39	271	16	it	it	PRON
aji-39	271	17	is	be	AUX
aji-39	271	18	an	an	DET
aji-39	271	19	institution	institution	NOUN
aji-39	271	20	based	base	VERB
aji-39	271	21	study	study	NOUN
aji-39	271	22	.	.	PUNCT
aji-39	272	1	a	a	DET
aji-39	272	2	subsequent	subsequent	ADJ
aji-39	272	3	community	community	NOUN
aji-39	272	4	based	base	VERB
aji-39	272	5	longitudinal	longitudinal	ADJ
aji-39	272	6	study	study	NOUN
aji-39	272	7	may	may	AUX
aji-39	272	8	resolve	resolve	VERB
aji-39	272	9	these	these	DET
aji-39	272	10	limitations	limitation	NOUN
aji-39	272	11	.	.	PUNCT
aji-39	273	1	4	4	X
aji-39	273	2	.	.	X
aji-39	273	3	conclusion	conclusion	NOUN
aji-39	273	4	this	this	DET
aji-39	273	5	study	study	NOUN
aji-39	273	6	reveals	reveal	VERB
aji-39	273	7	a	a	DET
aji-39	273	8	high	high	ADJ
aji-39	273	9	rate	rate	NOUN
aji-39	273	10	of	of	ADP
aji-39	273	11	exposure	exposure	NOUN
aji-39	273	12	of	of	ADP
aji-39	273	13	pregnant	pregnant	ADJ
aji-39	273	14	women	woman	NOUN
aji-39	273	15	to	to	PART
aji-39	273	16	rubella	rubella	VERB
aji-39	273	17	virus	virus	NOUN
aji-39	273	18	in	in	ADP
aji-39	273	19	this	this	DET
aji-39	273	20	study	study	NOUN
aji-39	273	21	area	area	NOUN
aji-39	273	22	.	.	PUNCT
aji-39	274	1	this	this	PRON
aji-39	274	2	suggests	suggest	VERB
aji-39	274	3	continuous	continuous	ADJ
aji-39	274	4	transmission	transmission	NOUN
aji-39	274	5	and	and	CCONJ
aji-39	274	6	endermicity	endermicity	NOUN
aji-39	274	7	of	of	ADP
aji-39	274	8	rubella	rubella	NOUN
aji-39	274	9	in	in	ADP
aji-39	274	10	the	the	DET
aji-39	274	11	area	area	NOUN
aji-39	274	12	.	.	PUNCT
aji-39	275	1	prevalence	prevalence	NOUN
aji-39	275	2	showed	show	VERB
aji-39	275	3	similar	similar	ADJ
aji-39	275	4	distribution	distribution	NOUN
aji-39	275	5	pattern	pattern	NOUN
aji-39	275	6	irrespective	irrespective	ADV
aji-39	275	7	of	of	ADP
aji-39	275	8	sociodemographic	sociodemographic	ADJ
aji-39	275	9	features	feature	NOUN
aji-39	275	10	examined	examine	VERB
aji-39	275	11	.	.	PUNCT
aji-39	276	1	however	however	ADV
aji-39	276	2	,	,	PUNCT
aji-39	276	3	infection	infection	NOUN
aji-39	276	4	is	be	AUX
aji-39	276	5	significant	significant	ADJ
aji-39	276	6	with	with	ADP
aji-39	276	7	respect	respect	NOUN
aji-39	276	8	to	to	ADP
aji-39	276	9	parity	parity	NOUN
aji-39	276	10	.	.	PUNCT
aji-39	277	1	the	the	DET
aji-39	277	2	findings	finding	NOUN
aji-39	277	3	emphasize	emphasize	VERB
aji-39	277	4	the	the	DET
aji-39	277	5	need	need	NOUN
aji-39	277	6	to	to	PART
aji-39	277	7	implement	implement	VERB
aji-39	277	8	routine	routine	ADJ
aji-39	277	9	childhood	childhood	NOUN
aji-39	277	10	immunization	immunization	NOUN
aji-39	277	11	against	against	ADP
aji-39	277	12	rubella	rubella	NOUN
aji-39	277	13	virus	virus	NOUN
aji-39	277	14	as	as	ADV
aji-39	277	15	well	well	ADV
aji-39	277	16	as	as	ADP
aji-39	277	17	vaccinating	vaccinate	VERB
aji-39	277	18	susceptible	susceptible	ADJ
aji-39	277	19	women	woman	NOUN
aji-39	277	20	of	of	ADP
aji-39	277	21	childbearing	childbeare	VERB
aji-39	277	22	age	age	NOUN
aji-39	277	23	.	.	PUNCT
aji-39	278	1	consent	consent	VERB
aji-39	278	2	the	the	DET
aji-39	278	3	authors	author	NOUN
aji-39	278	4	declare	declare	VERB
aji-39	278	5	that	that	SCONJ
aji-39	278	6	written	write	VERB
aji-39	278	7	informed	informed	ADJ
aji-39	278	8	consent	consent	NOUN
aji-39	278	9	was	be	AUX
aji-39	278	10	obtained	obtain	VERB
aji-39	278	11	from	from	ADP
aji-39	278	12	the	the	DET
aji-39	278	13	patients	patient	NOUN
aji-39	278	14	for	for	ADP
aji-39	278	15	the	the	DET
aji-39	278	16	publication	publication	NOUN
aji-39	278	17	of	of	ADP
aji-39	278	18	this	this	DET
aji-39	278	19	report	report	NOUN
aji-39	278	20	.	.	PUNCT
aji-39	279	1	a	a	DET
aji-39	279	2	copy	copy	NOUN
aji-39	279	3	of	of	ADP
aji-39	279	4	the	the	DET
aji-39	279	5	written	write	VERB
aji-39	279	6	consent	consent	NOUN
aji-39	279	7	is	be	AUX
aji-39	279	8	available	available	ADJ
aji-39	279	9	for	for	ADP
aji-39	279	10	review	review	NOUN
aji-39	279	11	by	by	ADP
aji-39	279	12	the	the	DET
aji-39	279	13	editorial	editorial	ADJ
aji-39	279	14	office	office	NOUN
aji-39	279	15	/	/	SYM
aji-39	279	16	chief	chief	ADJ
aji-39	279	17	editor	editor	NOUN
aji-39	279	18	/	/	SYM
aji-39	279	19	editorial	editorial	NOUN
aji-39	279	20	board	board	NOUN
aji-39	279	21	members	member	NOUN
aji-39	279	22	of	of	ADP
aji-39	279	23	this	this	DET
aji-39	279	24	journal	journal	NOUN
aji-39	279	25	.	.	PUNCT
aji-39	280	1	ethical	ethical	ADJ
aji-39	280	2	approval	approval	NOUN
aji-39	280	3	the	the	DET
aji-39	280	4	authors	author	NOUN
aji-39	280	5	hereby	hereby	ADV
aji-39	280	6	declare	declare	VERB
aji-39	280	7	that	that	SCONJ
aji-39	280	8	ethical	ethical	ADJ
aji-39	280	9	approval	approval	NOUN
aji-39	280	10	for	for	ADP
aji-39	280	11	the	the	DET
aji-39	280	12	study	study	NOUN
aji-39	280	13	was	be	AUX
aji-39	280	14	obtained	obtain	VERB
aji-39	280	15	from	from	ADP
aji-39	280	16	the	the	DET
aji-39	280	17	ethics	ethic	NOUN
aji-39	280	18	and	and	CCONJ
aji-39	280	19	research	research	NOUN
aji-39	280	20	committee	committee	NOUN
aji-39	280	21	,	,	PUNCT
aji-39	280	22	federal	federal	ADJ
aji-39	280	23	teaching	teaching	NOUN
aji-39	280	24	hospital	hospital	NOUN
aji-39	280	25	ido	ido	PROPN
aji-39	280	26	-	-	PUNCT
aji-39	280	27	ekiti	ekiti	ADJ
aji-39	280	28	,	,	PUNCT
aji-39	280	29	reference	reference	NOUN
aji-39	280	30	number	number	NOUN
aji-39	280	31	:	:	PUNCT
aji-39	280	32	erc/2017/02/20/	erc/2017/02/20/	PROPN
aji-39	280	33	50b	50b	PROPN
aji-39	280	34	.	.	PUNCT
aji-39	281	1	subjects	subject	NOUN
aji-39	281	2	were	be	AUX
aji-39	281	3	fully	fully	ADV
aji-39	281	4	informed	inform	VERB
aji-39	281	5	of	of	ADP
aji-39	281	6	their	their	PRON
aji-39	281	7	right	right	NOUN
aji-39	281	8	to	to	PART
aji-39	281	9	opt	opt	VERB
aji-39	281	10	-	-	PUNCT
aji-39	281	11	out	out	NOUN
aji-39	281	12	of	of	ADP
aji-39	281	13	the	the	DET
aji-39	281	14	study	study	NOUN
aji-39	281	15	at	at	ADP
aji-39	281	16	any	any	DET
aji-39	281	17	point	point	NOUN
aji-39	281	18	they	they	PRON
aji-39	281	19	so	so	ADV
aji-39	281	20	desire	desire	VERB
aji-39	281	21	.	.	PUNCT
aji-39	282	1	they	they	PRON
aji-39	282	2	were	be	AUX
aji-39	282	3	informed	inform	VERB
aji-39	282	4	about	about	ADP
aji-39	282	5	investigations	investigation	NOUN
aji-39	282	6	carried	carry	VERB
aji-39	282	7	out	out	ADP
aji-39	282	8	with	with	ADP
aji-39	282	9	their	their	PRON
aji-39	282	10	samples	sample	NOUN
aji-39	282	11	,	,	PUNCT
aji-39	282	12	potential	potential	ADJ
aji-39	282	13	risk	risk	NOUN
aji-39	282	14	of	of	ADP
aji-39	282	15	the	the	DET
aji-39	282	16	study	study	NOUN
aji-39	282	17	,	,	PUNCT
aji-39	282	18	and	and	CCONJ
aji-39	282	19	were	be	AUX
aji-39	282	20	assured	assure	VERB
aji-39	282	21	of	of	ADP
aji-39	282	22	confidentiality	confidentiality	NOUN
aji-39	282	23	of	of	ADP
aji-39	282	24	the	the	DET
aji-39	282	25	results	result	NOUN
aji-39	282	26	.	.	PUNCT
aji-39	283	1	acknowledgements	acknowledgement	NOUN
aji-39	283	2	the	the	DET
aji-39	283	3	authors	author	NOUN
aji-39	283	4	are	be	AUX
aji-39	283	5	grateful	grateful	ADJ
aji-39	283	6	to	to	ADP
aji-39	283	7	the	the	DET
aji-39	283	8	authority	authority	NOUN
aji-39	283	9	of	of	ADP
aji-39	283	10	federal	federal	ADJ
aji-39	283	11	medical	medical	ADJ
aji-39	283	12	teaching	teaching	NOUN
aji-39	283	13	hospital	hospital	NOUN
aji-39	283	14	ido	ido	PROPN
aji-39	283	15	-	-	PUNCT
aji-39	283	16	ekiti	ekiti	PROPN
aji-39	283	17	who	who	PRON
aji-39	283	18	permitted	permit	VERB
aji-39	283	19	us	we	PRON
aji-39	283	20	to	to	PART
aji-39	283	21	carry	carry	VERB
aji-39	283	22	out	out	ADP
aji-39	283	23	this	this	DET
aji-39	283	24	study	study	NOUN
aji-39	283	25	in	in	ADP
aji-39	283	26	their	their	PRON
aji-39	283	27	facility	facility	NOUN
aji-39	283	28	through	through	ADP
aji-39	283	29	the	the	DET
aji-39	283	30	ethical	ethical	ADJ
aji-39	283	31	committee	committee	NOUN
aji-39	283	32	.	.	PUNCT
aji-39	284	1	the	the	DET
aji-39	284	2	cooperation	cooperation	NOUN
aji-39	284	3	akele	akele	PROPN
aji-39	284	4	et	et	PROPN
aji-39	284	5	al	al	PROPN
aji-39	284	6	.	.	PROPN
aji-39	284	7	;	;	PUNCT
aji-39	284	8	aji	aji	PROPN
aji-39	284	9	,	,	PUNCT
aji-39	284	10	3(1	3(1	NUM
aji-39	284	11	):	):	PUNCT
aji-39	284	12	199	199	NUM
aji-39	284	13	-	-	SYM
aji-39	284	14	207	207	NUM
aji-39	284	15	,	,	PUNCT
aji-39	284	16	2020	2020	NUM
aji-39	284	17	;	;	PUNCT
aji-39	284	18	article	article	NOUN
aji-39	284	19	no.aji.57099	no.aji.57099	VERB
aji-39	284	20	206	206	NUM
aji-39	284	21	of	of	ADP
aji-39	284	22	the	the	DET
aji-39	284	23	nurses	nurse	NOUN
aji-39	284	24	and	and	CCONJ
aji-39	284	25	doctors	doctor	NOUN
aji-39	284	26	at	at	ADP
aji-39	284	27	the	the	DET
aji-39	284	28	antenatal	antenatal	NOUN
aji-39	284	29	clinic	clinic	NOUN
aji-39	284	30	during	during	ADP
aji-39	284	31	this	this	DET
aji-39	284	32	study	study	NOUN
aji-39	284	33	is	be	AUX
aji-39	284	34	acknowledged	acknowledge	VERB
aji-39	284	35	.	.	PUNCT
aji-39	285	1	we	we	PRON
aji-39	285	2	also	also	ADV
aji-39	285	3	appreciate	appreciate	VERB
aji-39	285	4	afe	afe	PROPN
aji-39	285	5	babalola	babalola	PROPN
aji-39	285	6	university	university	PROPN
aji-39	285	7	for	for	ADP
aji-39	285	8	granting	grant	VERB
aji-39	285	9	us	we	PRON
aji-39	285	10	access	access	NOUN
aji-39	285	11	to	to	ADP
aji-39	285	12	their	their	PRON
aji-39	285	13	medical	medical	ADJ
aji-39	285	14	laboratory	laboratory	NOUN
aji-39	285	15	where	where	SCONJ
aji-39	285	16	the	the	DET
aji-39	285	17	sample	sample	NOUN
aji-39	285	18	analysis	analysis	NOUN
aji-39	285	19	was	be	AUX
aji-39	285	20	carried	carry	VERB
aji-39	285	21	out	out	ADP
aji-39	285	22	.	.	PUNCT
aji-39	286	1	competing	compete	VERB
aji-39	286	2	interests	interest	NOUN
aji-39	286	3	authors	author	NOUN
aji-39	286	4	have	have	AUX
aji-39	286	5	declared	declare	VERB
aji-39	286	6	that	that	SCONJ
aji-39	286	7	no	no	DET
aji-39	286	8	competing	compete	VERB
aji-39	286	9	interests	interest	NOUN
aji-39	286	10	exist	exist	VERB
aji-39	286	11	.	.	PUNCT
aji-39	287	1	references	reference	NOUN
aji-39	287	2	1	1	NUM
aji-39	287	3	.	.	PUNCT
aji-39	287	4	mayo	mayo	PROPN
aji-39	287	5	foundation	foundation	PROPN
aji-39	287	6	for	for	ADP
aji-39	287	7	medical	medical	ADJ
aji-39	287	8	education	education	NOUN
aji-39	287	9	and	and	CCONJ
aji-39	287	10	research	research	NOUN
aji-39	287	11	.	.	PUNCT
aji-39	288	1	rubella	rubella	NOUN
aji-39	288	2	:	:	PUNCT
aji-39	289	1	complications	complication	NOUN
aji-39	289	2	,	,	PUNCT
aji-39	289	3	diseases	disease	NOUN
aji-39	289	4	and	and	CCONJ
aji-39	289	5	conditions	condition	NOUN
aji-39	289	6	.	.	PUNCT
aji-39	290	1	healthline	healthline	PROPN
aji-39	290	2	.	.	PUNCT
aji-39	291	1	2015;25:45	2015;25:45	NUM
aji-39	291	2	-	-	SYM
aji-39	291	3	50	50	NUM
aji-39	291	4	.	.	X
aji-39	292	1	2	2	X
aji-39	292	2	.	.	X
aji-39	292	3	willey	willey	PROPN
aji-39	292	4	j	j	PROPN
aji-39	292	5	,	,	PUNCT
aji-39	292	6	sherwood	sherwood	PROPN
aji-39	292	7	l	l	PROPN
aji-39	292	8	,	,	PUNCT
aji-39	292	9	woolverton	woolverton	PROPN
aji-39	292	10	c.	c.	PROPN
aji-39	292	11	human	human	ADJ
aji-39	292	12	diseases	disease	NOUN
aji-39	292	13	caused	cause	VERB
aji-39	292	14	by	by	ADP
aji-39	292	15	viruses	virus	NOUN
aji-39	292	16	and	and	CCONJ
aji-39	292	17	prions	prion	NOUN
aji-39	292	18	.	.	PUNCT
aji-39	293	1	in	in	ADP
aji-39	293	2	:	:	PUNCT
aji-39	293	3	prescott	prescott	PROPN
aji-39	293	4	’s	’s	PART
aji-39	293	5	microbiology	microbiology	NOUN
aji-39	293	6	,	,	PUNCT
aji-39	293	7	8	8	NUM
aji-39	293	8	th	th	NUM
aji-39	293	9	ed	ed	NOUN
aji-39	293	10	.	.	PUNCT
aji-39	294	1	new	new	PROPN
aji-39	294	2	york	york	PROPN
aji-39	294	3	:	:	PUNCT
aji-39	294	4	mcgraw	mcgraw	PROPN
aji-39	294	5	-	-	PUNCT
aji-39	294	6	hill	hill	NOUN
aji-39	294	7	.	.	PUNCT
aji-39	295	1	2011;905	2011;905	VERB
aji-39	295	2	-	-	PUNCT
aji-39	295	3	906	906	NUM
aji-39	295	4	.	.	PUNCT
aji-39	296	1	3	3	X
aji-39	296	2	.	.	X
aji-39	297	1	cdc	cdc	PROPN
aji-39	297	2	.	.	PUNCT
aji-39	297	3	rubella	rubella	NOUN
aji-39	297	4	(	(	PUNCT
aji-39	297	5	german	german	ADJ
aji-39	297	6	measles	measle	NOUN
aji-39	297	7	,	,	PUNCT
aji-39	297	8	threeday	threeday	NOUN
aji-39	297	9	measles	measle	NOUN
aji-39	297	10	)	)	PUNCT
aji-39	297	11	;	;	PUNCT
aji-39	297	12	2011	2011	NUM
aji-39	297	13	.	.	PUNCT
aji-39	298	1	accessed	access	VERB
aji-39	298	2	july	july	PROPN
aji-39	298	3	13	13	NUM
aji-39	298	4	2017	2017	NUM
aji-39	298	5	available	available	ADJ
aji-39	298	6	:	:	PUNCT
aji-39	298	7	http://www.cdc.gov	http://www.cdc.gov	NOUN
aji-39	298	8	/	/	SYM
aji-39	298	9	globalhealth	globalhealth	NOUN
aji-39	298	10	/	/	SYM
aji-39	298	11	i	i	PRON
aji-39	298	12	mmunizationinfographic	mmunizationinfographic	ADJ
aji-39	298	13	/	/	SYM
aji-39	298	14	stop	stop	NOUN
aji-39	298	15	-	-	PUNCT
aji-39	298	16	rubella.htm	rubella.htm	X
aji-39	298	17	4	4	NUM
aji-39	298	18	.	.	PUNCT
aji-39	298	19	banatvala	banatvala	PROPN
aji-39	298	20	je	je	PROPN
aji-39	298	21	,	,	PUNCT
aji-39	298	22	brown	brown	PROPN
aji-39	298	23	dw	dw	PROPN
aji-39	298	24	.	.	PROPN
aji-39	298	25	rubella	rubella	PROPN
aji-39	298	26	.	.	PUNCT
aji-39	299	1	lancent	lancent	NOUN
aji-39	299	2	.	.	PUNCT
aji-39	300	1	2015;363(9415):1127–1137	2015;363(9415):1127–1137	NUM
aji-39	300	2	.	.	PUNCT
aji-39	301	1	5	5	NUM
aji-39	301	2	.	.	X
aji-39	301	3	olajide	olajide	ADV
aji-39	301	4	om	om	PROPN
aji-39	301	5	,	,	PUNCT
aji-39	301	6	aminu	aminu	PROPN
aji-39	301	7	m	m	PROPN
aji-39	301	8	,	,	PUNCT
aji-39	301	9	randawa	randawa	PROPN
aji-39	301	10	aj	aj	PROPN
aji-39	301	11	,	,	PUNCT
aji-39	301	12	adejo	adejo	ADJ
aji-39	301	13	ds	ds	PROPN
aji-39	301	14	.	.	PROPN
aji-39	301	15	seroprevalence	seroprevalence	NOUN
aji-39	301	16	of	of	ADP
aji-39	301	17	rubella	rubella	NOUN
aji-39	301	18	-	-	PUNCT
aji-39	301	19	specific	specific	ADJ
aji-39	301	20	igm	igm	NOUN
aji-39	301	21	and	and	CCONJ
aji-39	301	22	igg	igg	PROPN
aji-39	301	23	antibodies	antibodie	VERB
aji-39	301	24	among	among	ADP
aji-39	301	25	pregnant	pregnant	ADJ
aji-39	301	26	women	woman	NOUN
aji-39	301	27	seen	see	VERB
aji-39	301	28	in	in	ADP
aji-39	301	29	a	a	DET
aji-39	301	30	tertiary	tertiary	ADJ
aji-39	301	31	hospital	hospital	NOUN
aji-39	301	32	in	in	ADP
aji-39	301	33	nigeria	nigeria	PROPN
aji-39	301	34	.	.	PUNCT
aji-39	302	1	int	int	PROPN
aji-39	302	2	j	j	PROPN
aji-39	302	3	women	woman	NOUN
aji-39	302	4	's	's	PART
aji-39	302	5	health	health	NOUN
aji-39	302	6	.	.	PUNCT
aji-39	303	1	2015;7:75	2015;7:75	PROPN
aji-39	303	2	–	–	PUNCT
aji-39	303	3	83	83	NUM
aji-39	303	4	.	.	NOUN
aji-39	304	1	6	6	NUM
aji-39	304	2	.	.	PUNCT
aji-39	304	3	mirambo	mirambo	PROPN
aji-39	304	4	mm	mm	PROPN
aji-39	304	5	,	,	PUNCT
aji-39	304	6	majigo	majigo	PROPN
aji-39	304	7	m	m	PROPN
aji-39	304	8	,	,	PUNCT
aji-39	304	9	aboud	aboud	PROPN
aji-39	304	10	s	s	NOUN
aji-39	304	11	,	,	PUNCT
aji-39	304	12	gross	gross	ADJ
aji-39	304	13	u	u	NOUN
aji-39	304	14	,	,	PUNCT
aji-39	304	15	mshana	mshana	NOUN
aji-39	304	16	se	se	PROPN
aji-39	304	17	.	.	PUNCT
aji-39	305	1	serological	serological	ADJ
aji-39	305	2	makers	maker	NOUN
aji-39	305	3	of	of	ADP
aji-39	305	4	rubella	rubella	NOUN
aji-39	305	5	infection	infection	NOUN
aji-39	305	6	in	in	ADP
aji-39	305	7	africa	africa	PROPN
aji-39	305	8	in	in	ADP
aji-39	305	9	the	the	DET
aji-39	305	10	pre	pre	ADJ
aji-39	305	11	vaccination	vaccination	NOUN
aji-39	305	12	era	era	NOUN
aji-39	305	13	:	:	PUNCT
aji-39	305	14	a	a	DET
aji-39	305	15	systematic	systematic	ADJ
aji-39	305	16	review	review	NOUN
aji-39	305	17	.	.	PUNCT
aji-39	306	1	bmc	bmc	ADJ
aji-39	306	2	res	re	NOUN
aji-39	306	3	notes	note	NOUN
aji-39	306	4	.	.	PUNCT
aji-39	307	1	2015;8(1):716	2015;8(1):716	X
aji-39	307	2	-	-	SYM
aji-39	307	3	726	726	NUM
aji-39	307	4	.	.	NOUN
aji-39	308	1	7	7	NUM
aji-39	308	2	.	.	X
aji-39	309	1	who	who	PRON
aji-39	309	2	.	.	PUNCT
aji-39	310	1	rubella	rubella	NOUN
aji-39	310	2	vaccine	vaccine	NOUN
aji-39	310	3	.	.	PUNCT
aji-39	311	1	who	who	PRON
aji-39	311	2	position	position	VERB
aji-39	311	3	paper	paper	NOUN
aji-39	311	4	.	.	PUNCT
aji-39	312	1	weekly	weekly	ADJ
aji-39	312	2	epidemiological	epidemiological	ADJ
aji-39	312	3	record	record	NOUN
aji-39	312	4	.	.	PUNCT
aji-39	313	1	2013;29(86):301–316	2013;29(86):301–316	NUM
aji-39	313	2	.	.	PUNCT
aji-39	314	1	available	available	ADJ
aji-39	314	2	:	:	PUNCT
aji-39	314	3	http://www.who.int	http://www.who.int	NOUN
aji-39	314	4	/	/	SYM
aji-39	314	5	wer/2011	wer/2011	ADJ
aji-39	314	6	/	/	SYM
aji-39	314	7	wer	wer	NOUN
aji-39	314	8	8629.pdf	8629.pdf	ADJ
aji-39	314	9	8	8	NUM
aji-39	314	10	.	.	PUNCT
aji-39	315	1	kwofie	kwofie	NOUN
aji-39	315	2	tb	tb	PROPN
aji-39	315	3	,	,	PUNCT
aji-39	315	4	ayensu	ayensu	PROPN
aji-39	315	5	f	f	PROPN
aji-39	315	6	,	,	PUNCT
aji-39	315	7	mutocheluh	mutocheluh	PROPN
aji-39	315	8	m	m	PROPN
aji-39	315	9	,	,	PUNCT
aji-39	315	10	narkwa	narkwa	NOUN
aji-39	315	11	p	p	NOUN
aji-39	315	12	,	,	PUNCT
aji-39	315	13	nguah	nguah	PROPN
aji-39	315	14	sb	sb	PROPN
aji-39	315	15	,	,	PUNCT
aji-39	315	16	turpin	turpin	PROPN
aji-39	315	17	ca	ca	PROPN
aji-39	315	18	,	,	PUNCT
aji-39	315	19	owusu	owusu	PROPN
aji-39	315	20	m.	m.	PROPN
aji-39	315	21	seroprevalence	seroprevalence	NOUN
aji-39	315	22	of	of	ADP
aji-39	315	23	rubella	rubella	NOUN
aji-39	315	24	virus	virus	NOUN
aji-39	315	25	,	,	PUNCT
aji-39	315	26	cytomegalovirus	cytomegalovirus	NOUN
aji-39	315	27	and	and	CCONJ
aji-39	315	28	herpes	herpe	NOUN
aji-39	315	29	simplex	simplex	NOUN
aji-39	315	30	virus	virus	NOUN
aji-39	315	31	among	among	ADP
aji-39	315	32	pregnant	pregnant	ADJ
aji-39	315	33	women	woman	NOUN
aji-39	315	34	at	at	ADP
aji-39	315	35	the	the	DET
aji-39	315	36	komfo	komfo	PROPN
aji-39	315	37	anokye	anokye	PROPN
aji-39	315	38	teaching	teaching	NOUN
aji-39	315	39	hospital	hospital	NOUN
aji-39	315	40	.	.	PUNCT
aji-39	316	1	journal	journal	NOUN
aji-39	316	2	of	of	ADP
aji-39	316	3	public	public	ADJ
aji-39	316	4	health	health	NOUN
aji-39	316	5	in	in	ADP
aji-39	316	6	developing	develop	VERB
aji-39	316	7	countries	country	NOUN
aji-39	316	8	.	.	PUNCT
aji-39	317	1	2015;1(2):56	2015;1(2):56	NUM
aji-39	317	2	-	-	SYM
aji-39	317	3	63	63	NUM
aji-39	317	4	.	.	PUNCT
aji-39	318	1	9	9	NUM
aji-39	318	2	.	.	X
aji-39	318	3	dimech	dimech	PROPN
aji-39	318	4	w	w	PROPN
aji-39	318	5	,	,	PUNCT
aji-39	318	6	grangeot	grangeot	ADJ
aji-39	318	7	-	-	PUNCT
aji-39	318	8	keros	keros	NOUN
aji-39	318	9	l	l	NOUN
aji-39	318	10	,	,	PUNCT
aji-39	318	11	vauloupfellous	vauloupfellous	ADJ
aji-39	318	12	c.	c.	NOUN
aji-39	318	13	standardization	standardization	NOUN
aji-39	318	14	of	of	ADP
aji-39	318	15	assays	assay	NOUN
aji-39	318	16	that	that	PRON
aji-39	318	17	detect	detect	VERB
aji-39	318	18	anti	anti	ADJ
aji-39	318	19	-	-	ADJ
aji-39	318	20	rubella	rubella	ADJ
aji-39	318	21	virus	virus	NOUN
aji-39	318	22	igg	igg	PROPN
aji-39	318	23	antibodies	antibodie	VERB
aji-39	318	24	.	.	PUNCT
aji-39	319	1	clin	clin	PROPN
aji-39	319	2	microbiolrev	microbiolrev	PROPN
aji-39	319	3	.	.	PUNCT
aji-39	320	1	2016;29(1):163–174	2016;29(1):163–174	PRON
aji-39	320	2	.	.	PUNCT
aji-39	320	3	doi	doi	NOUN
aji-39	320	4	:	:	PUNCT
aji-39	320	5	10.1128	10.1128	NUM
aji-39	320	6	/	/	SYM
aji-39	320	7	cmr.00045	cmr.00045	NUM
aji-39	320	8	-	-	SYM
aji-39	320	9	15	15	NUM
aji-39	320	10	10	10	NUM
aji-39	320	11	.	.	PUNCT
aji-39	321	1	onyenekwe	onyenekwe	PROPN
aji-39	321	2	cc	cc	PROPN
aji-39	321	3	,	,	PUNCT
aji-39	321	4	kehinde	kehinde	NOUN
aji-39	321	5	-	-	PUNCT
aji-39	321	6	agbeyangi	agbeyangi	ADJ
aji-39	321	7	ta	ta	PART
aji-39	321	8	,	,	PUNCT
aji-39	321	9	ofor	ofor	ADP
aji-39	321	10	us	we	PRON
aji-39	321	11	,	,	PUNCT
aji-39	321	12	arinola	arinola	PROPN
aji-39	322	1	og	og	INTJ
aji-39	322	2	.	.	PUNCT
aji-39	323	1	prevalence	prevalence	NOUN
aji-39	323	2	of	of	ADP
aji-39	323	3	rubella	rubella	NOUN
aji-39	323	4	-	-	PUNCT
aji-39	323	5	igg	igg	NOUN
aji-39	323	6	antibody	antibody	NOUN
aji-39	323	7	in	in	ADP
aji-39	323	8	women	woman	NOUN
aji-39	323	9	of	of	ADP
aji-39	323	10	childbearing	childbeare	VERB
aji-39	323	11	age	age	NOUN
aji-39	323	12	in	in	ADP
aji-39	323	13	lagos	lagos	PROPN
aji-39	323	14	,	,	PUNCT
aji-39	323	15	nigeria	nigeria	PROPN
aji-39	323	16	.	.	PUNCT
aji-39	324	1	west	west	PROPN
aji-39	324	2	african	african	PROPN
aji-39	324	3	journal	journal	PROPN
aji-39	324	4	of	of	ADP
aji-39	324	5	medicine	medicine	NOUN
aji-39	324	6	.	.	PUNCT
aji-39	325	1	2000;19(1	2000;19(1	NUM
aji-39	325	2	):	):	PUNCT
aji-39	326	1	23–26	23–26	NUM
aji-39	326	2	.	.	PUNCT
aji-39	327	1	11	11	NUM
aji-39	327	2	.	.	PUNCT
aji-39	328	1	amina	amina	PROPN
aji-39	328	2	md	md	PROPN
aji-39	328	3	,	,	PUNCT
aji-39	328	4	oladapo	oladapo	PROPN
aji-39	328	5	s	s	PROPN
aji-39	328	6	,	,	PUNCT
aji-39	328	7	habib	habib	PROPN
aji-39	328	8	s	s	PROPN
aji-39	328	9	,	,	PUNCT
aji-39	328	10	adebola	adebola	PROPN
aji-39	328	11	o	o	NOUN
aji-39	328	12	,	,	PUNCT
aji-39	328	13	bimbo	bimbo	PROPN
aji-39	328	14	k	k	PROPN
aji-39	328	15	,	,	PUNCT
aji-39	328	16	daniel	daniel	PROPN
aji-39	328	17	a	a	PROPN
aji-39	328	18	,	,	PUNCT
aji-39	328	19	et	et	PROPN
aji-39	328	20	al	al	PROPN
aji-39	328	21	.	.	PUNCT
aji-39	329	1	prevalence	prevalence	NOUN
aji-39	329	2	of	of	ADP
aji-39	329	3	rubella	rubella	NOUN
aji-39	329	4	igg	igg	PROPN
aji-39	329	5	antibodies	antibodie	VERB
aji-39	329	6	among	among	ADP
aji-39	329	7	pregnant	pregnant	ADJ
aji-39	329	8	women	woman	NOUN
aji-39	329	9	in	in	ADP
aji-39	329	10	zaria	zaria	PROPN
aji-39	329	11	,	,	PUNCT
aji-39	329	12	nigeria	nigeria	PROPN
aji-39	329	13	.	.	PUNCT
aji-39	330	1	int	int	PROPN
aji-39	330	2	health	health	NOUN
aji-39	330	3	.	.	PUNCT
aji-39	331	1	2010	2010	NUM
aji-39	331	2	;	;	PUNCT
aji-39	331	3	2(2):156	2(2):156	NUM
aji-39	331	4	-	-	SYM
aji-39	331	5	159	159	NUM
aji-39	331	6	.	.	PUNCT
aji-39	332	1	12	12	NUM
aji-39	332	2	.	.	PUNCT
aji-39	333	1	onyeukwu	onyeukwu	PROPN
aji-39	333	2	eu	eu	PROPN
aji-39	333	3	,	,	PUNCT
aji-39	333	4	ogbonnaya	ogbonnaya	ADJ
aji-39	333	5	o	o	NOUN
aji-39	333	6	,	,	PUNCT
aji-39	333	7	oseni	oseni	ADJ
aji-39	333	8	om	om	NOUN
aji-39	333	9	,	,	PUNCT
aji-39	333	10	anyigor	anyigor	NOUN
aji-39	333	11	e	e	NOUN
aji-39	333	12	,	,	PUNCT
aji-39	333	13	elom	elom	ADJ
aji-39	333	14	o	o	NOUN
aji-39	333	15	,	,	PUNCT
aji-39	333	16	ethel	ethel	PROPN
aji-39	333	17	n.	n.	PROPN
aji-39	333	18	seroprevalence	seroprevalence	PROPN
aji-39	333	19	survey	survey	NOUN
aji-39	333	20	of	of	ADP
aji-39	333	21	rubella	rubella	NOUN
aji-39	333	22	igg	igg	PROPN
aji-39	333	23	antibodies	antibodie	VERB
aji-39	333	24	among	among	ADP
aji-39	333	25	pregnant	pregnant	ADJ
aji-39	333	26	women	woman	NOUN
aji-39	333	27	attending	attend	VERB
aji-39	333	28	antenatal	antenatal	ADJ
aji-39	333	29	clinics	clinic	NOUN
aji-39	333	30	in	in	ADP
aji-39	333	31	abakaliki	abakaliki	ADJ
aji-39	333	32	,	,	PUNCT
aji-39	333	33	ebonyi	ebonyi	PROPN
aji-39	333	34	state	state	PROPN
aji-39	333	35	,	,	PUNCT
aji-39	333	36	nigeria	nigeria	PROPN
aji-39	333	37	.	.	PUNCT
aji-39	333	38	ujmr	ujmr	PROPN
aji-39	333	39	.	.	PUNCT
aji-39	334	1	2018;3(2	2018;3(2	NUM
aji-39	334	2	):	):	PUNCT
aji-39	334	3	50	50	NUM
aji-39	334	4	-	-	SYM
aji-39	334	5	55	55	NUM
aji-39	334	6	.	.	PUNCT
aji-39	335	1	13	13	NUM
aji-39	335	2	.	.	X
aji-39	335	3	getahun	getahun	PROPN
aji-39	335	4	m	m	PROPN
aji-39	335	5	,	,	PUNCT
aji-39	335	6	beyene	beyene	PROPN
aji-39	335	7	b	b	PROPN
aji-39	335	8	,	,	PUNCT
aji-39	335	9	gallagher	gallagher	PROPN
aji-39	335	10	k	k	PROPN
aji-39	335	11	,	,	PUNCT
aji-39	335	12	ademe	ademe	NOUN
aji-39	335	13	a	a	NOUN
aji-39	335	14	,	,	PUNCT
aji-39	335	15	teshome	teshome	NOUN
aji-39	335	16	b	b	NOUN
aji-39	335	17	,	,	PUNCT
aji-39	335	18	tefera	tefera	NOUN
aji-39	335	19	m	m	PROPN
aji-39	335	20	,	,	PUNCT
aji-39	335	21	et	et	PROPN
aji-39	335	22	al	al	PROPN
aji-39	335	23	.	.	PUNCT
aji-39	336	1	epidemiology	epidemiology	NOUN
aji-39	336	2	of	of	ADP
aji-39	336	3	rubella	rubella	NOUN
aji-39	336	4	virus	virus	NOUN
aji-39	336	5	cases	case	NOUN
aji-39	336	6	in	in	ADP
aji-39	336	7	the	the	DET
aji-39	336	8	pre	pre	ADJ
aji-39	336	9	-	-	ADJ
aji-39	336	10	vaccination	vaccination	ADJ
aji-39	336	11	era	era	NOUN
aji-39	336	12	of	of	ADP
aji-39	336	13	ethiopia	ethiopia	PROPN
aji-39	336	14	,	,	PUNCT
aji-39	336	15	2009	2009	NUM
aji-39	336	16	–	–	PUNCT
aji-39	336	17	2015	2015	NUM
aji-39	336	18	.	.	PUNCT
aji-39	337	1	bmc	bmc	ADJ
aji-39	337	2	public	public	ADJ
aji-39	337	3	health	health	NOUN
aji-39	337	4	.	.	PUNCT
aji-39	338	1	2016;16:1168	2016;16:1168	X
aji-39	338	2	.	.	PUNCT
aji-39	338	3	doi	doi	NOUN
aji-39	338	4	:	:	PUNCT
aji-39	338	5	10.1186	10.1186	NUM
aji-39	338	6	/	/	SYM
aji-39	338	7	s12889	s12889	NOUN
aji-39	338	8	-	-	PUNCT
aji-39	338	9	016	016	NUM
aji-39	338	10	-	-	PUNCT
aji-39	338	11	3841	3841	NUM
aji-39	338	12	-	-	PUNCT
aji-39	338	13	z	z	NOUN
aji-39	338	14	14	14	NUM
aji-39	338	15	.	.	PUNCT
aji-39	339	1	tamirat	tamirat	PROPN
aji-39	339	2	b	b	PROPN
aji-39	339	3	,	,	PUNCT
aji-39	339	4	hussen	hussen	NOUN
aji-39	339	5	s	s	PART
aji-39	339	6	,	,	PUNCT
aji-39	339	7	shimelis	shimelis	VERB
aji-39	339	8	t.	t.	NOUN
aji-39	339	9	rubella	rubella	NOUN
aji-39	339	10	virus	virus	NOUN
aji-39	339	11	infection	infection	NOUN
aji-39	339	12	and	and	CCONJ
aji-39	339	13	associated	associated	ADJ
aji-39	339	14	factors	factor	NOUN
aji-39	339	15	among	among	ADP
aji-39	339	16	pregnant	pregnant	ADJ
aji-39	339	17	women	woman	NOUN
aji-39	339	18	attending	attend	VERB
aji-39	339	19	the	the	DET
aji-39	339	20	antenatal	antenatal	NOUN
aji-39	339	21	care	care	NOUN
aji-39	339	22	clinics	clinic	NOUN
aji-39	339	23	of	of	ADP
aji-39	339	24	public	public	ADJ
aji-39	339	25	hospitals	hospital	NOUN
aji-39	339	26	in	in	ADP
aji-39	339	27	hawassa	hawassa	ADJ
aji-39	339	28	city	city	NOUN
aji-39	339	29	,	,	PUNCT
aji-39	339	30	southern	southern	ADJ
aji-39	339	31	ethiopia	ethiopia	PROPN
aji-39	339	32	:	:	PUNCT
aji-39	339	33	a	a	DET
aji-39	339	34	crosssectional	crosssectional	ADJ
aji-39	339	35	study	study	NOUN
aji-39	339	36	.	.	PUNCT
aji-39	340	1	bmj	bmj	PROPN
aji-39	340	2	open	open	ADJ
aji-39	340	3	.	.	PUNCT
aji-39	341	1	2017;7	2017;7	NOUN
aji-39	341	2	:	:	PUNCT
aji-39	342	1	e016824	e016824	NOUN
aji-39	342	2	.	.	PUNCT
aji-39	343	1	doi	doi	PROPN
aji-39	343	2	:	:	PUNCT
aji-39	343	3	10.1136/	10.1136/	NUM
aji-39	343	4	bmjopen-2017	bmjopen-2017	NOUN
aji-39	343	5	-	-	PUNCT
aji-39	343	6	016824	016824	NUM
aji-39	343	7	15	15	NUM
aji-39	343	8	.	.	PUNCT
aji-39	344	1	who	who	PRON
aji-39	344	2	.	.	PUNCT
aji-39	345	1	vaccine	vaccine	NOUN
aji-39	345	2	-	-	PUNCT
aji-39	345	3	preventable	preventable	ADJ
aji-39	345	4	diseases	disease	NOUN
aji-39	345	5	:	:	PUNCT
aji-39	345	6	monitoring	monitor	VERB
aji-39	345	7	system	system	NOUN
aji-39	345	8	.	.	PUNCT
aji-39	346	1	2017	2017	NUM
aji-39	346	2	global	global	ADJ
aji-39	346	3	summary	summary	NOUN
aji-39	346	4	;	;	PUNCT
aji-39	346	5	2017	2017	NUM
aji-39	346	6	.	.	PUNCT
aji-39	347	1	[	[	X
aji-39	347	2	accessed	access	VERB
aji-39	347	3	26	26	NUM
aji-39	347	4	mar	mar	PROPN
aji-39	347	5	2019	2019	NUM
aji-39	347	6	]	]	PUNCT
aji-39	347	7	available	available	ADJ
aji-39	347	8	:	:	PUNCT
aji-39	347	9	http://apps.who.int	http://apps.who.int	NOUN
aji-39	347	10	/	/	SYM
aji-39	347	11	immunization	immunization	NOUN
aji-39	347	12	_	_	PUNCT
aji-39	347	13	monitoring	monitoring	NOUN
aji-39	347	14	/	/	SYM
aji-39	347	15	globalsummary/	globalsummary/	NUM
aji-39	347	16	16	16	NUM
aji-39	347	17	.	.	PUNCT
aji-39	348	1	cdc	cdc	PROPN
aji-39	348	2	.	.	PUNCT
aji-39	348	3	epidemiology	epidemiology	NOUN
aji-39	348	4	and	and	CCONJ
aji-39	348	5	prevention	prevention	NOUN
aji-39	348	6	of	of	ADP
aji-39	348	7	vaccine	vaccine	NOUN
aji-39	348	8	-	-	PUNCT
aji-39	348	9	preventable	preventable	ADJ
aji-39	348	10	diseases	disease	NOUN
aji-39	348	11	.	.	PUNCT
aji-39	349	1	chapter	chapter	NOUN
aji-39	349	2	20	20	NUM
aji-39	349	3	,	,	PUNCT
aji-39	349	4	rubella.pink	rubella.pink	NUM
aji-39	349	5	book	book	NOUN
aji-39	349	6	.	.	PUNCT
aji-39	349	7	13	13	NUM
aji-39	349	8	th	th	NUM
aji-39	349	9	ed	ed	NOUN
aji-39	349	10	;	;	PUNCT
aji-39	349	11	2015	2015	NUM
aji-39	349	12	.	.	PUNCT
aji-39	349	13	17	17	NUM
aji-39	349	14	.	.	PUNCT
aji-39	350	1	chukwuedo	chukwuedo	PROPN
aji-39	350	2	aa	aa	PROPN
aji-39	350	3	,	,	PUNCT
aji-39	350	4	zirawaga	zirawaga	PROPN
aji-39	350	5	ss	ss	PROPN
aji-39	350	6	,	,	PUNCT
aji-39	350	7	banda	banda	PROPN
aji-39	350	8	jm	jm	PROPN
aji-39	350	9	,	,	PUNCT
aji-39	350	10	chukwu	chukwu	NOUN
aji-39	350	11	co	co	NOUN
aji-39	350	12	,	,	PUNCT
aji-39	350	13	olabode	olabode	ADJ
aji-39	350	14	ao	ao	PROPN
aji-39	350	15	.	.	PUNCT
aji-39	351	1	seroprevalence	seroprevalence	NOUN
aji-39	351	2	of	of	ADP
aji-39	351	3	rubella	rubella	NOUN
aji-39	351	4	antibody	antibody	NOUN
aji-39	351	5	in	in	ADP
aji-39	351	6	pregnant	pregnant	ADJ
aji-39	351	7	women	woman	NOUN
aji-39	351	8	attending	attend	VERB
aji-39	351	9	antenatal	antenatal	ADJ
aji-39	351	10	clinics	clinic	NOUN
aji-39	351	11	in	in	ADP
aji-39	351	12	adamawa	adamawa	PROPN
aji-39	351	13	and	and	CCONJ
aji-39	351	14	kaduna	kaduna	PROPN
aji-39	351	15	states	states	PROPN
aji-39	351	16	of	of	ADP
aji-39	351	17	nigeria	nigeria	PROPN
aji-39	351	18	.	.	PUNCT
aji-39	352	1	int	int	PROPN
aji-39	353	1	j	j	PROPN
aji-39	353	2	nat	nat	PROPN
aji-39	353	3	appl	appl	PROPN
aji-39	353	4	sci	sci	PROPN
aji-39	353	5	.	.	PUNCT
aji-39	354	1	2010;6(1):131	2010;6(1):131	NUM
aji-39	354	2	-	-	SYM
aji-39	354	3	134	134	NUM
aji-39	354	4	.	.	PUNCT
aji-39	355	1	18	18	NUM
aji-39	355	2	.	.	PUNCT
aji-39	355	3	world	world	PROPN
aji-39	355	4	health	health	PROPN
aji-39	355	5	organization	organization	PROPN
aji-39	355	6	.	.	PUNCT
aji-39	356	1	global	global	ADJ
aji-39	356	2	vaccine	vaccine	NOUN
aji-39	356	3	action	action	NOUN
aji-39	356	4	plan	plan	NOUN
aji-39	356	5	.	.	PUNCT
aji-39	357	1	priority	priority	NOUN
aji-39	357	2	country	country	NOUN
aji-39	357	3	reports	report	VERB
aji-39	357	4	on	on	ADP
aji-39	357	5	progress	progress	NOUN
aji-39	357	6	towards	towards	ADP
aji-39	357	7	gvap	gvap	NOUN
aji-39	357	8	-	-	PUNCT
aji-39	357	9	rvap	rvap	NOUN
aji-39	357	10	goals	goal	NOUN
aji-39	357	11	.	.	PUNCT
aji-39	358	1	annex	annex	VERB
aji-39	358	2	to	to	ADP
aji-39	358	3	the	the	DET
aji-39	358	4	gvap	gvap	NOUN
aji-39	358	5	secretariat	secretariat	PROPN
aji-39	358	6	annual	annual	ADJ
aji-39	358	7	report	report	NOUN
aji-39	358	8	.	.	PUNCT
aji-39	359	1	geneva	geneva	PROPN
aji-39	359	2	,	,	PUNCT
aji-39	359	3	switzerland	switzerland	PROPN
aji-39	359	4	;	;	PUNCT
aji-39	359	5	2016	2016	NUM
aji-39	359	6	.	.	PUNCT
aji-39	360	1	available	available	ADJ
aji-39	360	2	:	:	PUNCT
aji-39	360	3	http://www.who.int	http://www.who.int	NOUN
aji-39	360	4	/	/	SYM
aji-39	360	5	immunization/	immunization/	PROPN
aji-39	360	6	global_vaccine_action_plan	global_vaccine_action_plan	NOUN
aji-39	360	7	/	/	SYM
aji-39	360	8	web_regional	web_regional	PROPN
aji-39	360	9	_	_	PRON
aji-39	360	10	2017.pdf?ua+1	2017.pdf?ua+1	NUM
aji-39	360	11	19	19	NUM
aji-39	360	12	.	.	PUNCT
aji-39	361	1	adewumi	adewumi	PROPN
aji-39	361	2	om	om	PROPN
aji-39	361	3	,	,	PUNCT
aji-39	361	4	olayinka	olayinka	NOUN
aji-39	361	5	oa	oa	PROPN
aji-39	361	6	,	,	PUNCT
aji-39	361	7	olusola	olusola	PROPN
aji-39	361	8	ba	ba	PROPN
aji-39	361	9	,	,	PUNCT
aji-39	361	10	faleye	faleye	NOUN
aji-39	361	11	to	to	ADP
aji-39	361	12	,	,	PUNCT
aji-39	361	13	sule	sule	PROPN
aji-39	361	14	wf	wf	PROPN
aji-39	361	15	,	,	PUNCT
aji-39	361	16	adesina	adesina	PROPN
aji-39	361	17	o.	o.	PROPN
aji-39	361	18	http://www.cdc.gov/globalhealth/immunizationinfographic/stop-rubella.htm	http://www.cdc.gov/globalhealth/immunizationinfographic/stop-rubella.htm	PROPN
aji-39	362	1	http://www.cdc.gov/globalhealth/immunizationinfographic/stop-rubella.htm	http://www.cdc.gov/globalhealth/immunizationinfographic/stop-rubella.htm	PROPN
aji-39	362	2	http://www.who.int/wer/2011/wer8629.pdf	http://www.who.int/wer/2011/wer8629.pdf	PROPN
aji-39	362	3	http://www.who.int/wer/2011/wer8629.pdf	http://www.who.int/wer/2011/wer8629.pdf	PROPN
aji-39	362	4	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4771216/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4771216/	NOUN
aji-39	362	5	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4771216/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4771216/	NOUN
aji-39	362	6	http://www.who.int/immunization/global_vaccine_action_plan/web_regional_2017.pdf?ua+1	http://www.who.int/immunization/global_vaccine_action_plan/web_regional_2017.pdf?ua+1	PROPN
aji-39	362	7	http://www.who.int/immunization/global_vaccine_action_plan/web_regional_2017.pdf?ua+1	http://www.who.int/immunization/global_vaccine_action_plan/web_regional_2017.pdf?ua+1	PROPN
aji-39	362	8	http://www.who.int/immunization/global_vaccine_action_plan/web_regional_2017.pdf?ua+1	http://www.who.int/immunization/global_vaccine_action_plan/web_regional_2017.pdf?ua+1	PROPN
aji-39	362	9	akele	akele	PROPN
aji-39	362	10	et	et	PROPN
aji-39	362	11	al	al	PROPN
aji-39	362	12	.	.	PROPN
aji-39	362	13	;	;	PUNCT
aji-39	363	1	aji	aji	PROPN
aji-39	363	2	,	,	PUNCT
aji-39	363	3	3(1	3(1	NUM
aji-39	363	4	):	):	PUNCT
aji-39	363	5	199	199	NUM
aji-39	363	6	-	-	SYM
aji-39	363	7	207	207	NUM
aji-39	363	8	,	,	PUNCT
aji-39	363	9	2020	2020	NUM
aji-39	363	10	;	;	PUNCT
aji-39	363	11	article	article	NOUN
aji-39	363	12	no.aji.57099	no.aji.57099	VERB
aji-39	363	13	207	207	NUM
aji-39	363	14	epidemiological	epidemiological	ADJ
aji-39	363	15	evaluation	evaluation	NOUN
aji-39	363	16	of	of	ADP
aji-39	363	17	rubella	rubella	NOUN
aji-39	363	18	virus	virus	NOUN
aji-39	363	19	infection	infection	NOUN
aji-39	363	20	among	among	ADP
aji-39	363	21	pregnant	pregnant	ADJ
aji-39	363	22	women	woman	NOUN
aji-39	363	23	in	in	ADP
aji-39	363	24	ibadan	ibadan	PROPN
aji-39	363	25	,	,	PUNCT
aji-39	363	26	nigeria	nigeria	PROPN
aji-39	363	27	.	.	PUNCT
aji-39	364	1	j	j	PROPN
aji-39	364	2	immunoassay	immunoassay	PROPN
aji-39	364	3	immunochemistry	immunochemistry	PROPN
aji-39	364	4	.	.	PUNCT
aji-39	365	1	2015;36(6):613	2015;36(6):613	NUM
aji-39	365	2	-	-	PUNCT
aji-39	365	3	621	621	NUM
aji-39	365	4	.	.	PUNCT
aji-39	366	1	doi:10.1080/15321819.2015.1027404.pmi	doi:10.1080/15321819.2015.1027404.pmi	NOUN
aji-39	366	2	d:25774539	d:25774539	NOUN
aji-39	366	3	20	20	NUM
aji-39	366	4	.	.	PUNCT
aji-39	367	1	adebayo	adebayo	PROPN
aji-39	367	2	wo	will	AUX
aji-39	367	3	,	,	PUNCT
aji-39	367	4	jegede	jegede	VERB
aji-39	367	5	ao	ao	PROPN
aji-39	367	6	.	.	PUNCT
aji-39	368	1	the	the	DET
aji-39	368	2	environmental	environmental	ADJ
aji-39	368	3	effect	effect	NOUN
aji-39	368	4	of	of	ADP
aji-39	368	5	flooding	flood	VERB
aji-39	368	6	transportation	transportation	NOUN
aji-39	368	7	land	land	NOUN
aji-39	368	8	use	use	NOUN
aji-39	368	9	in	in	ADP
aji-39	368	10	benin	benin	PROPN
aji-39	368	11	city	city	PROPN
aji-39	368	12	nigeria	nigeria	PROPN
aji-39	368	13	.	.	PUNCT
aji-39	369	1	african	african	ADJ
aji-39	369	2	research	research	PROPN
aji-39	369	3	review	review	PROPN
aji-39	369	4	,	,	PUNCT
aji-39	369	5	2010;4(1):390	2010;4(1):390	NOUN
aji-39	369	6	-	-	SYM
aji-39	369	7	400	400	NUM
aji-39	369	8	.	.	PUNCT
aji-39	370	1	21	21	NUM
aji-39	370	2	.	.	PUNCT
aji-39	371	1	oluboyo	oluboyo	PROPN
aji-39	371	2	ob	ob	PROPN
aji-39	371	3	,	,	PUNCT
aji-39	371	4	musa	musa	PROPN
aji-39	371	5	hs	hs	PROPN
aji-39	371	6	,	,	PUNCT
aji-39	371	7	akinseye	akinseye	PROPN
aji-39	371	8	jf	jf	PROPN
aji-39	371	9	,	,	PUNCT
aji-39	371	10	akele	akele	PROPN
aji-39	371	11	ry	ry	PROPN
aji-39	371	12	,	,	PUNCT
aji-39	371	13	oluboyo	oluboyo	NOUN
aji-39	371	14	ao	ao	PROPN
aji-39	371	15	,	,	PUNCT
aji-39	371	16	adewumi	adewumi	PROPN
aji-39	371	17	fa	fa	PROPN
aji-39	371	18	.	.	PUNCT
aji-39	371	19	risky	risky	ADJ
aji-39	371	20	sexual	sexual	ADJ
aji-39	371	21	behaviors	behavior	NOUN
aji-39	371	22	and	and	CCONJ
aji-39	371	23	prevalence	prevalence	NOUN
aji-39	371	24	of	of	ADP
aji-39	371	25	chlamydia	chlamydia	NOUN
aji-39	371	26	trachomatis	trachomatis	ADJ
aji-39	371	27	antibodies	antibody	NOUN
aji-39	371	28	among	among	ADP
aji-39	371	29	students	student	NOUN
aji-39	371	30	in	in	ADP
aji-39	371	31	a	a	DET
aji-39	371	32	tertiary	tertiary	ADJ
aji-39	371	33	institution	institution	NOUN
aji-39	371	34	.	.	PUNCT
aji-39	372	1	online	online	PROPN
aji-39	372	2	journal	journal	PROPN
aji-39	372	3	of	of	ADP
aji-39	372	4	health	health	PROPN
aji-39	372	5	allied	ally	VERB
aji-39	372	6	sciences	science	NOUN
aji-39	372	7	.	.	PUNCT
aji-39	372	8	2019	2019	NUM
aji-39	372	9	;	;	PUNCT
aji-39	372	10	18(3):3	18(3):3	PROPN
aji-39	372	11	-	-	SYM
aji-39	372	12	8	8	NUM
aji-39	372	13	.	.	PUNCT
aji-39	372	14	22	22	NUM
aji-39	372	15	.	.	PUNCT
aji-39	373	1	mohammed	mohammed	PROPN
aji-39	373	2	da	da	PROPN
aji-39	373	3	,	,	PUNCT
aji-39	373	4	shittu	shittu	ADJ
aji-39	373	5	o	o	NOUN
aji-39	373	6	,	,	PUNCT
aji-39	373	7	sadauki	sadauki	NOUN
aji-39	373	8	h	h	PROPN
aji-39	373	9	,	,	PUNCT
aji-39	373	10	olayinka	olayinka	PROPN
aji-39	373	11	a	a	PROPN
aji-39	373	12	,	,	PUNCT
aji-39	373	13	kolawole	kolawole	PROPN
aji-39	373	14	b	b	PROPN
aji-39	373	15	,	,	PUNCT
aji-39	373	16	adejo	adejo	ADJ
aji-39	373	17	d.	d.	PROPN
aji-39	373	18	prevalence	prevalence	NOUN
aji-39	373	19	of	of	ADP
aji-39	373	20	rubella	rubella	NOUN
aji-39	373	21	igg	igg	PROPN
aji-39	373	22	antibodies	antibodie	VERB
aji-39	373	23	among	among	ADP
aji-39	373	24	pregnant	pregnant	ADJ
aji-39	373	25	women	woman	NOUN
aji-39	373	26	in	in	ADP
aji-39	373	27	zaria	zaria	PROPN
aji-39	373	28	,	,	PUNCT
aji-39	373	29	nigeria	nigeria	PROPN
aji-39	373	30	.	.	PUNCT
aji-39	374	1	int	int	PROPN
aji-39	374	2	health	health	NOUN
aji-39	374	3	.	.	PUNCT
aji-39	375	1	2016;2(2):156	2016;2(2):156	NUM
aji-39	375	2	-	-	SYM
aji-39	375	3	159	159	NUM
aji-39	375	4	.	.	PUNCT
aji-39	376	1	23	23	NUM
aji-39	376	2	.	.	PUNCT
aji-39	377	1	gubio	gubio	PROPN
aji-39	377	2	ab	ab	PROPN
aji-39	377	3	,	,	PUNCT
aji-39	377	4	mamman	mamman	NOUN
aji-39	377	5	ai	ai	VERB
aji-39	377	6	,	,	PUNCT
aji-39	377	7	abdul	abdul	PROPN
aji-39	377	8	m	m	PROPN
aji-39	377	9	,	,	PUNCT
aji-39	377	10	olayinka	olayinka	NOUN
aji-39	377	11	at	at	ADP
aji-39	377	12	.	.	PUNCT
aji-39	378	1	the	the	DET
aji-39	378	2	risk	risk	NOUN
aji-39	378	3	factors	factor	NOUN
aji-39	378	4	of	of	ADP
aji-39	378	5	exposure	exposure	NOUN
aji-39	378	6	to	to	ADP
aji-39	378	7	rubella	rubella	NOUN
aji-39	378	8	among	among	ADP
aji-39	378	9	pregnant	pregnant	ADJ
aji-39	378	10	women	woman	NOUN
aji-39	378	11	in	in	ADP
aji-39	378	12	zaria	zaria	PROPN
aji-39	378	13	.	.	PUNCT
aji-39	379	1	pan	pan	PROPN
aji-39	379	2	africa	africa	PROPN
aji-39	379	3	medical	medical	PROPN
aji-39	379	4	journal	journal	PROPN
aji-39	379	5	.	.	PUNCT
aji-39	380	1	2019;32(1):4	2019;32(1):4	NOUN
aji-39	380	2	.	.	PUNCT
aji-39	381	1	doi:10.11604	doi:10.11604	PROPN
aji-39	381	2	/	/	SYM
aji-39	381	3	pamj.21/01/2019.artvol	pamj.21/01/2019.artvol	NOUN
aji-39	381	4	.	.	PUNCT
aji-39	382	1	artissue.13335	artissue.13335	PROPN
aji-39	382	2	24	24	NUM
aji-39	382	3	.	.	PUNCT
aji-39	382	4	kolawole	kolawole	PROPN
aji-39	382	5	o	o	NOUN
aji-39	382	6	,	,	PUNCT
aji-39	382	7	anjorin	anjorin	ADJ
aji-39	382	8	e	e	NOUN
aji-39	382	9	,	,	PUNCT
aji-39	382	10	adokanle	adokanle	NOUN
aji-39	382	11	d	d	PROPN
aji-39	382	12	,	,	PUNCT
aji-39	382	13	kolawole	kolawole	PROPN
aji-39	382	14	fc	fc	PROPN
aji-39	382	15	,	,	PUNCT
aji-39	382	16	durowade	durowade	NOUN
aji-39	382	17	ka	ka	PROPN
aji-39	382	18	.	.	PROPN
aji-39	382	19	serology	serology	NOUN
aji-39	382	20	of	of	ADP
aji-39	382	21	rubella	rubella	NOUN
aji-39	382	22	igg	igg	NOUN
aji-39	382	23	antibody	antibody	NOUN
aji-39	382	24	in	in	ADP
aji-39	382	25	pregnant	pregnant	ADJ
aji-39	382	26	women	woman	NOUN
aji-39	382	27	in	in	ADP
aji-39	382	28	osogbo	osogbo	PROPN
aji-39	382	29	,	,	PUNCT
aji-39	382	30	nigeria	nigeria	PROPN
aji-39	382	31	.	.	PUNCT
aji-39	383	1	int	int	PROPN
aji-39	384	1	j	j	PROPN
aji-39	384	2	prev	prev	X
aji-39	384	3	med	med	PROPN
aji-39	384	4	.	.	PUNCT
aji-39	384	5	2014	2014	NUM
aji-39	384	6	;	;	PUNCT
aji-39	385	1	5(3):287–292	5(3):287–292	NUM
aji-39	385	2	.	.	PUNCT
aji-39	386	1	25	25	NUM
aji-39	386	2	.	.	PUNCT
aji-39	387	1	hamdan	hamdan	PROPN
aji-39	387	2	hz	hz	PROPN
aji-39	387	3	,	,	PUNCT
aji-39	387	4	abdelbagi	abdelbagi	ADJ
aji-39	387	5	ie	ie	PROPN
aji-39	387	6	,	,	PUNCT
aji-39	387	7	nasser	nasser	PROPN
aji-39	387	8	nm	nm	PROPN
aji-39	387	9	,	,	PUNCT
aji-39	387	10	adam	adam	PROPN
aji-39	387	11	i.	i.	PROPN
aji-39	387	12	seroprevalence	seroprevalence	NOUN
aji-39	387	13	of	of	ADP
aji-39	387	14	cytomegalovirus	cytomegalovirus	NOUN
aji-39	387	15	and	and	CCONJ
aji-39	387	16	rubella	rubella	NOUN
aji-39	387	17	among	among	ADP
aji-39	387	18	pregnant	pregnant	ADJ
aji-39	387	19	women	woman	NOUN
aji-39	387	20	in	in	ADP
aji-39	387	21	western	western	PROPN
aji-39	387	22	sudan	sudan	PROPN
aji-39	387	23	.	.	PUNCT
aji-39	388	1	virology	virology	NOUN
aji-39	388	2	journal	journal	PROPN
aji-39	388	3	.	.	PUNCT
aji-39	389	1	2011	2011	NUM
aji-39	389	2	;	;	PUNCT
aji-39	389	3	11(8):217	11(8):217	NUM
aji-39	389	4	-	-	SYM
aji-39	389	5	225	225	NUM
aji-39	389	6	doi	doi	NOUN
aji-39	389	7	:	:	PUNCT
aji-39	389	8	10.1186/1743	10.1186/1743	NUM
aji-39	389	9	-	-	SYM
aji-39	389	10	422x-8	422x-8	NUM
aji-39	389	11	-	-	SYM
aji-39	389	12	217	217	NUM
aji-39	389	13	26	26	NUM
aji-39	389	14	.	.	PUNCT
aji-39	390	1	oyinloye	oyinloye	PROPN
aji-39	390	2	so	so	ADV
aji-39	390	3	,	,	PUNCT
aji-39	390	4	amama	amama	NOUN
aji-39	390	5	ca	can	AUX
aji-39	390	6	,	,	PUNCT
aji-39	390	7	daniel	daniel	PROPN
aji-39	390	8	r	r	PROPN
aji-39	390	9	,	,	PUNCT
aji-39	390	10	ajayi	ajayi	NOUN
aji-39	390	11	bb	bb	NOUN
aji-39	390	12	,	,	PUNCT
aji-39	390	13	lawan	lawan	PROPN
aji-39	390	14	ma	ma	PROPN
aji-39	390	15	.	.	PROPN
aji-39	390	16	seroprevalence	seroprevalence	PROPN
aji-39	390	17	survey	survey	NOUN
aji-39	390	18	of	of	ADP
aji-39	390	19	rubella	rubella	NOUN
aji-39	390	20	antibodies	antibodie	VERB
aji-39	390	21	among	among	ADP
aji-39	390	22	pregnant	pregnant	ADJ
aji-39	390	23	women	woman	NOUN
aji-39	390	24	in	in	ADP
aji-39	390	25	maiduguri	maiduguri	PROPN
aji-39	390	26	,	,	PUNCT
aji-39	390	27	borno	borno	PROPN
aji-39	390	28	state	state	PROPN
aji-39	390	29	,	,	PUNCT
aji-39	390	30	nigeria	nigeria	PROPN
aji-39	390	31	.	.	PUNCT
aji-39	391	1	african	african	ADJ
aji-39	391	2	journal	journal	PROPN
aji-39	391	3	of	of	ADP
aji-39	391	4	clinical	clinical	ADJ
aji-39	391	5	and	and	CCONJ
aji-39	391	6	experimental	experimental	ADJ
aji-39	391	7	microbiology	microbiology	NOUN
aji-39	391	8	.	.	PUNCT
aji-39	392	1	2014;15:151–157	2014;15:151–157	NUM
aji-39	392	2	.	.	PUNCT
aji-39	393	1	27	27	NUM
aji-39	393	2	.	.	PUNCT
aji-39	393	3	mengouo	mengouo	PROPN
aji-39	393	4	nm	nm	PROPN
aji-39	393	5	,	,	PUNCT
aji-39	393	6	ndze	ndze	ADJ
aji-39	393	7	vn	vn	PROPN
aji-39	393	8	,	,	PUNCT
aji-39	393	9	baonga	baonga	PROPN
aji-39	393	10	f	f	PROPN
aji-39	393	11	,	,	PUNCT
aji-39	393	12	kobela	kobela	PROPN
aji-39	393	13	n	n	CCONJ
aji-39	393	14	,	,	PUNCT
aji-39	393	15	wiysonge	wiysonge	PROPN
aji-39	393	16	cs	cs	PROPN
aji-39	393	17	.	.	PROPN
aji-39	393	18	epidemiology	epidemiology	NOUN
aji-39	393	19	of	of	ADP
aji-39	393	20	rubella	rubella	NOUN
aji-39	393	21	infection	infection	NOUN
aji-39	393	22	in	in	ADP
aji-39	393	23	cameroon	cameroon	PROPN
aji-39	393	24	:	:	PUNCT
aji-39	393	25	a	a	DET
aji-39	393	26	7	7	NUM
aji-39	393	27	-	-	PUNCT
aji-39	393	28	year	year	NOUN
aji-39	393	29	experience	experience	NOUN
aji-39	393	30	of	of	ADP
aji-39	393	31	measles	measle	NOUN
aji-39	393	32	and	and	CCONJ
aji-39	393	33	rubella	rubella	NOUN
aji-39	393	34	casebased	casebase	VERB
aji-39	393	35	surveillance	surveillance	NOUN
aji-39	393	36	,	,	PUNCT
aji-39	393	37	2008–2014	2008–2014	NUM
aji-39	393	38	bmj	bmj	NOUN
aji-39	393	39	open	open	ADJ
aji-39	393	40	.	.	PUNCT
aji-39	394	1	2017;7(4):e012959	2017;7(4):e012959	NOUN
aji-39	394	2	.	.	PUNCT
aji-39	395	1	doi	doi	NOUN
aji-39	395	2	:	:	PUNCT
aji-39	395	3	10.1136	10.1136	NUM
aji-39	395	4	/	/	SYM
aji-39	395	5	bmjopen-2016	bmjopen-2016	NOUN
aji-39	395	6	-	-	PUNCT
aji-39	395	7	012959	012959	NUM
aji-39	395	8	28	28	NUM
aji-39	395	9	.	.	PUNCT
aji-39	396	1	junaid	junaid	PROPN
aji-39	396	2	sa	sa	PROPN
aji-39	396	3	,	,	PUNCT
aji-39	396	4	akpan	akpan	VERB
aji-39	396	5	kj	kj	PROPN
aji-39	396	6	,	,	PUNCT
aji-39	397	1	olabode	olabode	ADJ
aji-39	397	2	ao	ao	PROPN
aji-39	397	3	.	.	PUNCT
aji-39	397	4	serosurvey	serosurvey	NOUN
aji-39	397	5	of	of	ADP
aji-39	397	6	rubella	rubella	NOUN
aji-39	397	7	igm	igm	NOUN
aji-39	397	8	antibodies	antibodie	VERB
aji-39	397	9	among	among	ADP
aji-39	397	10	children	child	NOUN
aji-39	397	11	in	in	ADP
aji-39	397	12	jos	jos	PROPN
aji-39	397	13	,	,	PUNCT
aji-39	397	14	nigeria	nigeria	PROPN
aji-39	397	15	.	.	PUNCT
aji-39	398	1	virology	virology	NOUN
aji-39	398	2	journal	journal	NOUN
aji-39	398	3	.	.	PUNCT
aji-39	399	1	2011;19(8):244	2011;19(8):244	NUM
aji-39	399	2	-	-	PUNCT
aji-39	399	3	249	249	NUM
aji-39	399	4	.	.	PUNCT
aji-39	400	1	doi	doi	NOUN
aji-39	400	2	:	:	PUNCT
aji-39	400	3	10.1186/1743	10.1186/1743	NUM
aji-39	400	4	-	-	SYM
aji-39	400	5	422x-8	422x-8	NUM
aji-39	400	6	-	-	SYM
aji-39	400	7	244	244	NUM
aji-39	400	8	29	29	NUM
aji-39	400	9	.	.	PUNCT
aji-39	401	1	mitiku	mitiku	PROPN
aji-39	401	2	k	k	PROPN
aji-39	401	3	,	,	PUNCT
aji-39	401	4	bedada	bedada	PROPN
aji-39	401	5	t	t	PROPN
aji-39	401	6	,	,	PUNCT
aji-39	401	7	masresha	masresha	PROPN
aji-39	401	8	b	b	PROPN
aji-39	401	9	,	,	PUNCT
aji-39	401	10	kegne	kegne	PROPN
aji-39	401	11	w	w	PROPN
aji-39	401	12	,	,	PUNCT
aji-39	401	13	nafo	nafo	NOUN
aji-39	401	14	-	-	PUNCT
aji-39	401	15	traore	traore	NOUN
aji-39	401	16	f	f	NOUN
aji-39	401	17	,	,	PUNCT
aji-39	401	18	tesfaye	tesfaye	VERB
aji-39	401	19	n	n	CCONJ
aji-39	401	20	,	,	PUNCT
aji-39	401	21	et	et	PROPN
aji-39	401	22	al	al	PROPN
aji-39	401	23	.	.	PUNCT
aji-39	402	1	the	the	DET
aji-39	402	2	epidemiology	epidemiology	NOUN
aji-39	402	3	of	of	ADP
aji-39	402	4	rubella	rubella	NOUN
aji-39	402	5	disease	disease	NOUN
aji-39	402	6	in	in	ADP
aji-39	402	7	ethiopia	ethiopia	PROPN
aji-39	402	8	:	:	PUNCT
aji-39	402	9	data	datum	NOUN
aji-39	402	10	from	from	ADP
aji-39	402	11	the	the	DET
aji-39	402	12	measles	measle	NOUN
aji-39	402	13	casebased	casebase	VERB
aji-39	402	14	surveillance	surveillance	NOUN
aji-39	402	15	system	system	NOUN
aji-39	402	16	.	.	PUNCT
aji-39	403	1	journal	journal	NOUN
aji-39	403	2	of	of	ADP
aji-39	403	3	infectious	infectious	ADJ
aji-39	403	4	diseases	disease	NOUN
aji-39	403	5	.	.	PUNCT
aji-39	404	1	2011;204(suppl	2011;204(suppl	NUM
aji-39	404	2	1	1	NUM
aji-39	404	3	):	):	PUNCT
aji-39	404	4	s239	s239	PROPN
aji-39	404	5	–	–	PUNCT
aji-39	404	6	s242	s242	PROPN
aji-39	404	7	.	.	PUNCT
aji-39	404	8	doi	doi	NOUN
aji-39	404	9	:	:	PUNCT
aji-39	404	10	10.1093	10.1093	NUM
aji-39	404	11	/	/	SYM
aji-39	404	12	infdis	infdis	PROPN
aji-39	404	13	/	/	SYM
aji-39	404	14	jir120	jir120	PROPN
aji-39	404	15	30	30	NUM
aji-39	404	16	.	.	PUNCT
aji-39	405	1	mwambe	mwambe	PROPN
aji-39	405	2	b	b	PROPN
aji-39	405	3	,	,	PUNCT
aji-39	405	4	mirambo	mirambo	PROPN
aji-39	405	5	m	m	PROPN
aji-39	405	6	,	,	PUNCT
aji-39	405	7	mshana	mshana	NOUN
aji-39	405	8	s	s	PROPN
aji-39	405	9	,	,	PUNCT
aji-39	405	10	massinde	massinde	VERB
aji-39	405	11	an	an	DET
aji-39	405	12	,	,	PUNCT
aji-39	405	13	kidenya	kidenya	PROPN
aji-39	405	14	br	br	PROPN
aji-39	405	15	,	,	PUNCT
aji-39	405	16	michael	michael	PROPN
aji-39	405	17	d	d	PROPN
aji-39	405	18	,	,	PUNCT
aji-39	405	19	et	et	PROPN
aji-39	405	20	al	al	PROPN
aji-39	405	21	.	.	PROPN
aji-39	405	22	seropositivity	seropositivity	PROPN
aji-39	405	23	rate	rate	NOUN
aji-39	405	24	of	of	ADP
aji-39	405	25	rubella	rubella	NOUN
aji-39	405	26	and	and	CCONJ
aji-39	405	27	associated	associated	ADJ
aji-39	405	28	factors	factor	NOUN
aji-39	405	29	among	among	ADP
aji-39	405	30	pregnant	pregnant	ADJ
aji-39	405	31	women	woman	NOUN
aji-39	405	32	attending	attend	VERB
aji-39	405	33	antenatal	antenatal	ADJ
aji-39	405	34	clinics	clinic	NOUN
aji-39	405	35	in	in	ADP
aji-39	405	36	mwanza	mwanza	PROPN
aji-39	405	37	,	,	PUNCT
aji-39	405	38	tanzania	tanzania	PROPN
aji-39	405	39	.	.	PUNCT
aji-39	406	1	bmc	bmc	PROPN
aji-39	406	2	pregnancy	pregnancy	NOUN
aji-39	406	3	childbirth	childbirth	NOUN
aji-39	406	4	.	.	PUNCT
aji-39	407	1	2014;14:95	2014;14:95	NUM
aji-39	407	2	-	-	SYM
aji-39	407	3	102	102	NUM
aji-39	407	4	.	.	PUNCT
aji-39	408	1	31	31	NUM
aji-39	408	2	.	.	PUNCT
aji-39	409	1	ogbonnaya	ogbonnaya	PROPN
aji-39	409	2	ec	ec	PROPN
aji-39	409	3	,	,	PUNCT
aji-39	409	4	chinedum	chinedum	PROPN
aji-39	409	5	ek	ek	PROPN
aji-39	409	6	,	,	PUNCT
aji-39	409	7	john	john	PROPN
aji-39	409	8	a	a	PROPN
aji-39	409	9	,	,	PUNCT
aji-39	409	10	esther	esther	PROPN
aji-39	409	11	a.	a.	NOUN
aji-39	409	12	survey	survey	NOUN
aji-39	409	13	of	of	ADP
aji-39	409	14	the	the	DET
aji-39	409	15	seroprevalence	seroprevalence	NOUN
aji-39	409	16	of	of	ADP
aji-39	409	17	igm	igm	PROPN
aji-39	409	18	antibodies	antibodie	VERB
aji-39	409	19	in	in	ADP
aji-39	409	20	pregnant	pregnant	ADJ
aji-39	409	21	women	woman	NOUN
aji-39	409	22	infected	infect	VERB
aji-39	409	23	with	with	ADP
aji-39	409	24	rubella	rubella	NOUN
aji-39	409	25	virus	virus	NOUN
aji-39	409	26	.	.	PUNCT
aji-39	410	1	j	j	PROPN
aji-39	410	2	biotechnol	biotechnol	PROPN
aji-39	410	3	pharm	pharm	NOUN
aji-39	410	4	res	re	NOUN
aji-39	410	5	.	.	PUNCT
aji-39	411	1	2012;3:10–14	2012;3:10–14	NUM
aji-39	411	2	.	.	NOUN
aji-39	412	1	32	32	NUM
aji-39	412	2	.	.	PUNCT
aji-39	412	3	onakewhor	onakewhor	PROPN
aji-39	412	4	ju	ju	PROPN
aji-39	412	5	,	,	PUNCT
aji-39	412	6	chiwuzie	chiwuzie	PROPN
aji-39	412	7	j.	j.	PROPN
aji-39	412	8	seroprevalence	seroprevalence	PROPN
aji-39	412	9	survey	survey	NOUN
aji-39	412	10	of	of	ADP
aji-39	412	11	rubella	rubella	NOUN
aji-39	412	12	infection	infection	NOUN
aji-39	412	13	in	in	ADP
aji-39	412	14	pregnancy	pregnancy	NOUN
aji-39	412	15	at	at	ADP
aji-39	412	16	the	the	DET
aji-39	412	17	university	university	PROPN
aji-39	412	18	of	of	ADP
aji-39	412	19	benin	benin	PROPN
aji-39	412	20	teaching	teaching	NOUN
aji-39	412	21	hospital	hospital	PROPN
aji-39	412	22	,	,	PUNCT
aji-39	412	23	benin	benin	PROPN
aji-39	412	24	city	city	PROPN
aji-39	412	25	,	,	PUNCT
aji-39	412	26	nigeria	nigeria	PROPN
aji-39	412	27	.	.	PUNCT
aji-39	413	1	nigerian	nigerian	PROPN
aji-39	413	2	journal	journal	PROPN
aji-39	413	3	of	of	ADP
aji-39	413	4	clinical	clinical	ADJ
aji-39	413	5	practice	practice	NOUN
aji-39	413	6	.	.	PUNCT
aji-39	414	1	2011	2011	NUM
aji-39	414	2	;	;	PUNCT
aji-39	414	3	14(2):140–145	14(2):140–145	PROPN
aji-39	414	4	doi	doi	NOUN
aji-39	414	5	:	:	PUNCT
aji-39	414	6	10.4103/1119	10.4103/1119	NUM
aji-39	414	7	-	-	SYM
aji-39	414	8	3077.84002	3077.84002	NUM
aji-39	414	9	33	33	NUM
aji-39	414	10	.	.	PUNCT
aji-39	415	1	fokunang	fokunang	PROPN
aji-39	415	2	cn	cn	PROPN
aji-39	415	3	,	,	PUNCT
aji-39	415	4	chia	chia	PROPN
aji-39	415	5	j	j	PROPN
aji-39	415	6	,	,	PUNCT
aji-39	415	7	ndumbe	ndumbe	VERB
aji-39	415	8	p	p	NOUN
aji-39	415	9	,	,	PUNCT
aji-39	415	10	mbu	mbu	PROPN
aji-39	415	11	p	p	PROPN
aji-39	415	12	,	,	PUNCT
aji-39	415	13	atashili	atashili	PROPN
aji-39	415	14	j.	j.	PROPN
aji-39	415	15	clinical	clinical	PROPN
aji-39	415	16	studies	study	NOUN
aji-39	415	17	on	on	ADP
aji-39	415	18	seroprevalence	seroprevalence	NOUN
aji-39	415	19	of	of	ADP
aji-39	415	20	rubella	rubella	NOUN
aji-39	415	21	virus	virus	NOUN
aji-39	415	22	in	in	ADP
aji-39	415	23	pregnant	pregnant	ADJ
aji-39	415	24	women	woman	NOUN
aji-39	415	25	of	of	ADP
aji-39	415	26	cameroon	cameroon	NOUN
aji-39	415	27	regions	region	NOUN
aji-39	415	28	afr	afr	PROPN
aji-39	415	29	j	j	PROPN
aji-39	415	30	clin	clin	PROPN
aji-39	415	31	exp	exp	PROPN
aji-39	415	32	microbiol	microbiol	PROPN
aji-39	415	33	.	.	PUNCT
aji-39	416	1	2010;11(2):79	2010;11(2):79	NUM
aji-39	416	2	94	94	NUM
aji-39	416	3	.	.	PUNCT
aji-39	417	1	_	_	PUNCT
aji-39	418	1	_	_	PUNCT
aji-39	419	1	_	_	PUNCT
aji-39	420	1	_	_	PUNCT
aji-39	421	1	_	_	PUNCT
aji-39	422	1	_	_	PUNCT
aji-39	423	1	_	_	PUNCT
aji-39	424	1	_	_	PUNCT
aji-39	425	1	_	_	PUNCT
aji-39	426	1	_	_	PUNCT
aji-39	427	1	_	_	PUNCT
aji-39	428	1	_	_	PUNCT
aji-39	429	1	_	_	PUNCT
aji-39	430	1	_	_	PUNCT
aji-39	431	1	_	_	PUNCT
aji-39	432	1	_	_	PUNCT
aji-39	433	1	_	_	PUNCT
aji-39	434	1	_	_	PUNCT
aji-39	435	1	_	_	PUNCT
aji-39	436	1	_	_	PUNCT
aji-39	437	1	_	_	PUNCT
aji-39	438	1	_	_	PUNCT
aji-39	439	1	_	_	PUNCT
aji-39	440	1	_	_	PUNCT
aji-39	441	1	_	_	PUNCT
aji-39	442	1	_	_	PUNCT
aji-39	443	1	_	_	PUNCT
aji-39	444	1	_	_	PUNCT
aji-39	445	1	_	_	PUNCT
aji-39	446	1	_	_	PUNCT
aji-39	447	1	_	_	PUNCT
aji-39	448	1	_	_	PUNCT
aji-39	449	1	_	_	PUNCT
aji-39	450	1	_	_	PUNCT
aji-39	451	1	_	_	PUNCT
aji-39	452	1	_	_	PUNCT
aji-39	453	1	_	_	PUNCT
aji-39	454	1	_	_	PUNCT
aji-39	455	1	_	_	PUNCT
aji-39	456	1	_	_	PUNCT
aji-39	457	1	_	_	PUNCT
aji-39	458	1	_	_	PUNCT
aji-39	459	1	_	_	PUNCT
aji-39	460	1	_	_	PUNCT
aji-39	461	1	_	_	PUNCT
aji-39	462	1	_	_	PUNCT
aji-39	463	1	_	_	PUNCT
aji-39	464	1	_	_	PUNCT
aji-39	465	1	_	_	PUNCT
aji-39	466	1	_	_	PUNCT
aji-39	467	1	_	_	PUNCT
aji-39	468	1	_	_	PUNCT
aji-39	469	1	_	_	PUNCT
aji-39	470	1	_	_	PUNCT
aji-39	471	1	_	_	PUNCT
aji-39	472	1	_	_	PUNCT
aji-39	473	1	_	_	PUNCT
aji-39	474	1	_	_	PUNCT
aji-39	475	1	_	_	PUNCT
aji-39	476	1	_	_	PUNCT
aji-39	477	1	_	_	PUNCT
aji-39	478	1	_	_	PUNCT
aji-39	479	1	_	_	PUNCT
aji-39	480	1	_	_	PUNCT
aji-39	481	1	_	_	PUNCT
aji-39	482	1	_	_	PUNCT
aji-39	483	1	_	_	PUNCT
aji-39	484	1	_	_	PUNCT
aji-39	485	1	_	_	PUNCT
aji-39	486	1	_	_	PUNCT
aji-39	487	1	_	_	PUNCT
aji-39	488	1	_	_	PUNCT
aji-39	489	1	_	_	PUNCT
aji-39	490	1	_	_	PUNCT
aji-39	491	1	_	_	PUNCT
aji-39	492	1	_	_	PUNCT
aji-39	493	1	_	_	PUNCT
aji-39	494	1	_	_	PUNCT
aji-39	495	1	_	_	PUNCT
aji-39	496	1	_	_	PUNCT
aji-39	497	1	_	_	PUNCT
aji-39	498	1	©	©	ADP
aji-39	498	2	2020	2020	NUM
aji-39	498	3	akele	akele	PROPN
aji-39	498	4	et	et	PROPN
aji-39	498	5	al	al	PROPN
aji-39	498	6	.	.	PROPN
aji-39	498	7	;	;	PUNCT
aji-39	498	8	this	this	PRON
aji-39	498	9	is	be	AUX
aji-39	498	10	an	an	DET
aji-39	498	11	open	open	ADJ
aji-39	498	12	access	access	NOUN
aji-39	498	13	article	article	NOUN
aji-39	498	14	distributed	distribute	VERB
aji-39	498	15	under	under	ADP
aji-39	498	16	the	the	DET
aji-39	498	17	terms	term	NOUN
aji-39	498	18	of	of	ADP
aji-39	498	19	the	the	DET
aji-39	498	20	creative	creative	ADJ
aji-39	498	21	commons	common	NOUN
aji-39	498	22	attribution	attribution	NOUN
aji-39	498	23	license	license	NOUN
aji-39	498	24	(	(	PUNCT
aji-39	498	25	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-39	498	26	)	)	PUNCT
aji-39	498	27	,	,	PUNCT
aji-39	498	28	which	which	PRON
aji-39	498	29	permits	permit	VERB
aji-39	498	30	unrestricted	unrestricted	ADJ
aji-39	498	31	use	use	NOUN
aji-39	498	32	,	,	PUNCT
aji-39	498	33	distribution	distribution	NOUN
aji-39	498	34	,	,	PUNCT
aji-39	498	35	and	and	CCONJ
aji-39	498	36	reproduction	reproduction	NOUN
aji-39	498	37	in	in	ADP
aji-39	498	38	any	any	DET
aji-39	498	39	medium	medium	NOUN
aji-39	498	40	,	,	PUNCT
aji-39	498	41	provided	provide	VERB
aji-39	498	42	the	the	DET
aji-39	498	43	original	original	ADJ
aji-39	498	44	work	work	NOUN
aji-39	498	45	is	be	AUX
aji-39	498	46	properly	properly	ADV
aji-39	498	47	cited	cite	VERB
aji-39	498	48	.	.	PUNCT
aji-39	499	1	peer	peer	NOUN
aji-39	499	2	-	-	PUNCT
aji-39	499	3	review	review	NOUN
aji-39	499	4	history	history	NOUN
aji-39	499	5	:	:	PUNCT
aji-39	499	6	the	the	DET
aji-39	499	7	peer	peer	NOUN
aji-39	499	8	review	review	NOUN
aji-39	499	9	history	history	NOUN
aji-39	499	10	for	for	ADP
aji-39	499	11	this	this	DET
aji-39	499	12	paper	paper	NOUN
aji-39	499	13	can	can	AUX
aji-39	499	14	be	be	AUX
aji-39	499	15	accessed	access	VERB
aji-39	499	16	here	here	ADV
aji-39	499	17	:	:	PUNCT
aji-39	499	18	http://www.sdiarticle4.com/review-history/57099	http://www.sdiarticle4.com/review-history/57099	PROPN
aji-39	499	19	https://doi.org/10.11604/pamj.21/01/2019.artvol.artissue.13335	https://doi.org/10.11604/pamj.21/01/2019.artvol.artissue.13335	PUNCT
aji-39	500	1	https://doi.org/10.11604/pamj.21/01/2019.artvol.artissue.13335	https://doi.org/10.11604/pamj.21/01/2019.artvol.artissue.13335	NUM
aji-39	500	2	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	PROPN
aji-39	500	3	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	PROPN
aji-39	501	1	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	PROPN
aji-39	502	1	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5594209/	PROPN
aji-39	503	1	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	X